DXC Technology Co00016885683/312021Q2Falseus-gaap:AccountingStandardsUpdate201613MemberP1YP1YP3Yus-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationus-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationus-gaap:DebtCurrentus-gaap:DebtCurrentus-gaap:LongTermDebtNoncurrentus-gaap:LongTermDebtNoncurrent600016885682020-04-012020-09-300001688568us-gaap:CommonStockMember2020-04-012020-09-300001688568dxc:SeniorNotesDue2025OneMember2020-04-012020-09-300001688568dxc:SeniorNotesDue2026OneMember2020-04-012020-09-30xbrli:shares00016885682020-10-30iso4217:USD00016885682020-07-012020-09-3000016885682019-07-012019-09-3000016885682019-04-012019-09-30iso4217:USDxbrli:shares00016885682020-09-3000016885682020-03-3100016885682019-03-3100016885682019-09-300001688568us-gaap:CommonStockMember2020-06-300001688568us-gaap:AdditionalPaidInCapitalMember2020-06-300001688568us-gaap:RetainedEarningsMember2020-06-300001688568us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001688568us-gaap:TreasuryStockMember2020-06-300001688568us-gaap:ParentMember2020-06-300001688568us-gaap:NoncontrollingInterestMember2020-06-3000016885682020-06-300001688568us-gaap:RetainedEarningsMember2020-07-012020-09-300001688568us-gaap:ParentMember2020-07-012020-09-300001688568us-gaap:NoncontrollingInterestMember2020-07-012020-09-300001688568us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300001688568us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300001688568us-gaap:TreasuryStockMember2020-07-012020-09-300001688568us-gaap:CommonStockMember2020-07-012020-09-300001688568us-gaap:CommonStockMember2020-09-300001688568us-gaap:AdditionalPaidInCapitalMember2020-09-300001688568us-gaap:RetainedEarningsMember2020-09-300001688568us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300001688568us-gaap:TreasuryStockMember2020-09-300001688568us-gaap:ParentMember2020-09-300001688568us-gaap:NoncontrollingInterestMember2020-09-300001688568us-gaap:CommonStockMember2019-06-300001688568us-gaap:AdditionalPaidInCapitalMember2019-06-300001688568us-gaap:RetainedEarningsMember2019-06-300001688568us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-300001688568us-gaap:TreasuryStockMember2019-06-300001688568us-gaap:ParentMember2019-06-300001688568us-gaap:NoncontrollingInterestMember2019-06-3000016885682019-06-300001688568us-gaap:RetainedEarningsMember2019-07-012019-09-300001688568us-gaap:ParentMember2019-07-012019-09-300001688568us-gaap:NoncontrollingInterestMember2019-07-012019-09-300001688568us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-07-012019-09-300001688568us-gaap:AdditionalPaidInCapitalMember2019-07-012019-09-300001688568us-gaap:TreasuryStockMember2019-07-012019-09-300001688568us-gaap:CommonStockMember2019-07-012019-09-300001688568us-gaap:CommonStockMember2019-09-300001688568us-gaap:AdditionalPaidInCapitalMember2019-09-300001688568us-gaap:RetainedEarningsMember2019-09-300001688568us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-300001688568us-gaap:TreasuryStockMember2019-09-300001688568us-gaap:ParentMember2019-09-300001688568us-gaap:NoncontrollingInterestMember2019-09-300001688568us-gaap:CommonStockMember2020-03-310001688568us-gaap:AdditionalPaidInCapitalMember2020-03-310001688568us-gaap:RetainedEarningsMember2020-03-310001688568us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001688568us-gaap:TreasuryStockMember2020-03-310001688568us-gaap:ParentMember2020-03-310001688568us-gaap:NoncontrollingInterestMember2020-03-3100016885682019-04-012020-03-310001688568us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-03-310001688568us-gaap:ParentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-03-310001688568srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-03-310001688568us-gaap:RetainedEarningsMember2020-04-012020-09-300001688568us-gaap:ParentMember2020-04-012020-09-300001688568us-gaap:NoncontrollingInterestMember2020-04-012020-09-300001688568us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-09-300001688568us-gaap:AdditionalPaidInCapitalMember2020-04-012020-09-300001688568us-gaap:TreasuryStockMember2020-04-012020-09-300001688568us-gaap:CommonStockMember2020-04-012020-09-300001688568us-gaap:CommonStockMember2019-03-310001688568us-gaap:AdditionalPaidInCapitalMember2019-03-310001688568us-gaap:RetainedEarningsMember2019-03-310001688568us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-310001688568us-gaap:TreasuryStockMember2019-03-310001688568us-gaap:ParentMember2019-03-310001688568us-gaap:NoncontrollingInterestMember2019-03-310001688568us-gaap:RetainedEarningsMember2019-04-012019-09-300001688568us-gaap:ParentMember2019-04-012019-09-300001688568us-gaap:NoncontrollingInterestMember2019-04-012019-09-300001688568us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-04-012019-09-300001688568us-gaap:AdditionalPaidInCapitalMember2019-04-012019-09-300001688568us-gaap:TreasuryStockMember2019-04-012019-09-300001688568us-gaap:CommonStockMember2019-04-012019-09-300001688568dxc:HumanServicesBusinessMemberus-gaap:SubsequentEventMember2020-10-01iso4217:EUR0001688568dxc:HPSBusinessMembersrt:ScenarioForecastMember2020-10-012021-03-310001688568dxc:LuxoftHoldingInc.Member2019-06-142019-06-14xbrli:pure0001688568dxc:LuxoftHoldingInc.Member2019-06-140001688568dxc:LuxoftHoldingInc.Memberus-gaap:CustomerRelatedIntangibleAssetsMember2019-06-142019-06-140001688568us-gaap:TradeNamesMemberdxc:LuxoftHoldingInc.Member2019-06-142019-06-140001688568dxc:LuxoftHoldingInc.Memberdxc:ComputerSoftwareIntangibleAssetDevelopedTechnologyMember2019-06-142019-06-140001688568dxc:LuxoftHoldingInc.Memberdxc:ComputerSoftwareIntangibleAssetThirdPartyPurchasedSoftwareMember2019-06-142019-06-140001688568us-gaap:DiscontinuedOperationsHeldforsaleMemberdxc:HumanServicesBusinessMember2020-09-300001688568us-gaap:EmployeeStockOptionMember2020-07-012020-09-300001688568us-gaap:EmployeeStockOptionMember2019-07-012019-09-300001688568us-gaap:EmployeeStockOptionMember2020-04-012020-09-300001688568us-gaap:EmployeeStockOptionMember2019-04-012019-09-300001688568us-gaap:RestrictedStockUnitsRSUMember2020-07-012020-09-300001688568us-gaap:RestrictedStockUnitsRSUMember2019-07-012019-09-300001688568us-gaap:RestrictedStockUnitsRSUMember2020-04-012020-09-300001688568us-gaap:RestrictedStockUnitsRSUMember2019-04-012019-09-300001688568us-gaap:PerformanceSharesMember2020-07-012020-09-300001688568us-gaap:PerformanceSharesMember2019-07-012019-09-300001688568us-gaap:PerformanceSharesMember2020-04-012020-09-300001688568us-gaap:PerformanceSharesMember2019-04-012019-09-300001688568dxc:PurchasersMember2020-06-300001688568dxc:PurchasersMember2020-09-30dxc:extension0001688568dxc:PurchasersMember2020-04-012020-09-300001688568dxc:PurchasersMember2019-06-300001688568dxc:PurchasersMember2019-03-310001688568dxc:PurchasersMember2019-07-012019-09-300001688568dxc:PurchasersMember2019-04-012019-09-300001688568dxc:PurchasersMember2019-09-300001688568dxc:MilanoPurchasersMember2020-09-300001688568dxc:MilanoPurchasersMember2020-04-012020-09-300001688568dxc:DEPurchasersMember2020-09-300001688568dxc:DEPurchasersMember2020-03-310001688568dxc:DEPurchasersMember2020-04-012020-09-300001688568srt:MinimumMember2020-04-012020-09-300001688568srt:MaximumMember2020-04-012020-09-300001688568us-gaap:RealEstateMember2020-09-300001688568us-gaap:EquipmentMember2020-09-300001688568us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2020-09-300001688568us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2020-09-300001688568us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2020-09-300001688568us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMember2020-09-300001688568us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300001688568us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-09-300001688568us-gaap:FairValueInputsLevel2Memberus-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300001688568us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-09-300001688568us-gaap:FairValueMeasurementsRecurringMember2020-09-300001688568us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-09-300001688568us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-09-300001688568us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-09-300001688568us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2020-03-310001688568us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2020-03-310001688568us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2020-03-310001688568us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMember2020-03-310001688568us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001688568us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-03-310001688568us-gaap:FairValueInputsLevel2Memberus-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001688568us-gaap:BankTimeDepositsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-03-310001688568us-gaap:FairValueMeasurementsRecurringMember2020-03-310001688568us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-03-310001688568us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001688568us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-03-310001688568us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-09-300001688568us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-03-310001688568us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-09-300001688568us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-03-310001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2020-09-300001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2020-03-310001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2020-07-012020-09-300001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2020-04-012020-09-300001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2019-07-012019-09-300001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2019-04-012019-09-300001688568us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2020-09-300001688568us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2020-03-310001688568us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:OtherOperatingIncomeExpenseMember2020-07-012020-09-300001688568us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:OtherOperatingIncomeExpenseMember2019-07-012019-09-300001688568us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:OtherOperatingIncomeExpenseMember2020-04-012020-09-300001688568us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:OtherOperatingIncomeExpenseMember2019-04-012019-09-300001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueHedgingMember2020-09-300001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueHedgingMember2020-03-310001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2020-09-300001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2020-03-310001688568us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2020-09-300001688568us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2020-03-310001688568us-gaap:NondesignatedMember2020-09-300001688568us-gaap:NondesignatedMember2020-03-310001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberdxc:AccruedExpensesAndOtherCurrentLiabilitiesMemberus-gaap:FairValueHedgingMember2020-09-300001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberdxc:AccruedExpensesAndOtherCurrentLiabilitiesMemberus-gaap:FairValueHedgingMember2020-03-310001688568us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberdxc:AccruedExpensesAndOtherCurrentLiabilitiesMember2020-09-300001688568us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberdxc:AccruedExpensesAndOtherCurrentLiabilitiesMember2020-03-31dxc:counterparty0001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberdxc:ForeignCurrencyDenominatedDebtMember2020-09-300001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberdxc:ForeignCurrencyDenominatedDebtMember2020-03-310001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberdxc:ForeignCurrencyDenominatedDebtMember2020-07-012020-09-300001688568us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberdxc:ForeignCurrencyDenominatedDebtMember2020-04-012020-09-300001688568us-gaap:ComputerSoftwareIntangibleAssetMember2020-09-300001688568us-gaap:CustomerRelatedIntangibleAssetsMember2020-09-300001688568us-gaap:OtherIntangibleAssetsMember2020-09-300001688568us-gaap:ComputerSoftwareIntangibleAssetMember2020-03-310001688568us-gaap:CustomerRelatedIntangibleAssetsMember2020-03-310001688568us-gaap:OtherIntangibleAssetsMember2020-03-310001688568dxc:IntangibleAssetsOtherThanTransitionAndTransformationContractCostsMember2020-07-012020-09-300001688568dxc:IntangibleAssetsOtherThanTransitionAndTransformationContractCostsMember2019-07-012019-09-300001688568dxc:IntangibleAssetsOtherThanTransitionAndTransformationContractCostsMember2020-04-012020-09-300001688568dxc:IntangibleAssetsOtherThanTransitionAndTransformationContractCostsMember2019-04-012019-09-300001688568dxc:TransitionAndTransformationContractCostsMember2020-07-012020-09-300001688568dxc:TransitionAndTransformationContractCostsMember2019-07-012019-09-300001688568dxc:TransitionAndTransformationContractCostsMember2020-04-012020-09-300001688568dxc:TransitionAndTransformationContractCostsMember2019-04-012019-09-300001688568dxc:GBSSegmentMember2020-03-310001688568dxc:GISSegmentMember2020-03-310001688568dxc:GBSSegmentMember2020-04-012020-09-300001688568dxc:GISSegmentMember2020-04-012020-09-300001688568dxc:GBSSegmentMember2020-09-300001688568dxc:GISSegmentMember2020-09-300001688568us-gaap:CommercialPaperMembersrt:MinimumMember2020-09-300001688568us-gaap:CommercialPaperMembersrt:MaximumMember2020-09-300001688568dxc:FinanceLeaseLiabilityCurrentMembersrt:MinimumMember2020-09-300001688568dxc:FinanceLeaseLiabilityNoncurrentMembersrt:MinimumMember2020-09-300001688568dxc:FinanceLeaseLiabilityNoncurrentMembersrt:MaximumMember2020-09-300001688568dxc:FinanceLeaseLiabilityCurrentMembersrt:MaximumMember2020-09-300001688568dxc:TermLoanPayableAUDDue2022Memberus-gaap:NotesPayableToBanksMembersrt:MinimumMember2020-09-300001688568dxc:TermLoanPayableAUDDue2022Memberus-gaap:NotesPayableToBanksMembersrt:MaximumMember2020-09-300001688568dxc:TermLoanPayableAUDDue2022Memberus-gaap:NotesPayableToBanksMember2020-09-300001688568dxc:TermLoanPayableAUDDue2022Memberus-gaap:NotesPayableToBanksMember2020-03-310001688568dxc:TermLoanPayableGBPDue2022Memberus-gaap:NotesPayableToBanksMembersrt:MinimumMember2020-09-300001688568dxc:TermLoanPayableGBPDue2022Memberus-gaap:NotesPayableToBanksMembersrt:MaximumMember2020-09-300001688568dxc:TermLoanPayableGBPDue2022Memberus-gaap:NotesPayableToBanksMember2020-09-300001688568dxc:TermLoanPayableGBPDue2022Memberus-gaap:NotesPayableToBanksMember2020-03-310001688568dxc:TermLoanPayableEURDue20222023Memberus-gaap:NotesPayableToBanksMember2020-09-300001688568dxc:TermLoanPayableEURDue20222023Memberus-gaap:NotesPayableToBanksMember2020-03-310001688568dxc:TermLoanPayableEURDue20232024Memberus-gaap:NotesPayableToBanksMember2020-09-300001688568dxc:TermLoanPayableEURDue20232024Memberus-gaap:NotesPayableToBanksMember2020-03-310001688568dxc:TermLoanPayableUSDDue2025Memberus-gaap:NotesPayableToBanksMembersrt:MinimumMember2020-09-300001688568dxc:TermLoanPayableUSDDue2025Memberus-gaap:NotesPayableToBanksMembersrt:MaximumMember2020-09-300001688568dxc:TermLoanPayableUSDDue2025Memberus-gaap:NotesPayableToBanksMember2020-09-300001688568dxc:TermLoanPayableUSDDue2025Memberus-gaap:NotesPayableToBanksMember2020-03-310001688568dxc:SeniorNotesDue2023Memberus-gaap:SeniorNotesMember2020-09-300001688568dxc:SeniorNotesDue2023Memberus-gaap:SeniorNotesMember2020-03-310001688568dxc:SeniorNotesDue2023TwoMemberus-gaap:SeniorNotesMember2020-09-300001688568dxc:SeniorNotesDue2023TwoMemberus-gaap:SeniorNotesMember2020-03-310001688568dxc:SeniorNotesDue2025Memberus-gaap:SeniorNotesMember2020-09-300001688568dxc:SeniorNotesDue2025Memberus-gaap:SeniorNotesMember2020-03-310001688568dxc:SeniorNotesDue2024Memberus-gaap:SeniorNotesMember2020-09-300001688568dxc:SeniorNotesDue2024Memberus-gaap:SeniorNotesMember2020-03-310001688568dxc:SeniorNotesDue2026TwoMemberus-gaap:SeniorNotesMember2020-09-300001688568dxc:SeniorNotesDue2026TwoMemberus-gaap:SeniorNotesMember2020-03-31iso4217:GBP0001688568us-gaap:SeniorNotesMemberdxc:SeniorNotesDue2025OneMember2020-09-300001688568us-gaap:SeniorNotesMemberdxc:SeniorNotesDue2025OneMember2020-03-310001688568dxc:SeniorNotesDue2026OneMemberus-gaap:SeniorNotesMember2020-09-300001688568dxc:SeniorNotesDue2026OneMemberus-gaap:SeniorNotesMember2020-03-310001688568dxc:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2020-09-300001688568dxc:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2020-03-310001688568us-gaap:SeniorNotesMemberdxc:SeniorNotesDue2030Member2020-09-300001688568us-gaap:SeniorNotesMemberdxc:SeniorNotesDue2030Member2020-03-310001688568us-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2020-09-300001688568us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2020-09-300001688568us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-09-300001688568us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-03-310001688568dxc:LeaseCreditFacilityVariousMemberus-gaap:SecuredDebtMembersrt:MinimumMember2020-09-300001688568dxc:LeaseCreditFacilityVariousMemberus-gaap:SecuredDebtMembersrt:MaximumMember2020-09-300001688568dxc:LeaseCreditFacilityVariousMemberus-gaap:SecuredDebtMember2020-09-300001688568dxc:LeaseCreditFacilityVariousMemberus-gaap:SecuredDebtMember2020-03-310001688568dxc:BorrowingsForAssetsAcquiredUnderLongTermFinancingMembersrt:MinimumMember2020-09-300001688568dxc:BorrowingsForAssetsAcquiredUnderLongTermFinancingMembersrt:MaximumMember2020-09-300001688568dxc:BorrowingsForAssetsAcquiredUnderLongTermFinancingMember2020-09-300001688568dxc:BorrowingsForAssetsAcquiredUnderLongTermFinancingMember2020-03-310001688568us-gaap:MandatorilyRedeemablePreferredStockMember2020-09-300001688568us-gaap:MandatorilyRedeemablePreferredStockMember2020-03-310001688568us-gaap:NotesPayableOtherPayablesMember2020-09-300001688568us-gaap:NotesPayableOtherPayablesMember2020-03-310001688568us-gaap:CommercialPaperMember2020-09-300001688568us-gaap:CommercialPaperMember2020-04-012020-09-300001688568dxc:TermLoanPayableAUDDue2022Memberdxc:BankBillSwapRateMemberus-gaap:NotesPayableToBanksMembersrt:MinimumMember2020-04-012020-09-300001688568dxc:TermLoanPayableAUDDue2022Memberdxc:BankBillSwapRateMemberus-gaap:NotesPayableToBanksMembersrt:MaximumMember2020-04-012020-09-300001688568dxc:TermLoanPayableEURDue20222023Memberdxc:EURIBORMemberus-gaap:NotesPayableToBanksMembersrt:MinimumMember2020-04-012020-09-300001688568dxc:TermLoanPayableEURDue20222023Memberdxc:EURIBORMemberus-gaap:NotesPayableToBanksMembersrt:MaximumMember2020-04-012020-09-300001688568dxc:TermLoanPayableEURDue20232024Memberdxc:EURIBORMemberus-gaap:NotesPayableToBanksMembersrt:MinimumMember2020-04-012020-09-300001688568dxc:TermLoanPayableEURDue20232024Memberdxc:EURIBORMemberus-gaap:NotesPayableToBanksMembersrt:MaximumMember2020-04-012020-09-300001688568dxc:TermLoanPayableUSDDue2025Memberdxc:EURIBORMemberus-gaap:NotesPayableToBanksMembersrt:MinimumMember2020-04-012020-09-300001688568dxc:TermLoanPayableUSDDue2025Memberdxc:EURIBORMemberus-gaap:NotesPayableToBanksMembersrt:MaximumMember2020-04-012020-09-300001688568us-gaap:BaseRateMemberdxc:TermLoanPayableUSDDue2025Memberus-gaap:NotesPayableToBanksMembersrt:MinimumMember2020-04-012020-09-300001688568us-gaap:BaseRateMemberdxc:TermLoanPayableUSDDue2025Memberus-gaap:NotesPayableToBanksMembersrt:MaximumMember2020-04-012020-09-300001688568dxc:SeniorNotesDue2026TwoandSeniorNotes2024Memberus-gaap:SeniorNotesMember2020-06-300001688568dxc:SeniorNotesDue2024Memberus-gaap:SeniorNotesMember2020-06-300001688568dxc:SeniorNotesDue2026TwoMemberus-gaap:SeniorNotesMember2020-06-300001688568dxc:TermLoanPayableEURDue20222023Memberus-gaap:NotesPayableToBanksMember2020-04-012020-06-300001688568dxc:TermLoanPayableGBPDue2022Memberus-gaap:NotesPayableToBanksMember2020-04-012020-06-30iso4217:AUD0001688568dxc:TermLoanPayableAUDDue2022Memberus-gaap:NotesPayableToBanksMember2020-04-012020-06-300001688568dxc:TermLoanPayableUSDDue2025Memberus-gaap:NotesPayableToBanksMember2020-04-012020-06-300001688568dxc:TermLoanPayableGBPDue2022Memberus-gaap:NotesPayableToBanksMember2020-07-012020-09-300001688568us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-04-012020-06-300001688568us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-04-012020-09-300001688568country:US2020-07-012020-09-300001688568country:US2019-07-012019-09-300001688568country:US2020-04-012020-09-300001688568country:US2019-04-012019-09-300001688568country:GB2020-07-012020-09-300001688568country:GB2019-07-012019-09-300001688568country:GB2020-04-012020-09-300001688568country:GB2019-04-012019-09-300001688568dxc:OtherEuropeMember2020-07-012020-09-300001688568dxc:OtherEuropeMember2019-07-012019-09-300001688568dxc:OtherEuropeMember2020-04-012020-09-300001688568dxc:OtherEuropeMember2019-04-012019-09-300001688568country:AU2020-07-012020-09-300001688568country:AU2019-07-012019-09-300001688568country:AU2020-04-012020-09-300001688568country:AU2019-04-012019-09-300001688568dxc:OtherInternationalMember2020-07-012020-09-300001688568dxc:OtherInternationalMember2019-07-012019-09-300001688568dxc:OtherInternationalMember2020-04-012020-09-300001688568dxc:OtherInternationalMember2019-04-012019-09-3000016885682020-10-012020-09-300001688568dxc:RestructuringPlanFiscal2020PlanMember2020-09-300001688568us-gaap:EmployeeSeveranceMemberdxc:RestructuringPlanFiscal2020PlanMember2020-09-300001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanFiscal2020PlanMember2020-09-300001688568dxc:RestructuringPlanFiscal2019PlanMember2020-09-300001688568us-gaap:EmployeeSeveranceMemberdxc:RestructuringPlanFiscal2019PlanMember2020-09-300001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanFiscal2019PlanMember2020-09-300001688568dxc:RestructuringPlanFiscal2018PlanMember2020-09-300001688568us-gaap:EmployeeSeveranceMemberdxc:RestructuringPlanFiscal2018PlanMember2020-09-300001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanFiscal2018PlanMember2020-09-300001688568dxc:RestructuringPlanFiscal2021PlanMemberus-gaap:EmployeeSeveranceMember2020-03-310001688568dxc:RestructuringPlanFiscal2021PlanMemberus-gaap:EmployeeSeveranceMember2020-04-012020-09-300001688568dxc:RestructuringPlanFiscal2021PlanMemberus-gaap:EmployeeSeveranceMember2020-09-300001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanFiscal2021PlanMember2020-03-310001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanFiscal2021PlanMember2020-04-012020-09-300001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanFiscal2021PlanMember2020-09-300001688568dxc:RestructuringPlanFiscal2021PlanMember2020-03-310001688568dxc:RestructuringPlanFiscal2021PlanMember2020-04-012020-09-300001688568dxc:RestructuringPlanFiscal2021PlanMember2020-09-300001688568us-gaap:EmployeeSeveranceMemberdxc:RestructuringPlanFiscal2020PlanMember2020-03-310001688568us-gaap:EmployeeSeveranceMemberdxc:RestructuringPlanFiscal2020PlanMember2020-04-012020-09-300001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanFiscal2020PlanMember2020-03-310001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanFiscal2020PlanMember2020-04-012020-09-300001688568dxc:RestructuringPlanFiscal2020PlanMember2020-03-310001688568dxc:RestructuringPlanFiscal2020PlanMember2020-04-012020-09-300001688568us-gaap:EmployeeSeveranceMemberdxc:RestructuringPlanFiscal2019PlanMember2020-03-310001688568us-gaap:EmployeeSeveranceMemberdxc:RestructuringPlanFiscal2019PlanMember2020-04-012020-09-300001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanFiscal2019PlanMember2020-03-310001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanFiscal2019PlanMember2020-04-012020-09-300001688568dxc:RestructuringPlanFiscal2019PlanMember2020-03-310001688568dxc:RestructuringPlanFiscal2019PlanMember2020-04-012020-09-300001688568dxc:RestructuringPlanOtherPriorYearPlansMemberus-gaap:EmployeeSeveranceMember2020-03-310001688568dxc:RestructuringPlanOtherPriorYearPlansMemberus-gaap:EmployeeSeveranceMember2020-04-012020-09-300001688568dxc:RestructuringPlanOtherPriorYearPlansMemberus-gaap:EmployeeSeveranceMember2020-09-300001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanOtherPriorYearPlansMember2020-03-310001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanOtherPriorYearPlansMember2020-04-012020-09-300001688568us-gaap:FacilityClosingMemberdxc:RestructuringPlanOtherPriorYearPlansMember2020-09-300001688568dxc:RestructuringPlanOtherPriorYearPlansMember2020-03-310001688568dxc:RestructuringPlanOtherPriorYearPlansMember2020-04-012020-09-300001688568dxc:RestructuringPlanOtherPriorYearPlansMember2020-09-300001688568dxc:AcquiredLiabilitiesMemberus-gaap:EmployeeSeveranceMember2020-03-310001688568dxc:AcquiredLiabilitiesMemberus-gaap:EmployeeSeveranceMember2020-04-012020-09-300001688568dxc:AcquiredLiabilitiesMemberus-gaap:EmployeeSeveranceMember2020-09-300001688568us-gaap:FacilityClosingMemberdxc:AcquiredLiabilitiesMember2020-03-310001688568us-gaap:FacilityClosingMemberdxc:AcquiredLiabilitiesMember2020-04-012020-09-300001688568us-gaap:FacilityClosingMemberdxc:AcquiredLiabilitiesMember2020-09-300001688568dxc:AcquiredLiabilitiesMember2020-03-310001688568dxc:AcquiredLiabilitiesMember2020-04-012020-09-300001688568dxc:AcquiredLiabilitiesMember2020-09-300001688568us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2020-07-012020-09-300001688568us-gaap:PensionPlansDefinedBenefitMember2020-07-012020-09-300001688568us-gaap:PensionPlansDefinedBenefitMember2019-07-012019-09-300001688568us-gaap:PensionPlansDefinedBenefitMember2020-04-012020-09-300001688568us-gaap:PensionPlansDefinedBenefitMember2019-04-012019-09-300001688568srt:DirectorMember2020-04-012020-09-300001688568dxc:HewlettPackardEnterpriseServicesMember2020-09-300001688568dxc:PerspectaMember2020-09-300001688568srt:MinimumMember2020-09-300001688568srt:MaximumMember2020-09-3000016885682017-04-0300016885682018-11-080001688568dxc:OpenMarketPurchasesMember2019-04-012019-06-300001688568dxc:AcceleratedShareRepurchaseAgreementMember2019-04-012019-06-3000016885682019-04-012019-06-300001688568dxc:OpenMarketPurchasesMember2019-07-012019-09-300001688568dxc:AcceleratedShareRepurchaseAgreementMember2019-07-012019-09-300001688568us-gaap:AccumulatedTranslationAdjustmentMember2020-03-310001688568us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-03-310001688568us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-03-310001688568us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-03-310001688568us-gaap:AccumulatedTranslationAdjustmentMember2020-04-012020-09-300001688568us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-04-012020-09-300001688568us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-04-012020-09-300001688568us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-04-012020-09-300001688568us-gaap:AccumulatedTranslationAdjustmentMember2020-09-300001688568us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-09-300001688568us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-09-300001688568us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-300001688568us-gaap:AccumulatedTranslationAdjustmentMember2019-03-310001688568us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-03-310001688568us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-03-310001688568us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-03-310001688568us-gaap:AccumulatedTranslationAdjustmentMember2019-04-012019-09-300001688568us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-04-012019-09-300001688568us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-04-012019-09-300001688568us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-04-012019-09-300001688568us-gaap:AccumulatedTranslationAdjustmentMember2019-09-300001688568us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-09-300001688568us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-09-300001688568us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-09-300001688568us-gaap:RestrictedStockUnitsRSUMember2020-09-30dxc:anniversary0001688568dxc:ServiceBasedRsusMemberus-gaap:RestrictedStockUnitsRSUMember2020-04-012020-09-300001688568us-gaap:PerformanceSharesMember2020-04-012020-09-300001688568dxc:AnniversaryOneMemberus-gaap:RestrictedStockUnitsRSUMember2020-04-012020-09-300001688568dxc:AnniversaryTwoMemberus-gaap:RestrictedStockUnitsRSUMember2020-04-012020-09-300001688568dxc:AnniversaryThreeMemberus-gaap:RestrictedStockUnitsRSUMember2020-04-012020-09-300001688568us-gaap:EmployeeStockMemberdxc:DXCSharePurchasePlanMember2020-07-012020-09-300001688568us-gaap:EmployeeStockMemberdxc:DXCSharePurchasePlanMember2020-04-012020-09-300001688568dxc:DXCEmployeeEquityPlanMember2020-09-300001688568dxc:DXCDirectorEquityPlanMember2020-09-300001688568dxc:DXCSharePurchasePlanMember2020-09-300001688568us-gaap:EmployeeStockOptionMember2020-03-310001688568us-gaap:EmployeeStockOptionMember2019-04-012020-03-310001688568us-gaap:EmployeeStockOptionMember2020-04-012020-09-300001688568us-gaap:EmployeeStockOptionMember2020-09-300001688568dxc:DXCEmployeeEquityPlanMemberus-gaap:RestrictedStockUnitsRSUMember2020-03-310001688568dxc:DXCDirectorEquityPlanMemberus-gaap:RestrictedStockUnitsRSUMember2020-03-310001688568dxc:DXCEmployeeEquityPlanMemberus-gaap:RestrictedStockUnitsRSUMember2020-04-012020-09-300001688568dxc:DXCDirectorEquityPlanMemberus-gaap:RestrictedStockUnitsRSUMember2020-04-012020-09-300001688568dxc:DXCEmployeeEquityPlanMemberus-gaap:RestrictedStockUnitsRSUMember2020-09-300001688568dxc:DXCDirectorEquityPlanMemberus-gaap:RestrictedStockUnitsRSUMember2020-09-300001688568us-gaap:RestrictedStockUnitsRSUMember2020-04-012020-09-300001688568us-gaap:OperatingSegmentsMemberdxc:GBSSegmentMember2020-07-012020-09-300001688568us-gaap:OperatingSegmentsMemberdxc:GISSegmentMember2020-07-012020-09-300001688568us-gaap:OperatingSegmentsMember2020-07-012020-09-300001688568us-gaap:MaterialReconcilingItemsMember2020-07-012020-09-300001688568us-gaap:OperatingSegmentsMemberdxc:GBSSegmentMember2019-07-012019-09-300001688568us-gaap:OperatingSegmentsMemberdxc:GISSegmentMember2019-07-012019-09-300001688568us-gaap:OperatingSegmentsMember2019-07-012019-09-300001688568us-gaap:MaterialReconcilingItemsMember2019-07-012019-09-300001688568us-gaap:OperatingSegmentsMemberdxc:GBSSegmentMember2020-04-012020-09-300001688568us-gaap:OperatingSegmentsMemberdxc:GISSegmentMember2020-04-012020-09-300001688568us-gaap:OperatingSegmentsMember2020-04-012020-09-300001688568us-gaap:MaterialReconcilingItemsMember2020-04-012020-09-300001688568us-gaap:OperatingSegmentsMemberdxc:GBSSegmentMember2019-04-012019-09-300001688568us-gaap:OperatingSegmentsMemberdxc:GISSegmentMember2019-04-012019-09-300001688568us-gaap:OperatingSegmentsMember2019-04-012019-09-300001688568us-gaap:MaterialReconcilingItemsMember2019-04-012019-09-300001688568dxc:SuretyBondsPerformanceGuaranteeMember2020-09-300001688568dxc:LettersOfCreditPerformanceGuaranteeMember2020-09-300001688568us-gaap:FinancialStandbyLetterOfCreditMember2020-09-30dxc:administrator0001688568dxc:StrauchFairLaborStandardsActCollectiveActionMember2015-04-042015-07-03dxc:individual0001688568dxc:StrauchFairLaborStandardsActCollectiveActionMember2020-04-012020-09-300001688568dxc:StrauchFairLaborStandardsActCollectiveActionMember2019-08-062019-08-060001688568dxc:StrauchFairLaborStandardsActCollectiveActionMember2019-09-012019-09-300001688568dxc:StrauchFairLaborStandardsActCollectiveActionMember2020-07-012020-07-310001688568dxc:ComputerSciencesCorporationv.EricPulieretal.Memberus-gaap:SettledLitigationMember2016-02-29dxc:plaintiff0001688568dxc:Forsythetal.v.HPInc.andHewlettPackardEnterpriseMemberus-gaap:PendingLitigationMember2018-10-012018-10-310001688568dxc:Forsythetal.v.HPInc.andHewlettPackardEnterpriseMemberus-gaap:SettledLitigationMemberdxc:EmployeesofFormerBusinessUnitsofHPEMember2018-10-012018-10-310001688568dxc:Forsythetal.v.HPInc.andHewlettPackardEnterpriseMemberus-gaap:PendingLitigationMember2019-06-012019-06-300001688568dxc:Forsythetal.v.HPInc.andHewlettPackardEnterpriseMemberus-gaap:SettledLitigationMember2019-12-012019-12-310001688568dxc:Forsythetal.v.HPInc.andHewlettPackardEnterpriseMemberus-gaap:SettledLitigationMemberdxc:EmployeesofFormerBusinessUnitsofHPEMember2019-12-012019-12-31dxc:lawsuit0001688568dxc:InreDXCTechnologyCompanySecuritiesLitigationMember2019-03-012019-03-31dxc:officer0001688568dxc:InreDXCTechnologyCompanySecuritiesLitigationMembersrt:OfficerMember2019-03-012019-03-31dxc:joint_venture00016885682017-02-020001688568dxc:PerspectarelatedDisputesSeparationandDistributionAgreementMember2019-10-012019-10-310001688568dxc:PerspectarelatedDisputesSeparationandDistributionAgreementIncreaseOneMember2020-04-012020-09-300001688568dxc:PerspectarelatedDisputesSeparationandDistributionAgreementIncreaseTwoMember2020-04-012020-09-300001688568dxc:PerspectarelatedDisputesSeparationandDistributionAgreementIncreaseThreeMember2020-04-012020-09-300001688568dxc:PerspectarelatedDisputesITServicesAgreementMember2019-06-012019-06-300001688568dxc:PerspectarelatedDisputesITServicesAgreementMember2020-08-012020-08-310001688568us-gaap:SubsequentEventMember2020-10-012020-10-010001688568us-gaap:SubsequentEventMemberus-gaap:CommercialPaperMember2020-10-012020-10-010001688568dxc:MilanoPurchasersMemberus-gaap:SubsequentEventMember2020-10-012020-10-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2020
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____________ to ____________

Commission File No.: 001-38033
DXC-20200930_G1.JPG
DXC TECHNOLOGY COMPANY
(Exact name of registrant as specified in its charter)
Nevada
61-1800317
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
1775 Tysons Boulevard
                      Tysons , Virginia
22102
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (703) 245-9675
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value per share
DXC
New York Stock Exchange
2.750% Senior Notes Due 2025
DXC 25
New York Stock Exchange
1.750% Senior Notes Due 2026
DXC 26
New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d)
of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  x Yes  o No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). x Yes  o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer x Accelerated Filer o
Non-accelerated Filer o Smaller reporting company
☐
Emerging growth company
☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
       ☐ Yes  x   No

254,412,158 shares of common stock, par value $0.01 per share, were outstanding on October 30, 2020.


TABLE OF CONTENTS
Item Page
1.
1
2.
50
3.
69
4.
69
1.
72
1A.
72
2.
73
3.
74
4.
74
5.
74
6.
74




PART I

ITEM 1. FINANCIAL STATEMENTS

Index to Condensed Consolidated Financial Statements
Page
2
3
4
5
6
8
10
11
13
14
14
17
21
22
26
27
28
29
31
33
34
35
36
38
39
41
47



1

DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

Three Months Ended Six Months Ended
(in millions, except per-share amounts) September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Revenues $ 4,554  $ 4,851  $ 9,056  $ 9,741 
Costs of services (excludes depreciation and amortization and restructuring costs) 3,563  3,679  7,192  7,301 
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) 539  489  1,078  996 
Depreciation and amortization 525  467  1,017  937 
Goodwill impairment losses —  2,887  —  2,887 
Restructuring costs 265  32  337  174 
Interest expense 96  104  202  195 
Interest income (25) (67) (48) (97)
Gain on arbitration award —  (632) —  (632)
Other income, net (103) (109) (191) (227)
Total costs and expenses 4,860  6,850  9,587  11,534 
Loss before income taxes (306) (1,999) (531) (1,793)
Income tax (benefit) expense (60) 116  (86) 154 
Net loss (246) (2,115) (445) (1,947)
Less: net (loss) income attributable to non-controlling interest, net of tax (2) 4  4  9 
Net loss attributable to DXC common stockholders $ (244) $ (2,119) $ (449) $ (1,956)
Loss per common share:
Basic $ (0.96) $ (8.19) $ (1.77) $ (7.44)
Diluted $ (0.96) $ (8.19) $ (1.77) $ (7.44)


The accompanying notes are an integral part of these condensed consolidated financial statements.




2


DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)
Three Months Ended Six Months Ended
(in millions)
September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Net loss $ (246) $ (2,115) $ (445) $ (1,947)
Other comprehensive loss, net of taxes:
Foreign currency translation adjustments, net of tax (1)
33  (71) 30  (206)
Cash flow hedges adjustments, net of tax (2)
7  (2) 18  2 
Available-for-sale securities, net of tax (3)
1  1  5  2 
Pension and other post-retirement benefit plans, net of tax:
Amortization of prior service cost, net of tax (4)
(1) (3) (10) (4)
Pension and other post-retirement benefit plans, net of tax (1) (3) (10) (4)
Other comprehensive income (loss), net of taxes 40  (75) 43  (206)
Comprehensive loss (206) (2,190) (402) (2,153)
Less: comprehensive income (loss) attributable to non-controlling interest 1  6  6  (13)
Comprehensive loss attributable to DXC common stockholders $ (207) $ (2,196) $ (408) $ (2,140)
        

(1) Tax (benefit) expense related to foreign currency translation adjustments was $(15) and $(22) for the three and six months ended September 30, 2020, respectively, and $25 and $13 for the three and six months ended September 30, 2019, respectively.
(2) Tax expense related to cash flow hedge adjustments was $3 and $6 for the three and six months ended September 30, 2020, respectively. There was no tax expense related to cash flow hedge adjustments during the three and six months ended September 30, 2019.
(3) There was no tax expense related to available-for-sale securities during the three and six months ended September 30, 2020. Tax expense related to available-for-sale securities was $0 and $1 for the three and six months ended September 30, 2019, respectively.
(4) Tax benefit related to amortization of prior service costs was $1 and $2 for the three and six months ended September 30, 2020, respectively, and $1 and $1 for the three and six months ended September 30, 2019, respectively.

The accompanying notes are an integral part of these condensed consolidated financial statements.


3

DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)

As of
(in millions, except per-share and share amounts) September 30, 2020 March 31, 2020
ASSETS
Current assets:
Cash and cash equivalents $ 3,079  $ 3,679 
Receivables and contract assets, net of allowance of $162 and $74
4,194  4,392 
Prepaid expenses 604  646 
Other current assets 335  270 
Assets held for sale 125  — 
Total current assets 8,337  8,987 
Intangible assets, net of accumulated amortization of $4,364 and $4,347
4,146  5,731 
Operating right-of-use assets, net 1,555  1,428 
Goodwill 725  2,017 
Deferred income taxes, net 292  265 
Property and equipment, net of accumulated depreciation of $4,198 and $3,818
3,417  3,547 
Other assets 4,360  4,031 
Assets held for sale - non-current 2,838  — 
Total Assets $ 25,670  $ 26,006 
LIABILITIES and EQUITY
Current liabilities:
Short-term debt and current maturities of long-term debt $ 1,622  $ 1,276 
Accounts payable 1,345  1,598 
Accrued payroll and related costs 756  630 
Current operating lease liabilities 461  482 
Accrued expenses and other current liabilities 3,203  2,801 
Deferred revenue and advance contract payments 974  1,021 
Income taxes payable 111  87 
Liabilities related to assets held for sale 184  — 
Total current liabilities 8,656  7,895 
Long-term debt, net of current maturities 8,046  8,672 
Non-current deferred revenue 697  735 
Non-current operating lease liabilities 1,192  1,063 
Non-current income tax liabilities and deferred tax liabilities 917  1,157 
Other long-term liabilities 1,325  1,355 
Liabilities related to assets held for sale - non-current 86  — 
Total Liabilities 20,919  20,877 
Commitments and contingencies
DXC stockholders’ equity:
Preferred stock, par value $.01 per share, 1,000,000 shares authorized, none issued as of September 30, 2020 and March 31, 2020
—  — 
Common stock, par value $.01 per share, 750,000,000 shares authorized, 256,521,547 issued as of September 30, 2020 and 255,674,040 issued as of March 31, 2020
3  3 
Additional paid-in capital 10,746  10,714 
Accumulated deficit (5,631) (5,177)
Accumulated other comprehensive loss (562) (603)
Treasury stock, at cost, 2,327,868 and 2,148,708 shares as of September 30, 2020 and March 31, 2020
(155) (152)
Total DXC stockholders’ equity 4,401  4,785 
Non-controlling interest in subsidiaries 350  344 
Total Equity 4,751  5,129 
Total Liabilities and Equity $ 25,670  $ 26,006 

The accompanying notes are an integral part of these condensed consolidated financial statements.
4

DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

Six Months Ended
(in millions) September 30, 2020 September 30, 2019
Cash flows from operating activities:
Net loss $ (445) $ (1,947)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization 1,025  946 
Goodwill impairment losses —  2,887 
Operating right-of-use expense 307  340 
Pension & other post-employment benefits, actuarial & settlement losses 2  — 
Share-based compensation 36  48 
Loss (gain) on dispositions 14  (4)
Provision for losses on accounts receivable 45  — 
Unrealized foreign currency exchange gain (43) (50)
Impairment losses and contract write-offs 42  11 
Other non-cash charges, net (5) (9)
Changes in assets and liabilities, net of effects of acquisitions and dispositions:
Decrease in assets 57  167 
Decrease in operating lease liability (307) (340)
Decrease in other liabilities (137) (464)
Net cash provided by operating activities 591  1,585 
Cash flows from investing activities:
Purchases of property and equipment (156) (192)
Payments for transition and transformation contract costs (136) (158)
Software purchased and developed (102) (126)
Payments for acquisitions, net of cash acquired (10) (1,921)
Cash collections related to deferred purchase price receivable 159  371 
Proceeds from sale of assets 8  40 
Short-term investing —  (75)
Other investing activities, net 3  14 
Net cash used in investing activities (234) (2,047)
Cash flows from financing activities:
Borrowings of commercial paper 830  2,879 
Repayments of commercial paper (508) (2,866)
Borrowings under lines of credit 2,500  — 
Repayment of borrowings under lines of credit (2,750) — 
Borrowings on long-term debt, net of discount 993  2,198 
Principal payments on long-term debt (1,476) (519)
Payments on finance leases and borrowings for asset financing (487) (421)
Proceeds from stock options and other common stock transactions —  10 
Taxes paid related to net share settlements of share-based compensation awards (3) (12)
Repurchase of common stock and advance payment for accelerated share repurchase —  (650)
Dividend payments (53) (107)
Other financing activities, net (9) (32)
Net cash (used in) provided by financing activities (963) 480 
Effect of exchange rate changes on cash and cash equivalents 9  (37)
Net decrease in cash and cash equivalents including cash classified within current assets held for sale (597) (19)
Less: cash classified within current assets held for sale (3) — 
Net decrease in cash and cash equivalents (600) (19)
Cash and cash equivalents at beginning of year 3,679  2,899 
Cash and cash equivalents at end of period $ 3,079  $ 2,880 

The accompanying notes are an integral part of these condensed consolidated financial statements.
5

DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (unaudited)

Three Months Ended September 30, 2020
(in millions, except shares in thousands) Common Stock
Additional
Paid-in Capital
 Accumulated Deficit
Accumulated
Other
Comprehensive Loss
Treasury Stock (1)
Total
DXC Equity
Non-
Controlling Interest
Total Equity
Shares Amount
Balance at June 30, 2020 256,383  $ 3  $ 10,729  $ (5,386) $ (599) $ (154) $ 4,593  $ 349  $ 4,942 
Net loss (244) (244) (2) (246)
Other comprehensive income 37  37  3  40 
Share-based compensation expense 17  17  17 
Acquisition of treasury stock (1) (1) (1)
Stock option exercises and other common stock transactions 139  —  — 
Non-controlling interest distributions and other (1) (1) (1)
Balance at September 30, 2020 256,522 $ 3  $ 10,746  $ (5,631) $ (562) $ (155) $ 4,401  $ 350  $ 4,751 
Three Months Ended September 30, 2019
(in millions, except shares in thousands) Common Stock
Additional
Paid-in Capital
Retained Earnings
Accumulated
Other
Comprehensive
Loss
Treasury Stock
Total
DXC Equity
Non-
Controlling Interest
Total Equity
Shares Amount
Balance at June 30, 2019 263,709  $ 3  $ 10,916  $ 494  $ (351) $ (149) $ 10,913  $ 304  $ 11,217 
Net loss (2,119) (2,119) 4  (2,115)
Other comprehensive loss (77) (77) 2  (75)
Share-based compensation expense 31  31  31 
Acquisition of treasury stock (1) (1) (1)
Share repurchase program (6,220) (161) 11  (150) (150)
Stock option exercises and other common stock transactions 137  7  7  7 
Dividends declared ($0.21 per share)
(54) (54) (54)
Non-controlling interest distributions and other —  10  10 
Balance at September 30, 2019 257,626  $ 3  $ 10,793  $ (1,668) $ (428) $ (150) $ 8,550  $ 320  $ 8,870 

    



The accompanying notes are an integral part of these condensed consolidated financial statements.












6


DXC TECHNOLOGY COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (unaudited)
Six Months Ended September 30, 2020
(in millions, except shares in thousands) Common Stock
Additional
Paid-in Capital
 Accumulated Deficit
Accumulated
Other
Comprehensive Loss
Treasury Stock (1)
Total
DXC Equity
Non-
Controlling Interest
Total Equity
Shares Amount
Balance at March 31, 2020 255,674  $ 3  $ 10,714  $ (5,177) $ (603) $ (152) $ 4,785  $ 344  $ 5,129 
Cumulative effect of adopting ASU 2016-13
(4) (4) (4)
Net loss (449) (449) 4  (445)
Other comprehensive income 41  41  2  43 
Share-based compensation expense 32  32  32 
Acquisition of treasury stock (3) (3) (3)
Stock option exercises and other common stock transactions 848  —  — 
Non-controlling interest distributions and other (1) (1) (1)
Balance at September 30, 2020 256,522 $ 3  $ 10,746  $ (5,631) $ (562) $ (155) $ 4,401  $ 350  $ 4,751 
Six Months Ended September 30, 2019
(in millions, except shares in thousands) Common Stock
Additional
Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated
Other
Comprehensive
Loss
Treasury Stock
Total
DXC Equity
Non-
Controlling Interest
Total Equity
Shares Amount
Balance at March 31, 2019 270,214  $ 3  $ 11,301  $ 478  $ (244) $ (136) $ 11,402  $ 323  $ 11,725 
Net loss (1,956) (1,956) 9  (1,947)
Other comprehensive loss (184) (184) (22) (206)
Share-based compensation expense 49  49  49 
Acquisition of treasury stock (14) (14) (14)
Share repurchase program (13,580) (571) (79) (650) (650)
Stock option exercises and other common stock transactions 992  14  14  14 
Dividends declared ($0.42 per share)
(111) (111) (111)
Non-controlling interest distributions and other —  10  10 
Balance at September 30, 2019 257,626  $ 3  $ 10,793  $ (1,668) $ (428) $ (150) $ 8,550  $ 320  $ 8,870 
        

    (1) 2,327,868 treasury shares as of September 30, 2020.



The accompanying notes are an integral part of these condensed consolidated financial statements.
7
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 1 - Summary of Significant Accounting Policies

Business

DXC Technology Company ("DXC," the "Company," "we," "us," or "our") helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. With decades of driving innovation, the world’s largest companies trust DXC to deploy its enterprise technology stack to deliver new levels of performance, competitiveness and customer experiences.

HHS Sale

On October 1, 2020, DXC completed the sale of its U.S. State and Local Health and Human Services business ("HHS" or the "HHS Business") to Veritas Capital Fund Management, L.L.C. ("Veritas Capital") to form Gainwell Technologies. The sale was accomplished by the cash purchase of all equity interests and assets attributable to the HHS Business together with future services to be provided by the Company for a total enterprise value of $5.0 billion, subject to net working capital adjustments and assumed liabilities. See Note 4 - Assets Held for Sale and Note 22 - "Subsequent Events" for further information.

HPS Sale

On July 17, 2020, DXC entered into a purchase agreement to sell (the "HPS Sale") its healthcare provider software business ("HPS" or the "HPS Business") to Dedalus Holding S.p.A. ("Dedalus") for €459 million (approximately $525 million), subject to certain adjustments. The HPS Sale is expected to close by March 2021, subject to meeting certain closing conditions.

Luxoft Acquisition

On June 14, 2019, DXC completed its acquisition of Luxoft Holding, Inc. ("Luxoft"), a global digital strategy and software engineering firm (the "Luxoft Acquisition"). The acquisition builds on DXC’s unique value proposition as an end-to-end, mainstream IT and digital services market leader, and strengthens the Company’s ability to design and deploy transformative digital solutions for clients at scale. See Note 3 - "Acquisitions" for further information.

Basis of Presentation

In order to make this report easier to read, DXC refers throughout to (i) the interim unaudited Condensed Consolidated Financial Statements as the “financial statements,” (ii) the Condensed Consolidated Statements of Operations as the “statements of operations,” (iii) the Condensed Consolidated Statements of Comprehensive (Loss) Income as the "statements of comprehensive income," (iv) the Condensed Consolidated Balance Sheets as the “balance sheets,” and (v) the Condensed Consolidated Statements of Cash Flows as the “statements of cash flows.” In addition, references throughout to numbered “Notes” refer to the numbered Notes in these Notes to Condensed Consolidated Financial Statements, unless otherwise noted.

The accompanying financial statements include the accounts of DXC, its consolidated subsidiaries, and those business entities in which DXC maintains a controlling interest. Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for by the equity method. Other investments are accounted for by the cost method. Non-controlling interests are presented as a separate component within equity in the balance sheets. Net earnings attributable to the non-controlling interests are presented separately in the statements of operations and comprehensive income attributable to non-controlling interests are presented separately in the statements of comprehensive income. All intercompany transactions and balances have been eliminated. Certain amounts reported in the previous year have been reclassified to conform to the current year presentation.

8
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
The financial statements of the Company have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission for quarterly reports and accounting principles generally accepted in the United States ("GAAP"). Certain disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules. These financial statements should therefore be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2020 ("fiscal 2020").

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company's management to make estimates and assumptions that affect amounts reported in the financial statements. The Company bases its estimates on assumptions regarding historical experience, currently available information and anticipated developments that it believes are reasonable and appropriate. However, because the use of estimates involves an inherent degree of uncertainty, actual results could differ from those estimates. The severity, magnitude and duration, as well as the economic consequences of the coronavirus disease 2019 ("COVID-19") pandemic, are uncertain, rapidly changing and difficult to predict. Therefore, accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods. In the opinion of the Company's management, the accompanying financial statements of DXC contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company's financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full fiscal year.

Allowance for Credit Losses

Effective April 1, 2020, the Company adopted ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” using the modified retrospective method. Refer to Note 2 - "Recent Accounting Pronouncements" and Note 6 - "Receivables" for further discussion of the impact of adoption and other required disclosures. The amendments in this update changed the guidance for credit losses to an expected loss model rather than an incurred loss model. Financial assets subject to impairment under an expected credit loss model include billed and unbilled receivables, other receivables, and contract assets. Certain off-balance sheet arrangements, such as financial guarantees associated with receivables securitization facilities, are also subject to the guidance of ASU 2016-13.

Under an expected credit loss model, the Company immediately recognizes an estimate of credit losses expected to occur over the remaining life of financial assets that are in the scope of ASU 2016-13. DXC considers all available relevant information when estimating expected credit losses, including past events, current market conditions and forecasts and their implications for expected credit losses.


9
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 2 - Recent Accounting Pronouncements

During the six months ended September 30, 2020, DXC adopted the following Accounting Standards Updates ("ASU") issued by the Financial Accounting Standards Board:
Date Issued and ASU Date Adopted and Method Description Impact
June 2016

ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”
April 1, 2020
Modified Retrospective
This update requires the measurement and recognition of expected credit losses using the current expected credit loss model for financial assets held at amortized cost, which includes the Company’s trade accounts receivable, certain financial instruments and contract assets. It replaces the existing incurred loss impairment model with an expected loss methodology. The recorded credit losses are adjusted each period for changes in expected lifetime credit losses. The standard requires a cumulative effect adjustment to the statement of financial position as of the beginning of the first reporting period in which the guidance is effective.
The Company adopted this standard using the modified retrospective approach and recorded an immaterial cumulative effect adjustment in retained earnings as of April 1, 2020.


August 2018

ASU 2018-15,
"Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract"


April 1, 2020
Prospective

This update helps entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement includes a software license. Entities have the option to apply this standard prospectively to all implementation costs incurred after the date of adoption or retrospectively.

The Company adopted this standard using the prospective method and determined that the adoption of ASU 2018-15 had no material impact to its condensed consolidated financial statements.


The following ASUs were recently issued but have not yet been adopted by DXC:
Date Issued and ASU DXC Effective Date Description Impact
December 2019

ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes"
Fiscal 2022
This update is intended to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. Early adoption of this update is permitted.
The Company is currently evaluating the potential impact this standard may have on its financial statements in future reporting periods.

Other recently issued ASUs effective after September 30, 2020 are not expected to have a material effect on DXC's consolidated financial statements.
10
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 3 - Acquisitions

Fiscal 2020 Acquisitions
Luxoft Acquisition

On June 14, 2019, DXC completed the acquisition of Luxoft, a digital service provider whose offerings encompass strategic consulting, custom software development services, and digital solution engineering for total consideration of $2.0 billion. The acquisition will combine Luxoft’s digital engineering capabilities with DXC’s expertise in IT modernization and integration. The purchase agreement (“Merger Agreement”) was entered into by DXC and Luxoft on January 6, 2019 and the transaction was closed on June 14, 2019 (the "acquisition date.")

The transaction between DXC and Luxoft is an acquisition, with DXC as the acquirer and Luxoft as the acquiree, based on the fact that DXC acquired 100% of the equity interests and voting rights in Luxoft, and that DXC is the entity that transferred the cash consideration.

The Company's allocation of the purchase price to the assets acquired and liabilities assumed as of the Luxoft acquisition date is as follows:
(in millions) Fair Value
Cash and cash equivalents $ 113 
Accounts receivable 233 
Other current assets 15 
Total current assets 361 
Property and equipment 31 
Intangible assets 577 
Other assets 99 
Total assets acquired 1,068 
Accounts payable, accrued payroll, accrued expenses, and other current liabilities (121)
Deferred revenue (8)
Long-term deferred tax liabilities and income tax payable (106)
Other liabilities (72)
Total liabilities assumed (307)
Net identifiable assets acquired 761 
Goodwill 1,262 
Total consideration transferred $ 2,023 

Goodwill represents the excess of the purchase price over the fair value of identifiable assets acquired and liabilities assumed at the acquisition date. The goodwill recognized with the acquisition was attributable to the synergies expected to be achieved by combining the businesses of DXC and Luxoft, expected future contracts and the acquired workforce. The cost-saving opportunities are expected to include improved operating efficiencies and asset optimization. The total goodwill arising from the acquisition was allocated to Global Business Services and is not deductible for tax purposes.
11
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

The Company valued current assets and liabilities using existing carrying values as an estimate of the approximate fair value of those items at the acquisition date except for certain contract receivables for which the Company determined fair value based on a cost plus margin approach. The Company valued acquired property and equipment using predominately the direct capitalization method of the income approach and in certain specific cases, the Company determined that the net book value represents the fair value. The Company valued customer relationships using the multi-period excess earnings method under the income approach and valued trade names and developed technology using a relief from royalty method under the income approach. The Company determined that the net book value of the purchased software represents the fair value.

Below are the estimated useful lives of the acquired intangibles:
Estimated Useful Lives (Years)
Customer related intangibles 10
Trade names 20
Developed technology 3
Third-party purchased software 3

The Company valued deferred tax liabilities based on statutory tax rates in the jurisdictions of the legal entities where the acquired non-current assets and liabilities are taxed.

12
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 4 - Assets Held for Sale

On March 9, 2020, DXC entered into a definitive agreement to sell its HHS Business to Veritas Capital for a cash consideration of enterprise value of $5.0 billion (including $85 million related to future services to be provided by the Company). The HHS Business is an end-to-end provider of technology-enabled, mission critical solutions that are fundamental to the administration and operations of health programs throughout the United States. The transaction closed on October 1, 2020. See Note 22 - "Subsequent Events."

As of September 30, 2020 the disposition of the HHS Business, reported as part of the GBS segment, met the requirements for presentation as assets held for sale under GAAP.

Assets held for sale are reported at carrying value, which is less than fair value. Assets held for sale and related liabilities as of September 30, 2020 were as follows:

(in millions) September 30, 2020
Assets:
Cash and cash equivalents $ 3 
Accounts receivable, net 74 
Prepaid expenses 38 
Other current assets 2 
Total current assets held for sale 117 
Intangible assets, net 1,308 
Operating right-of-use assets, net 74 
Goodwill 1,354 
Property and equipment, net 43 
Other assets 53 
Total non-current assets held for sale 2,832 
Total assets acquired $ 2,949 
Liabilities:
Accounts payable $ 79 
Accrued payroll and related costs 13 
Current operating lease liabilities 27 
Accrued expenses and other current liabilities 38 
Deferred revenue and advance contract payments 20 
Total current liabilities related to assets held for sale 177 
Non-current deferred revenue 32 
Long-term operating lease liabilities 48 
Other long term liabilities 2 
Total long-term liabilities related to assets held for sale 82 
 Total liabilities related to assets held for sale $ 259 


During the second quarter of fiscal 2021, the Company entered into a definitive agreement to sell an insignificant business, which is also classified as held for sale.

13
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 5 - Loss per Share

Basic and diluted net loss per share is computed using the weighted average number of shares of common stock outstanding during the period. As the Company had net losses for the periods presented, diluted net loss per share is the same as basic net loss per share because the inclusion of all potentially dilutive shares of common stock would have been anti-dilutive. The following table reflects the calculation of basic and diluted net loss per share:

Three Months Ended Six Months Ended
(in millions, except per-share amounts)
September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Net loss attributable to DXC common shareholders: $ (244) $ (2,119) $ (449) $ (1,956)
Common share information:
Weighted average common shares outstanding for basic and diluted net loss per share 254.13  258.71  253.88  262.83 
Net loss per share:
Basic and diluted $ (0.96) $ (8.19) $ (1.77) $ (7.44)

The following share-based equity awards were excluded from the computation of diluted net loss per share because inclusion of these awards would have had an anti-dilutive effect. The number of awards excluded were as follows:

Three Months Ended Six Months Ended
September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Stock Options 1,625,591  765,883  1,735,395  979,644 
Restricted Stock Units 2,598,301  2,354,528  2,554,090  1,180,177 
Performance-based Restricted Stock Units 83,125  434,862  158,444  437,507 


14
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 6 - Receivables

Receivables Facility

The Company has an accounts receivable sales facility (as amended, restated, supplemented or otherwise modified as of September 30, 2020, the "Receivables Facility") with certain unaffiliated financial institutions (the "Purchasers") for the sale of commercial accounts receivable in the United States. Under the Receivables Facility, certain of the Company's subsidiaries (the "Sellers") sell accounts receivable to DXC Receivables LLC ("Receivables SPV"), a wholly owned bankruptcy-remote entity, in a true sale. Receivables SPV subsequently sells certain of the receivables in their entirety to the Purchasers pursuant to a receivables purchase agreement. The financial obligations of Receivables SPV to the Purchasers under the Receivables Facility are limited to the assets it owns and non-recourse to the Company. Sales of receivables by Receivables SPV occur continuously and are settled on a monthly basis. During the second quarter of fiscal 2021, Receivables SPV amended the Receivables Facility (the "Amendment") to decrease the facility limit from $600 million to $500 million and extend the termination date to August 5, 2021. As of the second quarter of fiscal 2020, there is no deferred purchase price ("DPP") for receivables as the entire purchase price is paid in cash when the receivables are sold to the Purchasers. DPPs were previously realized by Receivables SPV upon the ultimate collection of the underlying receivables sold to the Purchasers. Cash receipts on the DPP were classified as cash flows from investing activities.

The amount available under the Receivables Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business after deducting excess concentrations. As of September 30, 2020, the total availability under the Receivables Facility was $371 million, and the amount sold to the Purchasers was $452 million, which was derecognized from the Company's balance sheet. As of September 30, 2020, the Company recorded a $81 million liability within accounts payable because the amount of cash proceeds received by the Company under the Receivables Facility was more than the total availability. The Receivables Facility is scheduled to terminate on August 5, 2021, but provides for one or more optional one-year extensions, if agreed to by the Purchasers. The Company uses the proceeds from the sale of receivables under the Receivables Facility for general corporate purposes.

The fair value of the sold receivables approximated book value due to the short-term nature, and as a result, no gain or loss on sale of receivables was recorded.

While the Company guarantees certain non-financial performance obligations of the Sellers, the Purchasers bear customer credit risk associated with the receivables sold under the Receivables Facility and have recourse in the event of credit-related customer non-payment solely to the assets of the Receivables SPV.

The following table is a reconciliation of the beginning and ending balance of the DPP for the Receivables Facility:

(in millions) As of and for the Three Months Ended As of and for the Six Months Ended
September 30, 2019 September 30, 2019
Beginning balance $ 525  $ 574 
    Transfers of receivables —  1,214 
Collections —  (1,265)
Change in funding availability —  2 
Facility amendments (525) (525)
Ending balance $ —  $ — 

15
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Milano Receivables Facility

On June 5, 2020, the Company entered into an accounts receivable securitization facility (the "Milano Facility") with certain unaffiliated financial institutions (the "Milano Purchasers") for the sale of commercial accounts receivable related to HHS contracts in the United States. The Milano Facility is scheduled to terminate on June 4, 2021, but provides for one or more optional one-year extensions, if agreed to by the Purchasers. The Milano Facility has a facility limit of $275 million. Under the Milano Facility, certain of the Company's subsidiaries (the "Milano Sellers") sell HHS accounts receivable to Milano Receivables Funding LLC ("Milano Receivables SPV"), a wholly owned bankruptcy-remote entity, in a true sale. Milano Receivables SPV subsequently sells certain of the receivables in their entirety to the Milano Purchasers pursuant to a receivables purchase agreement. The financial obligations of Milano Receivables SPV to the Milano Purchasers under the Milano Facility are limited to the assets it owns and non-recourse to the Company. Sales of HHS receivables by Milano Receivables SPV occur continuously and are settled on a monthly basis.

The amount available under the Milano Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business after deducting excess concentrations. As of September 30, 2020, the amount sold to the Milano Purchasers was approximately $272 million. On October 1, 2020, and in connection with the consummation of the sale of the HHS Business, and at the direction of the purchaser of the HHS Business, the Milano Facility was terminated. For more information, refer to Note 22 - "Subsequent Events."

The fair value of the sold receivables approximated book value due to the short-term nature, and as a result, no gain or loss on sale of receivables was recorded.

While the Company guarantees certain non-financial performance obligations of the Milano Sellers, the Milano Purchasers bear customer credit risk associated with the receivables sold under the Milano Facility and have recourse in the event of credit-related customer non-payment solely to the assets of the Milano Receivables SPV.


German Receivables Facility

On October 1, 2019, the Company executed an accounts receivable securitization facility (as amended, restated, supplemented or otherwise modified as of September 30, 2020, the "DE Receivables Facility") with certain unaffiliated financial institutions (the "DE Purchasers") for the sale of commercial accounts receivable in Germany. The DE Receivables Facility has a facility limit of €150 million (approximately $175 million as of September 30, 2020). Under the DE Receivables Facility, certain of the Company's subsidiaries organized in Germany (the "DE Sellers") sell accounts receivable to DXC ARFacility Designated Activity Company ("DE Receivables SPV"), a trust-owned bankruptcy-remote entity, in a true sale. DE Receivables SPV subsequently sells certain of the receivables in their entirety to the DE Purchasers pursuant to a receivables purchase agreement. Sales of receivables by DE Receivables SPV occur continuously and are settled on a monthly basis. During the first quarter of fiscal 2021, DE Receivables SPV amended the DE Receivables Facility. Under the terms of the DE Receivables Facility, there is no longer any DPP for receivables as the entire purchase price is paid in cash when the receivables are sold to the DE Purchasers. Prior to the Amendment, DPPs were realized by DE Receivables SPV upon the ultimate collection of the underlying receivables sold to the DE Purchasers. Cash receipts on the DPPs were classified as cash flows from investing activities. The DPP balance was $102 million before the Amendment was executed. Upon execution of the Amendment, the Purchasers extinguished the DPP balance and returned title to the applicable underlying receivables to DE Receivables SPV. The DPP extinguishment was classified as a non-cash investing activity, please refer to Note 19 - "Cash Flows."

The amount available under the DE Receivables Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business after deducting excess concentrations. As of September 30, 2020, the total availability under the DE Receivables Facility was approximately $120 million, and the amount sold to the DE Purchasers was $124 million, which was derecognized from the Company's balance sheet. As of September 30, 2020, the Company recorded a $4 million liability within accounts payable because the amount of cash proceeds received by the Company under the DE Receivables Facility was more than the total availability. The DE Receivables Facility is scheduled to terminate on September 30, 2021, but provides for one or more optional one-year extensions, if agreed to by the DE Purchasers. The Company uses the proceeds from DE Receivables SPV's sale of receivables under the DE Receivables Facility for general corporate purposes.
16
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

The fair value of the sold receivables approximated book value due to the short-term nature, and as a result, no gain or loss on sale of receivables was recorded.

Certain obligations of DE Sellers under the DE Receivables Facility and certain DXC subsidiaries located in Germany, as initial servicers, are guaranteed by the Company under a performance guaranty, made in favor of an administrative agent on behalf of the DE Purchasers. However, the performance guaranty does not cover DE Receivables SPV’s obligations to pay yield, fees or invested amounts to the administrative agent or any of the DE Purchasers.

The following table is a reconciliation of the beginning and ending balances of the DPP for the DE Receivables Facility:
(in millions) As of and for the Six Months Ended September 30, 2020
Beginning balance $ 103 
Transfers of receivables 417 
Collections (420)
Change in funding availability 2 
Facility amendments (102)
Ending balance $ — 


Allowance

The Company calculates expected credit losses for trade accounts receivable based on historical credit loss rates for each aging category as adjusted for the current market conditions and forecasts about future economic conditions. The following table presents the activity in the allowance for doubtful accounts for trade accounts receivable:
(in millions) As of and for the Six Months Ended
September 30, 2020
Beginning balance $ 74 
Impact of adoption of the Credit Loss Standard 4 
Provisions for losses on accounts receivable 45 
Other adjustments to allowance and write-off's 39 
Ending balance $ 162 



17
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 7 - Leases

The Company has operating and finance leases for data centers, corporate offices, retail stores and certain equipment. Its leases have remaining lease terms of one to 12 years, some of which include options to extend the leases for up to 10 years, and some of which include options to terminate the leases within one to three years.

The components of lease expense were as follows:
Three Months Ended Six Months Ended
(in millions) September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Operating lease cost $ 151  $ 164  $ 307  $ 340 
Short-term lease cost 11  14  26  24 
Variable lease cost 15  11  23  26 
Sublease income (10) (10) (22) (19)
     Total operating costs $ 167  $ 179  $ 334  $ 371 
Finance lease cost:
     Amortization of right-of-use assets $ 99  $ 140  $ 215  $ 249 
     Interest on lease liabilities 11  17  25  34 
     Total finance lease cost $ 110  $ 157  $ 240  $ 283 

Cash payments made from variable lease costs and short-term leases are not included in the measurement of operating and finance lease liabilities, and as such, are excluded from the supplemental cash flow information stated below. In addition, for the supplemental non-cash information on operating and finance leases, please refer to Note 19 - "Cash Flows."

Supplemental cash flow information related to leases was as follows:
(in millions) Six Months Ended September 30, 2020 Six Months Ended September 30, 2019
Cash paid for amounts included in the measurement of:
     Operating cash flows used in operating leases $ 307  $ 340 
     Operating cash flows used in finance leases $ 25  $ 34 
     Financing cash flows used in finance leases $ 285  $ 279 

18
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Supplemental balance sheet information related to leases was as follows:
As of
(in millions) Balance Sheet Line Item September 30, 2020 March 31, 2020
Assets:
ROU operating lease assets Operating right-of-use assets, net $ 1,555  $ 1,428 
ROU finance lease assets Property and Equipment, net 1,098  1,220 
Total $ 2,653  $ 2,648 
Liabilities:
Current
Operating lease Current operating lease liabilities $ 461  $ 482 
Finance lease Short-term debt and current maturities of long-term debt 440  444 
Total $ 901  $ 926 
Non-current
Operating lease Non-current operating lease liabilities $ 1,192  $ 1,063 
Finance lease Long-term debt, net of current maturities 568  602 
Total $ 1,760  $ 1,665 

On September 30, 2020, in conjunction with the classification of the HHS Business' assets being held for sale, $74 million in ROU operating lease assets and $75 million in operating lease liabilities were transferred to assets held for sale and liabilities related to assets held for sale on the Consolidated Balance Sheet.

The following table provides information on the weighted average remaining lease term and weighted average discount rate for operating and finance leases:
As of
September 30, 2020 March 31, 2020
Weighted Average remaining lease term: Years
     Operating leases 4.7 4.8
     Finance leases 2.7 2.7
Weighted average remaining discount rate: Rate
     Operating leases 4.0  % 4.0  %
     Finance leases 4.0  % 6.4  %

19
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
The following maturity analysis presents expected undiscounted cash payments for operating and finance leases on an annual basis as of September 30, 2020:

Fiscal year Operating Leases
(in millions) Real Estate Equipment Finance Leases
Remainder of 2021 $ 244  $ 28  $ 246 
2022 419  34  393 
2023 340  17  250 
2024 262  9  121 
2025 188  5  35 
Thereafter 279  3  3 
     Total lease payments 1,732  96  1,048 
Less: imputed interest (171) (4) (40)
     Total payments $ 1,561  $ 92  $ 1,008 


20
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 8 - Fair Value

Fair Value Measurements on a Recurring Basis

The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis excluding pension assets and derivative assets and liabilities. See Note 9 - "Derivative and Hedging Activities" for information about the fair value of the Company's derivative assets and liabilities. There were no transfers between any of the levels during the periods presented.
Fair Value Hierarchy
(in millions) September 30, 2020
Assets: Fair Value Level 1 Level 2 Level 3
Money market funds and money market deposit accounts $ 5  $ 5  $ —  $ — 
Time deposits(1)
367  367  —  — 
Other debt securities(2)
59  —  56  3 
Total assets $ 431  $ 372  $ 56  $ 3 
Liabilities:
Contingent consideration $ 51  $ —  $ —  $ 51 
Total liabilities $ 51  $ —  $ —  $ 51 

March 31, 2020
Assets: Fair Value Level 1 Level 2 Level 3
Money market funds and money market deposit accounts $ 156  $ 156  $ —  $ — 
Time deposits(1)
595  595  —  — 
Other debt securities(2)
51  —  48  3 
Deferred purchase price receivable 103  —  —  103 
Total assets $ 905  $ 751  $ 48  $ 106 
Liabilities:
Contingent consideration $ 46  $ —  $ —  $ 46 
Total liabilities $ 46  $ —  $ —  $ 46 
        

(1) Cost basis approximated fair value due to the short period of time to maturity.
(2) Other debt securities include available-for-sale investments with Level 2 inputs that have a cost basis of $40 million and $37 million, and unrealized gains of $16 million and $11 million, as of September 30, 2020 and March 31, 2020, respectively.

The fair value of money market funds, money market deposit accounts with less than three months maturity, and time deposits included in cash and cash equivalents are based on quoted market prices. The fair value of other debt securities included in other long-term assets is based on actual market prices. The fair value of the DPPs included in receivables, net is determined by calculating the expected amount of cash to be received and is principally based on unobservable inputs consisting primarily of the face amount of the receivables adjusted for anticipated credit losses. The fair value of contingent consideration included in other liabilities is based on contractually defined targets of financial performance and other considerations.

Other Fair Value Disclosures

The carrying amounts of the Company’s financial instruments with short-term maturities, primarily accounts receivable, accounts payable, short-term debt, and financial liabilities included in other accrued liabilities are deemed to approximate their market values due to their short-term nature. If measured at fair value, these financial instruments would be classified as Level 2 or Level 3 within the fair value hierarchy.
21
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

The Company estimates the fair value of its long-term debt primarily by using quoted prices obtained from third-party providers such as Bloomberg and by using an expected present value technique that is based on observable market inputs for instruments with similar terms currently available to the Company. The estimated fair value of the Company's long-term debt excluding finance lease liabilities was $8.0 billion and $8.2 billion as of September 30, 2020 and March 31, 2020, respectively as compared with carrying value of $7.8 billion and $8.4 billion as of September 30, 2020 and March 31, 2020, respectively. If measured at fair value, long-term debt excluding finance lease liabilities would be classified as Level 1 or Level 2 within the fair value hierarchy.

Non-financial assets such as goodwill, tangible assets, intangible assets and other contract related long-lived assets are recorded at fair value in the period they are initially recognized, and such fair value may be adjusted in subsequent periods if an event occurs or circumstances change that indicate that the asset may be impaired. The fair value measurements in such instances would be classified as Level 3 within the fair value hierarchy. There were no significant impairments recorded during the fiscal period covered by this report.


22
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 9 - Derivative and Hedging Activities

In the normal course of business, the Company is exposed to interest rate and foreign exchange rate fluctuations. As part of its risk management strategy, the Company uses derivative instruments, primarily foreign currency forward contracts and interest rate swaps, to hedge certain foreign currency and interest rate exposures. The Company’s objective is to reduce earnings volatility by offsetting gains and losses resulting from these exposures with losses and gains on the derivative contracts used to hedge them. The Company does not use derivative instruments for trading or any speculative purposes.

Derivatives Designated for Hedge Accounting

Cash flow hedges

The Company has designated certain foreign currency forward contracts as cash flow hedges to reduce foreign currency risk related to certain Indian Rupee-denominated intercompany obligations and forecasted transactions. The notional amounts of foreign currency forward contracts designated as cash flow hedges as of September 30, 2020 and March 31, 2020 were $460 million and $455 million, respectively. As of September 30, 2020, the related forecasted transactions extend through March 2023.

For the three and six months ended September 30, 2020 and September 30, 2019, respectively, the Company performed an assessment at the inception of the cash flow hedge transactions and determined that all critical terms of the hedging instruments and hedged items matched. The Company performs an assessment of critical terms on an on-going basis throughout the hedging period. During the three and six months ended September 30, 2020 and September 30, 2019, respectively, the Company had no cash flow hedges for which it was probable that the hedged transaction would not occur. As of September 30, 2020, $1 million of the existing amount of loss related to the cash flow hedge reported in accumulated other comprehensive loss is expected to be reclassified into earnings within the next 12 months.

Net investment hedges

During the fiscal year ended March 31, 2019, the Company designated certain foreign currency forward contracts as net investment hedges to protect its investment in certain foreign operations against adverse changes in exchange rates between the Euro and the U.S. dollar. These contracts were de-designated and settled during the fiscal year ended March 31, 2020, and as of September 30, 2020, there were none outstanding.

The pre-tax gain (loss) on derivatives designated for hedge accounting recognized in loss from operation was $(2) million and $(6) million for the three and six months ended September 30, 2020. The pre-tax gain (loss) on derivatives designated for hedge accounting recognized in other comprehensive loss was $7 million and $18 million for the three and six months ended September 30, 2020, respectively.

Derivatives Not Designated for Hedge Accounting

The derivative instruments not designated as hedges for purposes of hedge accounting include certain short-term foreign currency forward contracts. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates to.

Foreign currency forward contracts

The Company manages the exposure to fluctuations in foreign currencies by using short-term foreign currency forward contracts to hedge certain foreign currency denominated assets and liabilities, including intercompany accounts and forecasted transactions. The notional amounts of the foreign currency forward contracts outstanding as of September 30, 2020 and March 31, 2020 were $1.5 billion and $2.2 billion, respectively.
23
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

The following table presents the pretax amounts impacting income related to designated and non-designated foreign currency forward contracts:
For the Three Months Ended For the Six Months Ended
(in millions) Statement of Operations Line Item September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Foreign currency forward contracts Other expense (income), net $ 33  $ (41) $ 58  $ (22)

Fair Value of Derivative Instruments

All derivative instruments are recorded at fair value. The Company’s accounting treatment for these derivative instruments is based on its hedge designation. The following tables present the fair values of derivative instruments included in the balance sheets:
Derivative Assets
As of
(in millions) Balance Sheet Line Item September 30, 2020 March 31, 2020
Derivatives designated for hedge accounting:
Foreign currency forward contracts Other current assets $ 5  $ — 
Total fair value of derivatives designated for hedge accounting $ 5  $ — 
Derivatives not designated for hedge accounting:
Foreign currency forward contracts Other current assets $ 3  $ 16 
Total fair value of derivatives not designated for hedge accounting $ 3  $ 16 

Derivative Liabilities
As of
(in millions) Balance Sheet Line Item September 30, 2020 March 31, 2020
Derivatives designated for hedge accounting:
Foreign currency forward contracts Accrued expenses and other current liabilities $ 2  $ 20 
Total fair value of derivatives designated for hedge accounting: $ 2  $ 20 
Derivatives not designated for hedge accounting:
Foreign currency forward contracts Accrued expenses and other current liabilities $ 7  $ 12 
Total fair value of derivatives not designated for hedge accounting $ 7  $ 12 


The fair value of foreign currency forward contracts represents the estimated amount required to settle the contracts using current market exchange rates and is based on the period-end foreign currency exchange rates and forward points which are classified as Level 2 inputs.
24
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Other Risks for Derivative Instruments

The Company is exposed to the risk of losses in the event of non-performance by the counterparties to its derivative contracts. The amount subject to credit risk related to derivative instruments is generally limited to the amount, if any, by which a counterparty's obligations exceed the obligations of the Company with that counterparty. To mitigate counterparty credit risk, the Company regularly reviews its credit exposure and the creditworthiness of the counterparties. With respect to its foreign currency derivatives, as of September 30, 2020, there were six counterparties with concentration of credit risk, and based on gross fair value, the maximum amount of loss that the Company could incur is approximately $1 million.

The Company also enters into enforceable master netting arrangements with some of its counterparties. However, for financial reporting purposes, it is the Company's policy not to offset derivative assets and liabilities despite the existence of enforceable master netting arrangements. The potential effect of such netting arrangements on the Company's balance sheets is not material for the periods presented.

Non-Derivative Financial Instruments Designated for Hedge Accounting

The Company applies hedge accounting for foreign currency-denominated debt used to manage foreign currency exposures on its net investments in certain non-U.S. operations. To qualify for hedge accounting, the hedging instrument must be highly effective at reducing the risk from the exposure being hedged.

Net Investment Hedges

DXC seeks to reduce the impact of fluctuations in foreign exchange rates on its net investments in certain non-U.S. operations with foreign currency-denominated debt. For foreign currency-denominated debt designated as a hedge, the effectiveness of the hedge is assessed based on changes in spot rates. For qualifying net investment hedges, all gains or losses on the hedging instruments are included in currency translation. Gains or losses on individual net investments in non-U.S. operations are reclassified to earnings from accumulated other comprehensive loss when such net investments are sold or substantially liquidated.

As of September 30, 2020, DXC had $1.5 billion of foreign currency-denominated debt designated as hedges of net investments in non-U.S. subsidiaries. As of March 31, 2020, DXC had $1.9 billion of foreign currency-denominated debt designated as hedges of net investments in non-U.S. subsidiaries. For the three and six months ended September 30, 2020, the pre-tax impact of loss on foreign currency-denominated debt designated for hedge accounting recognized in other comprehensive loss was $(61) million and $(89) million, respectively.

25
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 10 - Intangible Assets

Intangible assets consisted of the following:
As of September 30, 2020
(in millions) Gross Carrying Value Accumulated Amortization Net Carrying Value
Software $ 4,006  $ 2,819  $ 1,187 
Customer related intangible assets 4,246  1,502  2,744 
Other intangible assets 258  43  215 
Total intangible assets $ 8,510  $ 4,364  $ 4,146 

On September 30, 2020, in conjunction with the classification of the HHS Business' assets being held for sale, $1,308 million in customer related intangible assets, software, and related accumulated amortization were transferred to assets held for sale on the Consolidated Balance Sheet. Amortization of intangible assets ceased upon being classified as held for sale.

As of March 31, 2020
(in millions) Gross Carrying Value Accumulated Amortization Net Carrying Value
Software $ 4,048  $ 2,614  $ 1,434 
Customer related intangible assets 5,795  1,697  4,098 
Other intangible assets 235  36  199 
Total intangible assets $ 10,078  $ 4,347  $ 5,731 

The components of amortization expense were as follows:
Three Months Ended Six Months Ended
(in millions) September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Intangible asset amortization $ 258  $ 239  $ 511  $ 475 
Transition and transformation contract cost amortization(1)
67  59  128  126 
Total amortization expense $ 325  $ 298  $ 639  $ 601 
        

(1)Transition and transformation contract costs are included within other assets on the balance sheet.

Estimated future amortization related to intangible assets as of September 30, 2020 is as follows:

Fiscal Year (in millions)
Remainder of 2021 $ 458 
2022 $ 820 
2023 $ 755 
2024 $ 625 
2025 $ 573 
26
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 11 - Goodwill

The following table summarizes the changes in the carrying amount of goodwill, by segment, as of September 30, 2020.
(in millions) GBS GIS Total
Goodwill, gross $ 6,507  $ 5,066  $ 11,573 
Accumulated impairment losses (4,490) (5,066) (9,556)
Balance as of March 31, 2020, net $ 2,017  $ —  $ 2,017 
Acquisition related adjustments 23  —  23 
Foreign currency translation 39  —  39 
Assets held for sale (1,354) —  (1,354)
Goodwill, gross 5,215  5,066  10,281 
Accumulated impairment losses (4,490) (5,066) (9,556)
Balance as of September 30, 2020, net $ 725  $ —  $ 725 

The foreign currency translation amount reflects the impact of currency movements on non-U.S. dollar-denominated goodwill balances.

On September 30, 2020, in conjunction with the classification of the HHS Business' assets being held for sale, $1,354 million in goodwill was transferred to assets held for sale on the Consolidated Balance Sheet.

Goodwill Impairment Analyses

The Company tests goodwill for impairment on an annual basis, as of the first day of the second fiscal quarter, and between annual tests if circumstances change, or if an event occurs that would more likely than not reduce the fair value of a reporting unit below its carrying amount.

The Company concluded that as a result of its qualitative assessment performed on July 1, 2020, it remained more likely than not that the fair value of the GBS reporting unit exceeds its carrying amount.

As of September 30, 2020, the Company assessed whether there were events or changes in circumstances that would more likely than not reduce the fair value of any of its reporting units below its carrying amount and require goodwill to be tested for impairment. The Company determined that there have been no such indicators and therefore, it was unnecessary to perform an interim goodwill impairment test as of September 30, 2020.

27
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 12 - Debt

The following is a summary of the Company's debt:
(in millions) Interest Rates Fiscal Year Maturities September 30, 2020 March 31, 2020
Short-term debt and current maturities of long-term debt
Commercial paper(1)
(0.22)% - 0.44%
2021 - 2022 $ 900  $ 542 
Current maturities of long-term debt
Various 2021 - 2022 282  290 
Current maturities of finance lease liabilities
0.62% - 18.47%
2021 - 2022 440  444 
Short-term debt and current maturities of long-term debt $ 1,622  $ 1,276 
Long-term debt, net of current maturities
AUD term loan
0.94% - 0.96%(2)
2022 358  489 
GBP term loan
0.88% - 1.46%
2022 —  556 
EUR term loan
0.65%(3)
2022 - 2023 292  822 
EUR term loan
0.80%(4)
2023 - 2024 876  821 
USD term loan
1.40% - 2.24%(5)
2025 380  480 
$274 million Senior notes
4.45% 2023 276  276 
$171 million Senior notes
4.45% 2023 172  172 
$500 million Senior notes
4.25% 2025 504  505 
$500 million Senior notes
4.00% 2024 497  — 
$500 million Senior notes
4.13% 2026 496  — 
£250 million Senior notes
2.75% 2025 320  307 
€650 million Senior notes
1.75% 2026 758  709 
$500 million Senior notes
4.75% 2028 507  507 
$234 million Senior notes
7.45% 2030 270  271 
Revolving credit facility
1.26% - 2.08%
2024 - 2025 1,250  1,500 
Lease credit facility
1.15% - 1.99%
2021 - 2023 6  11 
Finance lease liabilities
0.62% - 18.47%
2021 - 2027 1,008  1,046 
Borrowings for assets acquired under long-term financing
0.00% - 6.39%
2021 - 2028 730  802 
Mandatorily redeemable preferred stock outstanding 6.00% 2023 63  62 
Other borrowings Various 2021 - 2022 5  70 
Long-term debt 8,768  9,406 
Less: current maturities 722  734 
Long-term debt, net of current maturities $ 8,046  $ 8,672 
        

(1)At DXC's option, DXC can borrow up to a maximum of €1 billion or its equivalent in €, £, and $. Under this existing €1.0 billion commercial paper program, the Company issued £600 million via direct sale to the Bank of England.
(2) Variable interest rate equal to the bank bill swap bid rate for a one-, two-, three- or six-month interest period plus 0.60% to 0.95% based on the published credit ratings of DXC.
(3) At DXC's option, the EUR term loan bears interest at the Eurocurrency Rate for a one-, two-, three-, or six-month interest period, plus a margin between 0.40% and 0.90%, based on published credit ratings of DXC.
(4) At DXC's option, the EUR term loan bears interest at the Eurocurrency Rate for a one-, two-, three-, or six-month interest period, plus a margin between 0.55% and 1.05%, based on published credit ratings of DXC.
(5) At DXC's option, the USD term loan bears interest at the Eurocurrency Rate for a one-, two-, three-, or six-month interest period, plus a margin between 1.00% and 1.50%, based on published credit ratings of DXC or the Base Rate plus a margin between 0.00% and 0.50%, based on published credit ratings of DXC.

Senior Notes and Term Loans

During the first quarter of fiscal 2021, the Company issued two senior notes with an aggregate principal of $1.0 billion consisting of (i) $500 million of 4.00% Senior Notes due fiscal 2024 and (ii) $500 million of 4.13% Senior Notes due fiscal 2026. The proceeds from these notes were applied towards the early prepayment of our term loan facilities including prepayment of €500 million of Euro Term Loan due fiscal 2023, £150 million of GBP Term Loan due fiscal 2022, A$300 million of AUD Term Loan due fiscal 2022, and $100 million of USD Term Loan due fiscal 2025.
28
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

During the second quarter of fiscal 2021, the Company repaid the remaining £300 million GBP Term Loan due fiscal 2022.

Interest on the Company's term loans is payable monthly or quarterly in arrears at the election of the borrowers. The Company fully and unconditionally guarantees term loans issued by its 100% owned subsidiaries. The interest on the Company's senior notes is payable semi-annually in arrears except for interest on the £250 million Senior Notes due fiscal 2025 and the €650 million Senior Notes due fiscal 2026, which are payable annually in arrears. Generally, the Company's notes are redeemable at the Company's discretion at the then-applicable redemption premium plus accrued interest.

Revolving Credit Facility

During the first quarter of fiscal 2021, the Company borrowed the remaining $2.5 billion under the $4.0 billion credit facility agreement ("Credit Agreement") as a precautionary measure to increase its cash position and increase financial flexibility in light of continuing uncertainty in the global economy and financial capital markets resulting from COVID-19.

The Company repaid $2,750 million during the first six months of fiscal 2021, which became available under the revolving credit facility for redraw at the request of the Company.

The Company expects to use the proceeds from the borrowings under the Credit Agreement for working capital, general corporate purposes or other purposes permitted under the Credit Agreement. Borrowings under the Credit Agreement will bear interest at a variable rate based on LIBOR or on a base rate, plus an individual margin based on DXC’s long-term debt rating.

In connection with the completion of the HHS Sale in October 2020, DXC used the proceeds from the sale to pay down additional debt. See Note 22 - "Subsequent Events" for details.


29
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 13 - Revenue

Revenue Recognition

The following table presents DXC's revenues disaggregated by geography, based on the location of incorporation of the DXC entity providing the related goods or services:
Three Months Ended Six Months Ended
(in millions) September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
United States $ 1,666  $ 1,806  $ 3,375  $ 3,657 
United Kingdom 579  678  1,152  1,393 
Other Europe 1,244  1,260  2,449  2,490 
Australia 390  366  751  739 
Other International 675  741  1,329  1,462 
Total Revenues $ 4,554  $ 4,851  $ 9,056  $ 9,741 

The revenue by geography pertains to both of the Company’s reportable segments. Refer to Note 20 - "Segment Information" for the Company’s segment disclosures.

Remaining Performance Obligations

Remaining performance obligations represent the aggregate amount of the transaction price in contracts allocated to performance obligations not delivered, or partially undelivered, as of the end of the reporting period. Remaining performance obligation estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, periodic revalidations, adjustments for revenue that have not materialized and adjustments for currency. As of September 30, 2020, approximately $23 billion of revenue is expected to be recognized from remaining performance obligations. We expect to recognize revenue on approximately 25% of these remaining performance obligations in fiscal 2021, with the remainder of the balance recognized thereafter.

Contract Balances

The following table provides information about the balances of the Company's trade receivables and contract assets and contract liabilities:
As of
(in millions) September 30, 2020 March 31, 2020
Trade receivables, net $ 2,950  $ 3,059 
Contract assets $ 413  $ 454 
Contract liabilities $ 1,671  $ 1,756 

Change in contract liabilities were as follows:
Six Months Ended
(in millions) September 30, 2020 September 30, 2019
Balance, beginning of period $ 1,756  $ 1,886 
Deferred revenue 1,355  1,400 
Recognition of deferred revenue (1,432) (1,416)
Currency translation adjustment 80  (48)
Other(1)
(88) (22)
Balance, end of period $ 1,671  $ 1,800 
        
(1) Other includes $51 million of contract liabilities reclassified as liabilities related to assets held for sale on the Consolidated Balance Sheet,
in conjunction with HHS Business classified as assets held for sale.
30
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 14 - Restructuring Costs

The Company recorded restructuring costs of $265 million and $32 million, net of reversals, for the three months ended September 30, 2020 and September 30, 2019, respectively. For the six months ended September 30, 2020 and September 30, 2019, the Company recorded restructuring costs of $337 million and $174 million, net of reversals, respectively. The costs recorded during the three and six months ended September 30, 2020 were largely a result of the Fiscal 2021 Plan (defined below).

The composition of restructuring liabilities by financial statement line item is as follows:
As of
(in millions) September 30, 2020
Accrued expenses and other current liabilities $ 289 
Other long-term liabilities 76 
Total $ 365 

Summary of Restructuring Plans

Fiscal 2021 Plan

During fiscal 2021, management approved global cost savings initiatives designed to better align the Company's workforce and facility structures (the "Fiscal 2021 Plan").

Fiscal 2020 Plan

During fiscal 2020, management approved cost savings initiatives designed to reduce operating costs by re-balancing its workforce and facilities structures (the "Fiscal 2020 Plan"). The Fiscal 2020 Plan includes workforce optimization programs and facilities and data center rationalization. Costs incurred to date under the Fiscal 2020 Plan total $283 million, comprising $266 million in employee severance and $17 million of facilities costs.

Fiscal 2019 Plan

During fiscal 2019, management approved global cost savings initiatives designed to better align the Company's organizational structure with its strategic initiatives and continue the integration of the Enterprise Services business of Hewlett Packard Enterprise Company ("HPES") and other acquisitions (the "Fiscal 2019 Plan"). The Fiscal 2019 Plan includes workforce optimization and rationalization of facilities and data center assets. Costs incurred to date under the Fiscal 2019 Plan total $476 million, comprising $335 million in employee severance and $141 million of facilities costs.

Other Prior Year Plans

In June 2017, management approved a post-HPES Merger (as defined below) restructuring plan to optimize the Company's operations in response to a continuing business contraction (the "Fiscal 2018 Plan"). The Fiscal 2018 Plan focuses mainly on optimizing specific aspects of global workforce, increasing the proportion of work performed in low cost offshore locations and re-balancing the organizational structure. Additionally, this plan included global facility restructuring, including a global data center restructuring program. Costs incurred to date under the Fiscal 2018 Plan total $986 million, comprising $790 million in employee severance and $196 million of facilities costs.

Acquired Restructuring Liabilities

As a result of the merger of Computer Sciences Corporation ("CSC") and HPES ("HPES Merger"), DXC acquired restructuring liabilities under restructuring plans that were initiated for HPES under plans approved by the HPE Board of Directors.

31
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Restructuring Liability Reconciliations by Plan
Restructuring Liability as of March 31, 2020
Costs Expensed, Net of Reversals(1)
Costs Not Affecting Restructuring Liability(2)
Cash Paid
Other(3)
Restructuring Liability as of September 30, 2020
Fiscal 2021 Plan
Workforce Reductions $ —  $ 340  $ (4) $ (89) $ —  $ 247 
Facilities Costs —  13  (4) (6) —  3 
Total $ —  $ 353  $ (8) $ (95) $ —  $ 250 
Fiscal 2020 Plan
Workforce Reductions $ 74  $ (5) $ 2  $ (38) $ 4  $ 37 
Facilities Costs 2  (4) 4  (2) —  — 
Total $ 76  $ (9) $ 6  $ (40) $ 4  $ 37 
Fiscal 2019 Plan
Workforce Reductions $ 25  $ (3) $ (2) $ (9) $ 1  $ 12 
Facilities Costs 5  (3) 2  —  1  5 
Total $ 30  $ (6) $ —  $ (9) $ 2  $ 17 
Other Prior Year Plans
Workforce Reductions $ 24  $ —  $ 3  $ (11) $ 2  $ 18 
Facilities Costs —  —  —  —  —  — 
Total $ 24  $ —  $ 3  $ (11) $ 2  $ 18 
Acquired Liabilities
Workforce Reductions $ 39  $ —  $ —  $ (3) $ —  $ 36 
Facilities Costs 11  (1) 1  (2) (2) 7 
Total $ 50  $ (1) $ 1  $ (5) $ (2) $ 43 
        

(1) Costs expensed, net of reversals include $11 million, $10 million, and $3 million of costs reversed from the Fiscal 2020 Plan, Fiscal 2019 Plan and Other Prior Year Plans, respectively.
(2) Costs Not Affecting Restructuring Liability include pension benefit augmentations recorded as a pension liability, asset impairments and restructuring costs associated with right-of-use assets.
(3)Other include foreign currency translation adjustments.
32
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 15 - Pension and Other Benefit Plans

The Company offers a number of pension and other post-retirement benefit ("OPEB") plans, life insurance benefits, deferred compensation and defined contribution plans. Most of the Company's pension plans are not admitting new participants, except where locally required; therefore, changes to pension liabilities are primarily due to market fluctuations of investments for existing participants and changes in interest rates.

Defined Benefit Plans

The Company sponsors a number of defined benefit and post-retirement medical benefit plans for the benefit of eligible employees. The benefit obligations of the Company's U.S. pension, U.S. OPEB, and non-U.S. OPEB represent an insignificant portion of the Company's pension and other post-retirement benefits. As a result, the disclosures below include the Company's U.S. and non-U.S. pension plans on a global consolidated basis.

During the three months ended June 30, 2020, the Company remeasured plan assets and liabilities as of June 1, 2020 under certain U.K. pension plans due to the end of a public sector contract. The remeasurement resulted in a net loss of $2 million, comprising a curtailment gain of $9 million and an actuarial loss of $11 million. The net loss was recognized within other income.

The components of net periodic pension income were:
Three Months Ended Six Months Ended
(in millions) September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Service cost $ 23  $ 23  $ 45  $ 46 
Interest cost 61  57  119  117 
Expected return on assets (161) (154) (314) (315)
Amortization of prior service costs (2) (2) (4) (4)
Contractual termination benefit 3  6  3  17 
Curtailment gain —  —  (9) — 
Recognition of actuarial loss —  —  11  — 
Net periodic pension income $ (76) $ (70) $ (149) $ (139)

The service cost component of net periodic pension income is presented in cost of services and selling, general and administrative and the other components of net periodic pension income are presented in other income, net, except for contractual termination benefit which is included in restructuring, in the Company’s statements of operations.

Deferred Compensation Plans

Effective as of the HPES Merger, DXC assumed sponsorship of the Computer Sciences Corporation Deferred Compensation Plan, which was renamed the “DXC Technology Company Deferred Compensation Plan” (the “DXC DCP”) and adopted the Enterprise Services Executive Deferred Compensation Plan (the “ES DCP”). Both plans are non-qualified deferred compensation plans maintained for a select group of management, highly compensated employees and non-employee directors.

The DXC DCP covers eligible employees who participated in CSC’s Deferred Compensation Plan prior to the HPES Merger. The ES DCP covers eligible employees who participated in the HPE Executive Deferred Compensation Plan prior to the HPES Merger. Both plans allow participating employees to defer the receipt of current compensation to a future distribution date or event above the amounts that may be deferred under DXC’s tax-qualified 401(k) plan, the DXC Technology Matched Asset Plan. Neither plan provides for employer contributions. As of April 3, 2017, the ES DCP does not admit new participants.

33
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Certain management and highly compensated employees are eligible to defer all, or a portion of, their regular salary that exceeds the limitation set forth in Internal Revenue Section 401(a)(17) and all or a portion of their incentive compensation. Non-employee directors are eligible to defer up to 100% of their cash compensation. The liability, which is included in other long-term liabilities in the Company's balance sheets, amounted to $45 million as of September 30, 2020 and $48 million as of March 31, 2020.

Note 16 - Income Taxes

The Company's effective tax rate ("ETR") was 19.6% and (5.8)% for the three months ended September 30, 2020 and September 30, 2019, respectively, and 16.2% and (8.6)% for the six months ended September 30, 2020 and September 30, 2019, respectively. For the three and six months ended September 30, 2020, the primary drivers of the ETR were the global mix of income, foreign tax credits and adjustment of the prior tax provisions due to the filing of tax returns in the U.S and the non-U.S. jurisdictions. For the three and six months ended September 30, 2019, the primary drivers of the ETR were the impact of the non-deductible goodwill impairment charge, the non-taxable gain on the arbitration award, the global mix of income, an increase in unrecognized tax benefits primarily related to the disallowance of certain legacy CSC foreign restructuring expenses deducted on the U.S. federal tax return for tax year March 31, 2013 and an increase in prior year U.S. federal research and development income tax credits.

The majority of unremitted foreign earnings have been taxed in the U.S. We expect a significant portion of the unremitted earnings of our foreign subsidiaries will no longer be subject to U.S. federal income tax upon repatriation to the U.S. However, a portion of these earnings may still be subject to foreign and U.S. state tax consequences when remitted. Earnings in India are indefinitely reinvested. Other foreign earnings are not indefinitely reinvested except for approximately $521 million that could be taxable when repatriated to the U.S. under Treasury regulations that were issued during the first quarter of fiscal 2020.

In connection with the HPES Merger, the Company entered into a tax matters agreement with HPE. HPE generally will be responsible for pre-HPES Merger tax liabilities including adjustments made by tax authorities to HPES U.S. and non-U.S. income tax returns. Likewise, DXC is liable to HPE for income tax receivables and refunds which it receives related to pre-HPES Merger periods. Pursuant to the tax matters agreement, the Company recorded a net payable of $6 million due to $44 million of tax indemnification receivable related to uncertain tax positions net of related deferred tax benefits, $91 million of tax indemnification receivable related to other tax payables and $141 million of tax indemnification payable related to other tax receivables.

In connection with the USPS Separation, the Company entered into a tax matters agreement with Perspecta. Pursuant to the tax matters agreement, the Company generally will be responsible for tax liabilities arising prior to the USPS Separation. Income tax liabilities transferred to Perspecta primarily relate to pre-HPES Merger periods, for which the Company is indemnified by HPE pursuant to the tax matters agreement between the Company and HPE. The Company remains liable to HPE for tax receivables and refunds which it receives from Perspecta related to pre-HPES Merger periods that were transferred to Perspecta. Pursuant to the tax matters agreement, the Company has recorded a tax indemnification receivable from Perspecta of $92 million and a tax indemnification payable to Perspecta of $49 million related to income tax and other tax liabilities.

The IRS is examining the Company's federal income tax returns for fiscal 2008 through tax year ended October 31, 2019. With respect to CSC's fiscal 2008 through 2010 federal tax returns, the Company previously entered into negotiations for a resolution through settlement with the IRS Office of Appeals. The IRS examined several issues for this audit that resulted in various audit adjustments. The Company and the IRS Office of Appeals have an agreement in principle as to some, but not all of these adjustments. The Company has agreed to extend the statute of limitations associated with this audit through March 31, 2021.

The Company has agreed to extend the statute of limitations associated with the fiscal years 2011 through 2013 through March 31, 2021. The Company has agreed to extend the statute of limitations for fiscal years 2014 through fiscal 2017 through October 31, 2021 and for the employment tax audit of fiscal years 2015 and 2016 until December 31, 2021. The Company expects to reach a resolution for all years no earlier than the third quarter of fiscal 2022 except agreed issues related to fiscal 2008 through 2010 and fiscal 2011 through 2013 federal tax returns, which are expected to be resolved within twelve months.
34
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

In addition, the Company may settle certain other tax examinations, have lapses in statutes of limitations, or voluntarily settle income tax positions in negotiated settlements for different amounts than the Company has accrued as uncertain tax positions. In the second quarter of fiscal 2021 the Company’s liability for uncertain tax positions decreased by $3 million (excluding interest and penalties and related tax attributes) primarily related to the disallowance of certain legacy CSC foreign restructuring expenses deducted in the U.S. The Company may need to accrue and ultimately pay additional amounts for tax positions that previously met a more-likely-than-not standard if such positions are not upheld. Conversely, the Company could settle positions by payment with the tax authorities for amounts lower than those that have been accrued or extinguish a position through payment. The Company believes that the outcomes that are reasonably possible within the next 12 months may result in a reduction in liability for uncertain tax positions of $34 million to $39 million, excluding interest, penalties and tax carry-forwards.

Note 17 - Stockholders' Equity

Share Repurchases

On April 3, 2017, DXC announced the establishment of a share repurchase program approved by the Board of Directors with an initial authorization of $2.0 billion for future repurchases of outstanding shares of DXC common stock. On November 8, 2018, DXC's Board of Directors approved an incremental $2.0 billion share repurchase authorization. An expiration date has not been established for this repurchase plan. Share repurchases may be made from time to time through various means, including in open market purchases, 10b5-1 plans, privately-negotiated transactions, accelerated stock repurchases, block trades and other transactions, in compliance with Rule 10b-18 under the Exchange Act as well as, to the extent applicable, other federal and state securities laws and other legal requirements. The timing, volume, and nature of share repurchases pursuant to the share repurchase plan are at the discretion of management and may be suspended or discontinued at any time.

The shares repurchased are retired immediately and included in the category of authorized but unissued shares. The excess of purchase price over par value of the common shares is allocated between additional paid-in capital and retained earnings. There was no share repurchase activity during the six months ended September 30, 2020. The details of shares repurchased during the six months ended September 30, 2019 are shown below:
Fiscal 2020
Fiscal Period Number of Shares Repurchased Average Price Per Share Amount (in millions)
1st Quarter
Open market purchases 5,510,415  $ 54.44  $ 300 
Accelerated stock repurchases 1,849,194  54.08  100 
1st Quarter Total 7,359,609  $ 54.35  $ 400 
2nd Quarter
Open market purchases 4,414,840  $ 33.96  $ 150 
Accelerated stock repurchases 1,805,350  $ 55.39  $ 100 
2nd Quarter Total 6,220,190  $ 40.18  $ 250 
Total 13,579,799  $ 47.86  $ 650 
35
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Accumulated Other Comprehensive Loss

The following table shows the changes in accumulated other comprehensive income (loss), net of taxes:
(in millions) Foreign Currency Translation Adjustments Cash Flow Hedges Available-for-sale Securities Pension and Other Post-retirement Benefit Plans Accumulated Other Comprehensive Loss
Balance at March 31, 2020 $ (851) $ (20) $ 9  $ 259  $ (603)
Current-period other comprehensive income 28  12  5  —  45 
Amounts reclassified from accumulated other comprehensive loss —  6  —  (10) (4)
Balance at September 30, 2020 $ (823) $ (2) $ 14  $ 249  $ (562)
(in millions) Foreign Currency Translation Adjustments Cash Flow Hedges Available-for-sale Securities Pension and Other Post-retirement Benefit Plans Accumulated Other Comprehensive Loss
Balance at March 31, 2019 $ (517) $ (3) $ 9  $ 267  $ (244)
Current-period other comprehensive loss (184) 2  2  —  (180)
Amounts reclassified from accumulated other comprehensive income (loss) —  —  —  (4) (4)
Balance at September 30, 2019 $ (701) $ (1) $ 11  $ 263  $ (428)

Note 18 - Stock Incentive Plans

Equity Plans

The Compensation Committee of the Board of Directors (the "Board") has broad authority to grant awards and otherwise administer the DXC Employee Equity Plan. The plan became effective March 30, 2017 and will continue in effect for a period of 10 years thereafter, unless earlier terminated by the Board. The Board has the authority to amend the plan in such respects as it deems desirable, subject to approval of DXC’s stockholders for material modifications.

Restricted stock units ("RSUs") represent the right to receive one share of DXC common stock upon a future settlement date, subject to vesting and other terms and conditions of the award, plus any dividend equivalents accrued during the award period. In general, if the employee’s status as a full-time employee is terminated prior to the vesting of the RSU grant in full, then the RSU grant is automatically canceled on the termination date and any unvested shares and dividend equivalents are forfeited. Certain executives were awarded service-based "career share" RSUs for which the shares are settled over the 10 anniversaries following the executive's separation from service as a full-time employee, provided the executive complies with certain non-competition covenants during that period. The Company also grants Performance-based restricted stock units ("PSUs"), which generally vest over a period of three years. The number of PSUs that ultimately vest is dependent upon the Company’s achievement of certain specified financial performance criteria over a three-year period. If the specified performance criteria are met, awards are settled for shares of DXC common stock and dividend equivalents upon the filing with the SEC of the Annual Report on Form 10-K for the last fiscal year of the performance period. PSU awards include the potential for up to 25% of the shares granted to be earned after the first and second fiscal years if certain of the Company's performance targets are met early, subject to vesting based on the participant's continued employment through the end of the three-year performance period.

In fiscal 2021, DXC issued awards that are considered to have a market condition. A Monte Carlo simulation model was used for the valuation of the grants. Settlement of shares for the fiscal 2021 PSU awards will be made at the end of the third fiscal year subject to certain compounded annual growth rates of the stock price and continued employment through the last day of the third fiscal year.

36
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
The terms of the DXC Director Equity Plan allow DXC to grant RSU awards to non-employee directors of DXC. Such RSU awards vest in full at the earlier of (i) the first anniversary of the grant date or (ii) the next annual meeting date, and are automatically redeemed for DXC common stock and dividend equivalents either at that time or, if an RSU deferral election form is submitted, upon the date or event elected by the director. Distributions made upon a director’s separation from the Board may occur in either a lump sum or in annual installments over periods of 5, 10, or 15 years, per the director’s election. In addition, RSUs vest in full upon a change in control of DXC.

The DXC Share Purchase Plan allows DXC’s employees located in the United Kingdom to purchase shares of DXC’s common stock at the fair market value of such shares on the applicable purchase date. There were 14,311 and 29,193 shares purchased under this plan during the three and six months ended September 30, 2020.

The Board has reserved for issuance shares of DXC common stock, par value $0.01 per share, under each of the plans as detailed below:
As of September 30, 2020
Reserved for Issuance Available for Future Grants
DXC Employee Equity Plan 51,200,000  31,705,400 
DXC Director Equity Plan 745,000  435,951 
DXC Share Purchase Plan 250,000  177,417 
Total 52,195,000  32,318,768 

Stock Options
Number
of Option Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(in millions)
Outstanding as of March 31, 2020 1,869,815  $ 29.92  4.27 $ — 
Granted —  $ — 
Exercised (4,328) $ 12.30  $ — 
Canceled/Forfeited —  $ — 
Expired (71,930) $ 31.05 
Outstanding as of September 30, 2020 1,793,557  $ 29.91  3.89 $ 1 
Vested and exercisable as of September 30, 2020 1,793,557  $ 29.91  3.89 $ 1 


Restricted Stocks
Employee Equity Plan Director Equity Plan
Number of
Shares 		Weighted
Average
Grant Date
Fair Value 		Number of
Shares
Weighted
Average
Grant Date
Fair Value
Outstanding as of March 31, 2020 4,174,476  $ 55.45  114,615  $ 37.69 
Granted 7,447,198  $ 17.05  118,500  $ 18.82 
Settled (802,392) $ 57.46  (47,090) $ 27.28 
Canceled/Forfeited (755,601) $ 36.90  —  $ — 
Outstanding as of September 30, 2020 10,063,681  $ 27.55  186,025  $ 28.31 

    
37
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Share-Based Compensation
Three Months Ended Six Months Ended
(in millions) September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Total share-based compensation cost $ 20  $ 30  $ 36  $ 48 
Related income tax benefit $ 3  $ 7  $ 5  $ 11 
Total intrinsic value of options exercised $ —  $ 1  $ —  $ 7 
Tax benefits from exercised stock options and awards $ 1  $ 1  $ 4  $ 10 

As of September 30, 2020, total unrecognized compensation expense related to unvested DXC stock options and unvested DXC RSUs, net of expected forfeitures was $0 million and $177 million, respectively. The unrecognized compensation expense for unvested RSUs is expected to be recognized over a weighted-average period of 2.20 years.

Note 19 - Cash Flows

Cash payments for interest on indebtedness and income taxes and other select non-cash activities are as follows:
Six Months Ended
(in millions) September 30, 2020 September 30, 2019
Cash paid for:
Interest $ 168  $ 178 
Taxes on income, net of refunds (1)
$ 84  $ 130 
Non-cash activities:
Operating:
ROU assets obtained in exchange for lease, net (2)
$ 410  $ 142 
   Prepaid assets acquired under long-term financing $ 43  $ 14 
Investing:
Capital expenditures in accounts payable and accrued expenses $ 46  $ 92 
Capital expenditures through finance lease obligations $ 205  $ 380 
Assets acquired under long-term financing $ 10  $ 248 
(Decrease) increase in deferred purchase price receivable $ (52) $ (204)
Contingent consideration $ 3  $ — 
Financing:
Dividends declared but not yet paid $ —  $ 55 
        
    
(1) Income tax refunds were $25 million and $20 million for the six months ended September 30, 2020 and September 30, 2019, respectively.
(2) Net of $87 million change in lease classification from operating to finance lease in fiscal 2020.
38
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 20 - Segment Information

DXC has a matrix form of organization and is managed in several different and overlapping groupings including services, industries and geographic regions. As a result, and in accordance with accounting standards, operating segments are organized by the type of services provided. DXC's chief operating decision maker ("CODM"), the chief executive officer, obtains, reviews, and manages the Company’s financial performance based on these segments. The CODM uses these results, in part, to evaluate the performance of, and allocate resources to, each of the segments.

Global Business Services ("GBS")

GBS provides innovative technology solutions that help its customers address key business challenges and accelerate digital transformations tailored to each customer's industry and specific objectives. GBS enterprise technology stack offerings include:

•Analytics and Engineering. GBS's portfolio of analytics services and extensive partner ecosystem help customers gain rapid insights, automate operations, and accelerate their digital transformation journeys. GBS provides software engineering and solutions that enable businesses to run and manage their mission-critical functions, transform their operations and develop new ways of doing business.
•Applications. GBS uses advanced technologies and methods to accelerate the creation, modernization, delivery and maintenance of high-quality, secure applications allowing customers to innovate faster while reducing risk, time to market, and total cost of ownership, across industries. GBS's vertical-specific IP includes solutions for insurance; banking and capital markets; and automotive, among others.

GBS offerings also includes business process services, which include digital integration and optimization of front and back office processes, and agile process automation. This helps companies to reduce cost, and minimize business disruption, human error, and operational risk while improving customer experiences.

Global Infrastructure Services ("GIS")

GIS provides a portfolio of technology offerings that deliver predictable outcomes and measurable results, while reducing business risk and operational costs for customers. GIS enterprise stack elements include:

•Cloud and Security. GIS helps customers to rapidly modernize by adapting legacy apps to cloud, migrate the right workloads, and securely manage their multi-cloud environments. GIS's security solutions help predict attacks, proactively respond to threats, ensure compliance and protect data, applications and infrastructure.
•IT Outsourcing ("ITO"). GIS's ITO services support infrastructure, applications, and workplace IT operations, including hardware, software, physical/virtual end-user devices, collaboration tools, and IT support services. GIS helps customers securely optimize operations to ensure continuity of their systems and respond to new business and workplace demands, while achieving cost takeout, all with limited resources, expertise and budget.

GIS offerings also include workplace and mobility services to fit its customer’s employee, business and IT needs from intelligent collaboration, modern device management, digital support services, Internet of Things ("IoT") and mobility services, providing a consumer-like, digital experience.

39
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Segment Measures

The following table summarizes operating results regularly provided to the CODM by reportable segment and a reconciliation to the financial statements:
(in millions) GBS GIS Total Reportable Segments All Other Totals
Three Months Ended September 30, 2020
Revenues $ 2,242  $ 2,312  $ 4,554  $ —  $ 4,554 
Segment profit $ 317  $ 36  $ 353  $ (70) $ 283 
Depreciation and amortization(1)
$ 59  $ 291  $ 350  $ 23  $ 373 
Three Months Ended September 30, 2019
Revenues $ 2,285  $ 2,566  $ 4,851  $ —  $ 4,851 
Segment profit $ 359  $ 243  $ 602  $ (73) $ 529 
Depreciation and amortization(1)
$ 39  $ 252  $ 291  $ 25  $ 316 


(in millions) GBS GIS Total Reportable Segments All Other Totals
Six Months Ended September 30, 2020
Revenues $ 4,416  $ 4,640  $ 9,056  $ —  $ 9,056 
Segment profit $ 532  $ 59  $ 591  $ (118) $ 473 
Depreciation and amortization(1)
$ 109  $ 558  $ 667  $ 50  $ 717 
Six Months Ended September 30, 2019
Revenues $ 4,444  $ 5,297  $ 9,741  $ —  $ 9,741 
Segment profit $ 725  $ 583  $ 1,308  $ (127) $ 1,181 
Depreciation and amortization(1)
$ 67  $ 527  $ 594  $ 54  $ 648 
        

(1) Depreciation and amortization as presented excludes amortization of acquired intangible assets of $152 million and $151 million for the three months ended September 30, 2020 and 2019, respectively, and $300 million and $289 million for the six months ended September 30, 2020 and 2019, respectively.

40
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Reconciliation of Reportable Segment Profit to Consolidated Total

The Company's management uses segment profit as the measure for assessing performance of its segments. Segment profit is defined as segment revenue less cost of services, segment selling, general and administrative, depreciation and amortization, and other income (excluding the movement in foreign currency exchange rates on DXC's foreign currency denominated assets and liabilities and the related economic hedges). The Company does not allocate to its segments certain operating expenses managed at the corporate level. These unallocated costs include certain corporate function costs, stock-based compensation expense, pension and OPEB actuarial and settlement gains and losses, restructuring costs, transaction, separation and integration-related costs and amortization of acquired intangible assets.
Three Months Ended Six Months Ended
(in millions) September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Profit
Total profit for reportable segments $ 353  $ 602  591  $ 1,308 
All other loss (70) (73) (118) (127)
Interest income 25  67  48  97 
Interest expense (96) (104) (202) (195)
Restructuring costs (265) (32) (337) (174)
Transaction, separation and integration-related costs
(101) (53) (211) (158)
Amortization of acquired intangible assets (152) (151) (300) (289)
Pension and OPEB actuarial and settlement losses —  —  (2) — 
Goodwill impairment losses —  (2,887) —  (2,887)
Gain on arbitration award —  632  —  632 
Loss before income taxes $ (306) $ (1,999) $ (531) $ (1,793)

Management does not use total assets by segment to evaluate segment performance or allocate resources. As a result, assets are not tracked by segment and therefore, total assets by segment is not disclosed.



41
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Note 21 - Commitments and Contingencies

Commitments

The Company signed long-term purchase agreements with certain software, hardware, telecommunication, and other service providers to obtain favorable pricing and terms for services, and products that are necessary for the operations of business activities. Under the terms of these agreements, the Company is contractually committed to purchase specified minimums over periods ranging from 1 to 5 years. If the Company does not meet the specified minimums, the Company would have an obligation to pay the service provider all, or a portion, of the shortfall. Minimum purchase commitments as of September 30, 2020 were as follows:
Fiscal year Minimum Purchase Commitment
(in millions)
Remainder of 2021 $ 1,558 
2022 1,047 
2023 860 
2024 269 
2025 25 
     Total $ 3,759 

In the normal course of business, the Company may provide certain clients with financial performance guarantees, and at times performance letters of credit or surety bonds. In general, the Company would only be liable for the amounts of these guarantees in the event that non-performance by the Company permits termination of the related contract by the Company’s client. The Company believes it is in compliance with its performance obligations under all service contracts for which there is a financial performance guarantee, and the ultimate liability, if any, incurred in connection with these guarantees will not have a material adverse effect on its consolidated results of operations or financial position.

The Company also uses stand-by letters of credit, in lieu of cash, to support various risk management insurance policies. These letters of credit represent a contingent liability and the Company would only be liable if it defaults on its payment obligations on these policies. The following table summarizes the expiration of the Company’s financial guarantees and stand-by letters of credit outstanding as of September 30, 2020:

(in millions)  Remainder of Fiscal 2021 Fiscal 2022 Fiscal 2023 and Thereafter Totals
Surety bonds $ 38  $ 262  $ 86  $ 386 
Letters of credit 58  135  462  655 
Stand-by letters of credit 61  15  24  100 
Totals $ 157  $ 412  $ 572  $ 1,141 

The Company generally indemnifies licensees of its proprietary software products against claims brought by third parties alleging infringement of their intellectual property rights, including rights in patents (with or without geographic limitations), copyrights, trademarks, and trade secrets. DXC’s indemnification of its licensees relates to costs arising from court awards, negotiated settlements, and the related legal and internal costs of those licensees. The Company maintains the right, at its own cost, to modify or replace software in order to eliminate any infringement. The Company has not incurred any significant costs related to licensee software indemnification.

Contingencies

Strauch Fair Labor Standards Act Collective Action: On July 1, 2014, several plaintiffs filed an action in the U.S. District Court for the District of Connecticut on behalf of themselves and a putative nationwide collective of CSC system administrators, alleging CSC’s failure to properly classify these employees as non-exempt under the federal Fair Labor Standards Act ("FLSA"). Plaintiffs alleged similar state-law Rule 23 class claims pursuant to Connecticut and California statutes. Plaintiffs claimed double overtime damages, liquidated damages, and other amounts and remedies.
42
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

In 2015 the Court entered an order granting conditional certification under the FLSA of the collective of over 4,000 system administrators. Approximately 1,000 system administrators filed consents with the Court to participate in the FLSA collective. The class/collective action is currently made up of approximately 800 individuals who held the title of associate professional or professional system administrator.

In June 2017, the Court granted Rule 23 certification of a Connecticut state-law class and a California state-law class consisting of professional system administrators and associate professional system administrators. Senior professional system administrators were found not to qualify for Rule 23 certification under the state-law claims. CSC sought permission to appeal the Rule 23 decision to the Second Circuit Court of Appeals, which was denied.

In December 2017, a jury trial was held and a verdict was returned in favor of plaintiffs. On August 6, 2019, the Court issued an order awarding plaintiffs $18.75 million in damages. In September 2019, Plaintiffs filed a motion seeking $14.1 million in attorneys’ fees and costs. In July 2020, the Court issued an order awarding Plaintiffs $8.1 million in attorneys’ fees and costs. The Company disagrees with the jury verdict, the damages award, and the fee award, and is appealing the judgment of the Court.

In October 2020, the Company reached an agreement in principle with the plaintiffs to resolve the matter. The Company plans to execute a settlement agreement and submit it to the Court for approval in November 2020.

Computer Sciences Corporation v. Eric Pulier, et al.: On May 12, 2015, CSC filed a civil complaint in the Court of Chancery of the State of Delaware against Eric Pulier, the former CEO of Service Mesh Inc. ("SMI"), which CSC had acquired in November 2013. The complaint asserted claims for fraud, breach of contract and breach of fiduciary duty, based on allegations that Mr. Pulier had engaged in fraudulent transactions with two employees of the Commonwealth Bank of Australia Ltd. (“CBA”). The Court dismissed CSC’s claim for breach of the implied covenant of good faith, but allowed substantially all of the remaining claims to proceed. Mr. Pulier asserted counter-claims for breach of contract, fraud, negligent representation, rescission, and violations of the California Blue Sky securities law, all of which the Court dismissed in whole or in part, except for claims for breach of Mr. Pulier’s retention agreement.

In July 2017, the Court granted a motion by the United States for a 90-day stay of discovery pending the completion of a criminal investigation by the U.S. Attorney’s Office for the Central District of California. In September 2017, a federal grand jury returned an indictment against Mr. Pulier, charging him with conspiracy, securities and wire fraud, obstruction of justice, and other violations of federal law (United States v. Eric Pulier, CR 17-599-AB). The Government sought an extension of the stay which the Delaware Chancery Court granted.

In December 2018, the Government filed an application to dismiss the indictment against Mr. Pulier, which was granted, and the indictment was dismissed with prejudice. In March 2019, the Delaware Chancery Court lifted the stay and denied CSC’s motion for a temporary restraining order and preliminary injunction with respect to certain of Mr. Pulier’s assets.

In August 2019, the Company entered into an agreement with Mr. Pulier, resolving all claims and counterclaims in the Delaware litigation through the division of amounts previously held in escrow for post-closing disputes.

The Securities and Exchange Commission (“SEC”) has filed a complaint against Mr. Pulier alleging various claims, including for fraud and falsifying books and records (Securities and Exchange Commission v. Eric Pulier, Case No. 2:17-cv-07124). The Court has set a trial date of December 1, 2020.

In February 2016, Mr. Pulier filed a complaint in Delaware Chancery Court seeking advancement of his legal fees and costs in the civil and criminal actions, pursuant to the terms of his agreements with SMI. The Court ruled that CSC Agility Platform - as the successor to SMI - is liable for advancing 80% of Mr. Pulier’s fees and costs in the civil and criminal actions. Pursuant to agreements with SMI, Mr. Pulier is obligated to repay all amounts advanced to him if it should ultimately be determined that he is not entitled to indemnification.

The Company remains obligated to advance amounts for Mr. Pulier’s legal fees and costs to defend the SEC action against him.

43
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Kemper Corporate Services, Inc. v. Computer Sciences Corporation: In October 2015, Kemper Corporate Services, Inc. (“Kemper”) filed a demand for arbitration against CSC with the American Arbitration Association (“AAA”), alleging that CSC breached the terms of a 2009 Master Software License and Services Agreement and related Work Orders (the “Agreement”) by failing to complete a software translation and implementation plan by certain contractual deadlines. Kemper claimed breach of contract, seeking approximately $100 million in damages. CSC answered the demand for arbitration denying Kemper’s claims and asserting a counterclaim for unpaid invoices for services rendered by CSC.

A single arbitrator conducted an evidentiary hearing on the merits of the claims and counterclaims in April 2017. In October 2017, the arbitrator issued a partial final award, finding for Kemper on its breach of contract theory, awarding Kemper $84.2 million in compensatory damages plus prejudgment interest, denying Kemper’s claim for rescission as moot, and denying CSC’s counterclaim. Kemper moved to confirm the award in federal district court in Texas.

CSC moved to vacate the award, and in August 2018, the Magistrate Judge issued its Report and Recommendation denying CSC's vacatur motion. In September 2018, the District Court summarily accepted the Report and Recommendation without further briefing and entered a Final Judgment in the case. The Company promptly filed a notice of appeal to the Fifth Circuit Court of Appeals. Following the submission of briefs, oral argument was held on September 5, 2019. On January 10, 2020, the Court of Appeals issued a decision denying the Company’s appeal. On January 24, 2020, the Company filed a Petition for Rehearing, seeking review by the entire en banc Court of Appeals. On February 14, 2020, the Court of Appeals denied the Company's Petition.

The Company has been pursuing coverage for the full scope of the award, interest, and legal fees and expenses, under the Company's applicable insurance policies. Certain carriers have accepted coverage while others have denied coverage. On February 21, 2020, the Company paid the balance of the judgment, which net of insurance recovery totalled $60 million. The Company has since recovered an additional $12.5 million from its insurance carriers. The Company continues to pursue recovery with its insurance carriers.

Forsyth, et al. v. HP Inc. and Hewlett Packard Enterprise:  On August 18, 2016, this purported class and collective action was filed in the U.S. District Court for the Northern District of California, against HP and HPE alleging violations of the Federal Age Discrimination in Employment Act (“ADEA”), the California Fair Employment and Housing Act, California public policy and the California Business and Professions Code. Former business units of HPE now owned by the Company may be proportionately liable for any recovery by plaintiffs in this matter.

Plaintiffs seek to certify a nationwide class action under the ADEA comprised of all U.S. residents employed by defendants who had their employment terminated pursuant to a work force reduction (“WFR”) plan and who were 40 years of age or older at the time of termination. The class seeks to cover those impacted by WFRs on or after December 2014. Plaintiffs also seek to represent a Rule 23 class under California law comprised of all persons 40 years of age or older employed by defendants in the state of California and terminated pursuant to a WFR plan on or after August 18, 2012.

In January 2017, defendants filed a partial motion to dismiss and a motion to compel arbitration of claims by certain named and opt-in plaintiffs who had signed release agreements as part of their WFR packages. In September 2017, the Court denied the partial motion to dismiss without prejudice, but granted defendants’ motions to compel arbitration for those named and opt-in plaintiffs. The Court has stayed the entire action pending arbitration for these individuals, and administratively closed the case.

A mediation was held in October 2018 with the 16 named and opt-in plaintiffs who were involved in the case at that time. A settlement was reached, which included seven plaintiffs who were employed by former business units of HPE that are now owned by the Company. In June 2019, a second mediation was held with 145 additional opt-in plaintiffs who were compelled to arbitration pursuant to their release agreements. In December 2019, a settlement was reached with 142 of the opt-in plaintiffs, 35 of whom were employed by former business units of HPE that are now owned by the Company, and for which the Company is liable.

Former business units of the Company now owned by Perspecta may be proportionately liable for any recovery by plaintiffs in this matter.

44
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
Oracle America, Inc., et al. v. Hewlett Packard Enterprise Company: On March 22, 2016, Oracle filed a complaint against HPE in the Northern District of California, alleging copyright infringement, interference with contract, intentional interference with prospective economic relations, and unfair competition. The litigation relates in part to former business units of HPE that are now owned by the Company. The Company may be required to indemnify HPE for a portion of any recovery by Oracle in the litigation related to these business units.

Oracle’s claims arise primarily out of HPE’s prior relationship with a third-party maintenance provider named Terix Computer Company, Inc. (“Terix”). Oracle claims that Terix infringed its copyrights while acting as HPE’s subcontractor for certain customers of HPE’s multivendor support business. Oracle claims that HPE is liable for vicarious and contributory infringement arising from the alleged actions of Terix and for direct infringement arising from its own alleged conduct.

On January 29, 2019, the court granted HPE’s motion for summary judgment and denied Oracle’s motion for summary judgment, resolving the matter in HPE’s favor. Oracle appealed the judgment to the U.S. Court of Appeals for the Ninth Circuit and in August 2020, the court granted Oracle’s appeal in part. The case has been remanded to the District Court for further proceedings.

In re DXC Technology Company Securities Litigation: On December 27, 2018, a purported class action lawsuit was filed in the United States District Court for the Eastern District of Virginia against the Company and two of its current officers. The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and is premised on allegedly false and/or misleading statements, and alleged non-disclosure of material facts, regarding the Company’s business, operations, prospects and performance during the proposed class period of February 8, 2018 to November 6, 2018. The Company moved to dismiss the claims in their entirety, and on June 2, 2020, the court granted the Company’s motion, dismissing all claims and entering judgment in the Company’s favor. On July 1, 2020, the plaintiffs filed a notice of appeal to the U.S. Court of Appeals for the Fourth Circuit. The appeal remains pending.

In March 2019, three related shareholder derivative lawsuits were filed in the Eighth Judicial District Court of the State of Nevada, in and for Clark County, against one of the Company’s current officers and a former officer as well as members of the Company’s board of directors, asserting claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment. By agreement of the parties and order of the court, those lawsuits were consolidated on July 18, 2019, and are presently stayed pending the outcome of the appeal of the Eastern District of Virginia matter.

On August 20, 2019, a purported class action lawsuit was filed in the Superior Court of the State of California, County of Santa Clara, against the Company, directors of the Company, and a former officer of the Company, among other defendants. On September 16, 2019, a substantially similar purported class action lawsuit was filed in the United States District Court for the Northern District of California against the Company, directors of the Company, and a former officer of the Company, among other defendants. On November 8, 2019, a third purported class action lawsuit was filed in the Superior Court of the State of California, County of San Mateo, against the Company, directors of the Company, and a former officer of the Company, among other defendants. The third lawsuit was voluntarily dismissed by the plaintiff and re-filed in the Superior Court of the State of California, County of Santa Clara on November 26, 2019, and thereafter was consolidated with the earlier-filed action in the same court on December 10, 2019. The California lawsuits assert claims under Sections 11, 12 and 15 of the Securities Act of 1933, as amended, and are premised on allegedly false and/or misleading statements, and alleged non-disclosure of material facts, regarding the Company’s prospects and expected performance. Plaintiff in the federal action filed an amended complaint on January 8, 2020. The putative class of plaintiffs in these cases includes all persons who acquired shares of the Company’s common stock pursuant to the offering documents filed with the Securities and Exchange Commission in connection with the April 2017 transaction that formed DXC. On July 15, 2020, the Superior Court of California, County of Santa Clara, denied the Company’s motion to stay the state court case but extended the Company’s deadline to seek dismissal of the state action, until after a decision on the Company’s motion to dismiss the federal action. On July 27, 2020, the United States District Court for the Northern District of California granted the Company’s motion to dismiss the federal action. The Court’s order permitted plaintiffs to amend and refile their complaint within 60 days, and on September 25, 2020, the plaintiffs filed an amended complaint. The Company plans to file a motion to dismiss the amended complaint.

45
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
On October 2, 2019, a shareholder derivative lawsuit was filed in the Eighth Judicial District Court of the State of Nevada, in and for Clark County, asserting various claims, including for breach of fiduciary duty and unjust enrichment, and challenging certain sales of securities by officers under Rule 10b5-1 plans. The shareholder filed this action after making a demand on the board of directors, alleging breaches of fiduciary duty, corporate waste and disclosure violations, and demanding that the Board take certain actions to evaluate the allegations and respond. The Company’s board of directors analyzed the demand, and has determined to defer its decision on the demand pending developments in the securities and derivative lawsuits described above. The Company moved to dismiss the complaint on the basis that the Board’s decision to defer action was not a refusal of the demand and was within its discretion. The Company’s motion to dismiss was denied on January 22, 2020. By agreement of the parties and order of the court, the case is presently stayed, pending the outcome of the appeal of the Eastern District of Virginia matter.
On March 31, 2020, a group of individual shareholders filed a complaint in the United States District Court for the Northern District of California, asserting non-class claims based on allegations substantially similar to those at issue in the earlier-filed putative class action complaints pending in the Northern District of California and Eastern District of Virginia. The plaintiffs assert claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and under Sections 11 and 15 of the Securities Act of 1933, as amended. On April 29, 2020, the court granted an administrative motion to relate the case with the earlier-filed putative class action pending in the Northern District of California. And on May 13, 2020, the parties filed a stipulation requesting to stay the case subject to resolution of the motions to dismiss in the Northern District of California and Eastern District of Virginia class actions.

The Company believes that the lawsuits described above are without merit, and it intends to vigorously defend them.

Voluntary Disclosure of Certain Possible Sanctions Law Violations: On February 2, 2017, CSC submitted an initial notification of voluntary disclosure to the U.S. Department of Treasury, Office of Foreign Assets Control ("OFAC") regarding certain possible violations of U.S. sanctions laws pertaining to insurance premium data and claims data processed by two partially-owned joint ventures of Xchanging, which CSC acquired during the first quarter of fiscal 2017. A copy of the disclosure was also provided to Her Majesty’s Treasury Office of Financial Sanctions Implementation in the United Kingdom. The Company provided supplemental information to OFAC on January 31, 2020.

Perspecta Arbitration: In October 2019, Perspecta Inc. (“Perspecta”) submitted a demand for arbitration claiming that in June 2018 DXC breached certain obligations under the Separation and Distribution Agreement ("SDA") between Perspecta and DXC and seeking at least $120 million in alleged damages. During the course of discovery, Perspecta increased the amount of its alleged damages, first to $500 million and then to over $800 million. Perspecta has since increased its damages calculations to include interest, bringing its total claim to $990 million. The Company believes there is no valid basis for Perspecta's claims for these amounts.

In its arbitration demand, Perspecta also challenges $39 million in invoices issued by DXC in June 2019 under its IT Services Agreement with Perspecta ("ITSA"). Perspecta subsequently challenged an additional $31 million sought by DXC in August 2020 under the ITSA. DXC believes the invoices were properly issued and the amounts are owed by Perspecta.

In October 2020, a hearing was held before an arbitration panel, during which the Company and Perspecta each presented evidence on the claims at issue. Closing arguments will take place in November 2020, after which the case will be submitted and the parties will await the decision of the arbitration panel.

46
DXC TECHNOLOGY COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
In addition to the matters noted above, the Company is currently subject in the normal course of business to various claims and contingencies arising from, among other things, disputes with customers, vendors, employees, contract counterparties and other parties, as well as securities matters, environmental matters, matters concerning the licensing and use of intellectual property, and inquiries and investigations by regulatory authorities and government agencies. Some of these disputes involve or may involve litigation. The financial statements reflect the treatment of claims and contingencies based on management's view of the expected outcome. DXC consults with outside legal counsel on issues related to litigation and regulatory compliance and seeks input from other experts and advisors with respect to matters in the ordinary course of business. Although the outcome of these and other matters cannot be predicted with certainty, and the impact of the final resolution of these and other matters on the Company’s results of operations in a particular subsequent reporting period could be material and adverse, management does not believe based on information currently available to the Company, that the resolution of any of the matters currently pending against the Company will have a material adverse effect on the financial position of the Company or the ability of the Company to meet its financial obligations as they become due. Unless otherwise noted, the Company is unable to determine at this time a reasonable estimate of a possible loss or range of losses associated with the foregoing disclosed contingent matters.

Note 22 - Subsequent Events

HHS Sale

On October 1, 2020, DXC completed the sale of its HHS Business to Veritas Capital. The sale was accomplished by the cash purchase of all equity interests and assets attributable to the HHS Business together with future services to be provided by the Company for a total enterprise value of $5.0 billion, subject to net working capital adjustments and assumed liabilities. The sale was not subject to any financing condition or shareholder approval. Following the transaction close, DXC retains its remaining healthcare practice, relating to the pending HPS sale.

Debt Repayments

DXC used the proceeds from the sale of the HHS Business to further strengthen its balance sheet and repaid approximately $3.5 billion of outstanding debt as of September 30, 2020. Except for £600 million (approximately $775 million) related to commercial paper, almost all of the remainder repayment related to bank debt including both remaining amounts drawn on the revolving credit facility and other outstanding term loans.

Termination of Milano Receivables Facility

On October 1, 2020, and in connection with the consummation of the sale of the HHS Business, the Milano Facility was terminated at the request of the buyer of the HHS Business. In connection with the termination, DXC paid the Milano Purchasers approximately $272 million on behalf of Milano Receivables SPV to repurchase HHS Business related commercial accounts receivable previously sold under the program as of the termination date. The Milano Receivables SPV, which owned all the accounts receivables of the HHS Business, including the repurchased accounts receivables, were part of the HHS Business that were transferred to Veritas Capital as part of the sale of the HHS Business.
47

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

All statements and assumptions contained in this Quarterly Report on Form 10-Q and in the documents incorporated by reference that do not directly and exclusively relate to historical facts constitute “forward-looking statements.” Forward-looking statements often include words such as “anticipates,” “believes,” “estimates,” “expects,” “forecast,” “goal,” “intends,” “objective,” “plans,” “projects,” “strategy,” “target,” and “will” and words and terms of similar substance in discussions of future operating or financial performance. These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved.

Forward-looking statements include, among other things, statements with respect to our financial condition, results of operations, cash flows, business strategies, operating efficiencies or synergies, divestitures, competitive position, growth opportunities, share repurchases, dividend payments, plans and objectives of management and other matters. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. Furthermore, many of these risks and uncertainties are currently amplified by and may continue to be amplified by or may, in the future, be amplified by, the coronavirus disease 2019 (“COVID-19”) pandemic and the impact of varying private and governmental responses that affect our customers, employees, vendors and the economies and communities where they operate.

Important factors that could cause actual results to differ materially from those described in forward-looking statements include, but are not limited to:

•the uncertainty of the magnitude, duration, geographic reach, impact on the global economy and current and potential travel restrictions, stay-at-home orders, economic restrictions implemented to address the COVID-19 pandemic;
•the current, and uncertain future, impact of the COVID-19 pandemic, as well as other emerging developments and disruption to economic activity, and their resulting impact on our clients that may affect our business, growth, prospects, financial condition, operating results, cash flows and liquidity;
•changes in governmental regulations or the adoption of new laws or regulations that may make it more difficult or expensive to operate our business;
•changes in senior management, the loss of key employees or the ability to retain and hire key personnel and maintain relationships with key business partners;
•the risk of liability or damage to our reputation resulting from security breaches, cyber-attacks or disclosure of sensitive data or failure to comply with data protection laws and regulations, including the ransomware attack recently experienced by our subsidiary, Xchanging;
•business interruptions in connection with our technology systems;
•the competitive pressures faced by our business;
•the effects of macroeconomic and geopolitical trends and events;
•the need to manage third-party suppliers and the effective distribution and delivery of our products and services;
•the protection of our intellectual property assets, including intellectual property licensed from third parties;
•the risks associated with international operations;
•the development and transition of new products and services and the enhancement of existing products and services to meet customer needs, respond to emerging technological trends and maintain and grow our customer relationships over time;
48

•the ability to succeed in our strategic objectives, including strategic alternatives material for our business;
•the ability to achieve the expected benefits of our restructuring plans;
•the ability to maintain and grow our customer relationships over time and to comply with customer contracts or government contracting regulations or requirements;
•the execution and performance of contracts by us and our suppliers, customers, clients and partners;
•our credit rating and the ability to manage working capital, refinance and raise additional capital for future needs;
•our substantial amount of indebtedness;
•our ability to remediate any material weakness and maintain effective internal control over financial reporting;
•the resolution of pending investigations, claims and disputes;
•the integration of Computer Sciences Corporation's ("CSC") and Enterprise Services business of Hewlett Packard Enterprise Company's ("HPES") businesses, operations, and culture and the ability to operate as effectively and efficiently as expected, and the combined company's ability to successfully manage and integrate acquisitions generally;
•the ability to realize the synergies and benefits expected to result from the merger of CSC and HPES (the "HPES Merger") within the anticipated time frame or in the anticipated amounts;
•other risks related to the HPES Merger including anticipated tax treatment, unforeseen liabilities, and future capital expenditures;
•the spin-off of our former U.S. public sector business and its related mergers with Vencore Holding Corp. and KeyPoint Government Solutions to form Perspecta Inc. (the "USPS") Separation and Mergers could result in substantial tax liability to DXC and our stockholders;
•risks relating to the respective abilities of the parties to our acquisition of Luxoft Holding, Inc. to achieve the expected results therefrom;
•risks relating to the consummation of sale of our healthcare provider software business to Dedalus, and the ability to achieve the expected results therefrom; and
•the other factors described in Part I Item 1A "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020 and Part II Item 1A "Risk Factors" of our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020 and of this Quarterly Report on Form 10-Q.

No assurance can be given that any goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect the occurrence of unanticipated events, except as required by law.
49

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Introduction

The purpose of the MD&A is to present information that management believes is relevant to an assessment and understanding of our results of operations and cash flows for the second quarter and first six months of fiscal 2021 and our financial condition as of September 30, 2020. The MD&A is provided as a supplement to, and should be read in conjunction with, our financial statements and accompanying notes.

The MD&A is organized into the following sections:
•Background
•Results of Operations
•Liquidity and Capital Resources
•Off-Balance Sheet Arrangements
•Contractual Obligations
•Critical Accounting Policies and Estimates

The following discussion includes a comparison of our results of operations and liquidity and capital resources for the second quarters and first six months of fiscal 2021 and fiscal 2020.

Background

DXC Technology helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. With decades of driving innovation, the world’s largest companies trust DXC to deploy our enterprise technology stack to deliver new levels of performance, competitiveness and customer experiences.

We generate revenue by offering a wide range of information technology services and solutions primarily in North America, Europe, Asia and Australia. We operate through two segments: Global Business Services ("GBS") and Global Infrastructure Services ("GIS"). We market and sell our services directly to clients through our direct sales force operating out of sales offices around the world. Our clients include commercial businesses of many sizes and in many industries and public sector enterprises.
50


Results of Operations

The following table sets forth certain financial data for the second quarters and first six months of fiscal 2021 and fiscal 2020:
Three Months Ended Six Months Ended
(In millions, except per-share amounts) September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Revenues $ 4,554  $ 4,851  $ 9,056  $ 9,741 
Loss before income taxes (306) (1,999) (531) (1,793)
Income tax (benefit) expense (60) 116  (86) 154 
Net loss $ (246) $ (2,115) $ (445) $ (1,947)
Diluted loss per share: $ (0.96) $ (8.19) $ (1.77) $ (7.44)

Fiscal 2021 Highlights

Financial highlights for the second quarter and first six months of fiscal 2021 include the following:

•Revenues for the second quarter and first six months of fiscal 2021 were $4.6 billion and $9.1 billion, respectively, a decrease of 6.1% and 7.0%, respectively, as compared to the second quarter and first six months of fiscal 2020. These decreases were primarily due to prior terminations and price-downs along with customer settlements that were actioned in the quarter. The decrease in revenue for the first six months of fiscal 2021 was partially offset by contributions from our Luxoft acquisition which was executed during the first quarter of fiscal 2020. Refer to the section below captioned "Revenues."
•Net loss and diluted loss per share for the second quarter of fiscal 2021 were $246 million and $0.96, respectively. Net loss decreased by $1,869 million during the second quarter of fiscal 2021 as compared to the same period of the prior fiscal year. The reduction was primarily due to goodwill impairment recognized in the prior year and cost optimization realized in the current year offset by a reduction in revenue previously mentioned and gain on arbitration in the prior year. Refer to the section below captioned "Cost and Expenses." Net loss included the cumulative impact of certain items of $407 million, reflecting restructuring costs, transaction, separation and integration-related costs, amortization of acquired intangible assets, and tax adjustment. This compares with net loss and diluted loss per share of $2,115 million and $8.19, respectively, for the second quarter of fiscal 2020.
•Net loss and diluted loss per share for the first six months of fiscal 2021 were $445 million and $1.77, respectively. Net loss decreased by $1,502 million during the first six months of fiscal 2021 as compared to the same period of the prior fiscal year. The reduction was primarily due to goodwill impairment recognized in the prior year and cost optimization realized in the current year offset by a reduction in revenue previously mentioned and gain on arbitration in the prior year. Refer to the section below captioned "Cost and Expenses." Net loss included the cumulative impact of certain items of $665 million, reflecting restructuring costs, transaction, separation and integration-related costs, amortization of acquired intangible assets, pension and other post-retirement benefit ("OPEB") actuarial and settlement losses, and tax adjustment. This compares with net loss and diluted loss per share of $1,947 million and $7.44, respectively, for the first six months of fiscal 2020.
•Our cash and cash equivalents were $3.1 billion as of September 30, 2020.
•We generated $591 million of cash from operations during the first six months of fiscal 2021, as compared to $1,585 million during the first six months of fiscal 2020.

51

Revenues
Three Months Ended
(in millions)
September 30, 2020 September 30, 2019 Change Percentage Change
GBS
$ 2,242  $ 2,285  $ (43) (1.9) %
GIS
2,312  2,566  (254) (9.9) %
Total Revenues
$ 4,554  $ 4,851  $ (297) (6.1) %

Six Months Ended
(in millions)
September 30, 2020 September 30, 2019 Change Percentage Change
GBS
$ 4,416  $ 4,444  $ (28) (0.6) %
GIS
4,640  5,297  (657) (12.4) %
Total Revenues
$ 9,056  $ 9,741  $ (685) (7.0) %

The decrease in revenues for the second quarter and first six months of fiscal 2021, compared with fiscal 2020 of the same period, reflects prior terminations and price-downs along with customer settlements that were actioned in the quarter. The decrease in revenue for the first six months of fiscal 2021 was partially offset by contributions from our Luxoft acquisition which was executed during the first quarter of fiscal 2020. Revenues for the second quarter included a favorable foreign currency exchange rate impact of 1.6% and an unfavorable foreign currency exchange rate impact of 0.2% for the first six months of fiscal 2021. These impacts were primarily driven by the weakening of the U.S. dollar against the Australian Dollar, Euro, and British Pound during the second quarter of fiscal 2021 and an overall strengthening of the U.S. dollar against those currencies for the first six months of fiscal 2021.
52


During the second quarter and first six months of fiscal 2021 and fiscal 2020, the distribution of our revenues across geographies was as follows:
DXC-20200930_G2.JPG

53

DXC-20200930_G3.JPG
For the discussion of risks associated with our foreign operations, see Part 1, Item 1A "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

As a global company, approximately 63% of our revenues for the first six months of fiscal 2021 were earned internationally. As a result, the comparison of revenues denominated in currencies other than the U.S. dollar, from period to period, is impacted by fluctuations in foreign currency exchange rates. Constant currency revenues are a non-GAAP measure calculated by translating current period activity into U.S. dollars using the comparable prior period’s currency conversion rates. This information is consistent with how management views our revenues and evaluates our operating performance and trends. The table below summarizes our constant currency revenues:

Three Months Ended
(in millions) Constant Currency September 30, 2020 September 30, 2019
Change
Percentage Change
GBS $ 2,207  $ 2,285  $ (78) (3.4) %
GIS 2,269  2,566  (297) (11.6) %
Total $ 4,476  $ 4,851  $ (375) (7.7) %

Six Months Ended
(in millions) Constant Currency September 30, 2020 September 30, 2019
Change
Percentage Change
GBS $ 4,419  $ 4,444  $ (25) (0.6) %
GIS 4,660  5,297  (637) (12.0) %
Total $ 9,079  $ 9,741  $ (662) (6.8) %

54

Global Business Services

Our GBS revenues were $2,242 million in the second quarter and $4,416 million in the first six months of fiscal 2021, a decrease of 1.9% and 0.6%, respectively, compared to the corresponding periods in fiscal 2020. GBS revenue in constant currency decreased 3.4% and 0.6% in the second quarter and first six months of fiscal 2021, respectively, as compared to the corresponding periods in fiscal 2020. The decrease in GBS revenues for the second quarter and first six months of fiscal 2021 were primarily due to prior terminations and price-downs along with customer settlements that we actioned in the quarter. The decrease in revenue for the first six months of fiscal 2021 was partially offset by contributions from our Luxoft acquisition which was executed during the first quarter of fiscal 2020.

For the second quarter and first six months of fiscal 2021, GBS contract awards were $2.4 billion and $5.9 billion, respectively, as compared to $1.9 billion and $4.3 billion in the corresponding periods of fiscal 2020.

Global Infrastructure Services

Our GIS revenues were $2,312 million in the second quarter and $4,640 million in the first six months of fiscal 2021, a decrease of 9.9% and 12.4%, respectively, compared to the corresponding periods in fiscal 2020. GIS revenue in constant currency decreased 11.6% and 12.0% in the second quarter and first six months of fiscal 2021, respectively, as compared to the corresponding periods in fiscal 2020. The decrease in GIS revenues for the second quarter and first six months of fiscal 2021 reflects prior terminations and price-downs along with customer settlements that we actioned in the quarter.

For the second quarter and first six months of fiscal 2021, GIS contract awards were $2.5 billion and $4.3 billion, respectively, as compared to $1.9 billion and $3.7 billion in the corresponding periods of fiscal 2020.

55

Costs and Expenses

Our total costs and expenses are shown in the tables below:
Three Months Ended
Amount Percentage of Revenues Percentage Point Change
(in millions)
September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Costs of services (excludes depreciation and amortization and restructuring costs)
$ 3,563  $ 3,679  78.3  % 75.8  % 2.5 
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs)
539  489  11.8  10.1  1.7 
Depreciation and amortization 525  467  11.5  9.6  1.9 
Goodwill impairment losses —  2,887  —  59.5  (59.5)
Restructuring costs 265  32  5.8  0.7  5.1 
Interest expense 96  104  2.1  2.1  — 
Interest income (25) (67) (0.5) (1.4) 0.9 
Gain on arbitration award —  (632) —  (13.0) 13.0 
Other income, net (103) (109) (2.3) (2.2) (0.1)
Total costs and expenses
$ 4,860  $ 6,850  106.7  % 141.2  % (34.5)

Six Months Ended
Amount Percentage of Revenues Percentage Point Change
(in millions)
September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Costs of services (excludes depreciation and amortization and restructuring costs)
$ 7,192  $ 7,301  79.5  % 75.0  % 4.5 
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs)
1,078  996  11.9  10.2  1.7 
Depreciation and amortization 1,017  937  11.2  9.6  1.6 
Goodwill impairment losses —  2,887  —  29.6  (29.6)
Restructuring costs 337  174  3.7  1.8  1.9 
Interest expense 202  195  2.2  2.0  0.2 
Interest income (48) (97) (0.5) (1.0) 0.5 
Gain on arbitration award —  (632) —  (6.5) 6.5 
Other income, net (191) (227) (2.1) (2.3) 0.2 
Total costs and expenses
$ 9,587  $ 11,534  105.9  % 118.4  % (12.5)

The 34.5 and 12.5 point decrease in total costs and expenses as a percentage of revenue for the second quarter and first six months of fiscal 2021 primarily reflects our goodwill impairment losses incurred during the second quarter and first six months of fiscal 2020 partially offset by gain on arbitration during the same periods in fiscal 2020 that didn’t occur in fiscal 2021.

Costs of Services

Cost of services, excluding depreciation and amortization and restructuring costs ("COS"), was $3.6 billion and $7.2 billion for the second quarter and first six months of fiscal 2021, respectively. COS decreased $116 million and $109 million during the second quarter and first six months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. These decreases were primarily due to cost optimization savings realized during fiscal 2021. COS as a percentage of revenue increased 2.5 and 4.5 points, respectively, as compared to the same periods of the prior fiscal year. These point increases were driven by a reduction in revenue during the same periods of the previous fiscal year.

56

Selling, General, and Administrative

Selling, general, and administrative expense, excluding depreciation and amortization and restructuring costs ("SG&A"), was $539 million and $1,078 million for the second quarter and first six months of fiscal 2021, respectively. SG&A increased $50 million and $82 million during the second quarter and first six months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. These increases were driven by higher transaction, separation and integration-related costs and SG&A related to the Luxoft Acquisition, which we acquired during the first quarter of fiscal 2020.

Transaction, separation and integration-related costs of $101 million and $211 million were included in SG&A for the second quarter and first six months of fiscal 2021, respectively, as compared to $53 million and $158 million for the comparable period of the prior fiscal year.

Depreciation and Amortization

Depreciation expense was $200 million and $378 million for the second quarter and first six months of fiscal 2021, respectively. Depreciation expense increased $31 million and $42 million during the second quarter and first six months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. The net increase in depreciation expense for the second quarter and first six months of fiscal 2021 was primarily due to an increase in assets placed into service.

Amortization expense was $325 million and $639 million for the second quarter and first six months of fiscal 2021, respectively. Amortization expense increased $27 million and $38 million during the second quarter and first six months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. The increase in amortization expense was primarily due to an increase in amortization related to software and customer related intangibles.

Goodwill Impairment Losses

DXC recognized goodwill impairment charges totaling $2,887 million for the second quarter and first six months of fiscal 2020.The impairment charge was primarily as a result of a decline in market capitalization during the fiscal 2020 second quarter. See Note 11, "Goodwill" for additional information.

Restructuring Costs

During fiscal 2021, management approved global cost savings initiatives designed to better align our workforce and facility structures. During the second quarter and first six months of fiscal 2021, restructuring costs, net of reversals, were $265 million and $337 million, respectively, as compared to $32 million and $174 million during the same periods of the prior fiscal year.

For an analysis of changes in our restructuring liabilities by restructuring plan, see Note 14 - "Restructuring Costs" to the financial statements.

Interest Expense and Interest Income

Interest expense was $96 million and $202 million for second quarter and first six months of fiscal 2021, respectively. Interest expense decreased $8 million during the second quarter of fiscal 2021 and increased $7 million during the first six months of fiscal 2021, as compared to the same periods of the prior fiscal year. The decrease during the second quarter of fiscal 2021 was primarily driven by decrease in term loans. The increase during the first six months of fiscal 2021 was primarily driven by increased amounts drawn on our revolving credit facilities partially offset by a decrease in term loans. See the "Capital Resources" caption below and Note 12 - “Debt” for additional information.

Interest income was $25 million and $48 million for second quarter and first six months of fiscal 2021, respectively. Interest income decreased $42 million and $49 million during the second quarter and first six months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. These decreases were primarily driven by interest income in the second quarter of fiscal year 2020 related to arbitration discussed below under the caption “Gain on Arbitration Award."

57

Gain on Arbitration Award

During the second quarter of fiscal 2020, DXC received final arbitration award proceeds of $666 million related to the HPE Enterprise Services merger completed in fiscal 2018. The arbitration award included $632 million in damages that were recorded as a gain. The remaining $34 million of the award related to pre-award interest. Dispute details are subject to confidentiality obligations.

Other Income, Net

Other income, net comprises non-service cost components of net periodic pension income, movement in foreign currency exchange rates on our foreign currency denominated assets and liabilities and the related economic hedges, equity earnings of unconsolidated affiliates and other miscellaneous gains and losses.

Other income was $103 million and $191 million for the second quarter and first six months of fiscal 2021, respectively, as compared to $109 million and $227 million during the same periods of the prior fiscal year.

The $6 million decrease in other income, net for the second quarter of fiscal 2021, as compared to the same period of the prior fiscal year, was primarily due to foreign exchange hedging and revaluations offset by a year-over-year increase of $2 million in other gains related to sales of non-operating assets and a year-over-year increase of $2 million in non-service components of net periodic pension income.

The $36 million decrease in other income, net for the first six months of fiscal 2021, as compared to the same period of the prior fiscal year, was primarily due to foreign exchange hedging and revaluations and a year-over-year decrease of $7 million in non-service components of net periodic pension income.

Taxes

Our effective tax rate ("ETR") was 19.6% and (5.8)% for the three months ended September 30, 2020 and September 30, 2019, respectively, and 16.2% and (8.6)% for the six months ended September 30, 2020 and September 30, 2019, respectively. For the three and six months ended September 30, 2020, the primary drivers of the ETR were the global mix of income, foreign tax credits and adjustment of the prior tax provisions due to the filing of tax returns in the U.S and non-U.S. jurisdictions. For the three and six months ended September 30, 2019, the primary drivers of the ETR were the impact of the non-deductible goodwill impairment charge, the non-taxable gain on the arbitration award, the global mix of income, an increase in unrecognized tax benefits primarily related to the disallowance of certain legacy CSC foreign restructuring expenses deducted on the U.S. federal tax return for tax year March 31, 2013 and an increase in prior year U.S. federal research and development income tax credits.

Loss Per Share

Diluted loss per share for the second quarter and first six months of fiscal 2021 was $(0.96) and $(1.77), respectively. Diluted loss per share increased $7.23 and $5.67 during the second quarter and first six months of fiscal 2021, respectively, as compared to the same periods of the prior fiscal year. This increase was due to a reduction of $1,869 million and $1,502 million in net loss for the second quarter and first six months of fiscal 2021, respectively, over the same periods in the prior fiscal year.

Diluted loss per share for the second quarter of fiscal 2021 includes $0.83 per share of restructuring costs, $0.29 per share of transaction, separation and integration-related costs, $0.46 per share of amortization of acquired intangible assets, and $0.01 per share of tax adjustment.

Diluted loss per share for the first six months of fiscal 2021 includes $1.07 per share of restructuring costs, $0.62 per share of transaction, separation and integration-related costs, $0.91 per share of amortization of acquired intangible assets, $0.01 per share of pension and OPEB actuarial and settlement losses, and $0.01 of tax adjustment.
58

Non-GAAP Financial Measures

We present non-GAAP financial measures of performance which are derived from the statements of operations of DXC. These non-GAAP financial measures include earnings before interest and taxes ("EBIT"), adjusted EBIT, non-GAAP income before income taxes, non-GAAP net income and non-GAAP EPS, constant currency revenues, net debt and net debt-to-total capitalization.

We present these non-GAAP financial measures to provide investors with meaningful supplemental financial information, in addition to the financial information presented on a GAAP basis. Non-GAAP financial measures exclude certain items from GAAP results which DXC management believes are not indicative of core operating performance. DXC management believes these non-GAAP measures allow investors to better understand the financial performance of DXC exclusive of the impacts of corporate-wide strategic decisions. DXC management believes that adjusting for these items provides investors with additional measures to evaluate the financial performance of our core business operations on a comparable basis from period to period. DXC management believes the non-GAAP measures provided are also considered important measures by financial analysts covering DXC, as equity research analysts continue to publish estimates and research notes based on our non-GAAP commentary, including our guidance around diluted non-GAAP EPS targets.

Non-GAAP financial measures exclude certain items from GAAP results which DXC management believes are not indicative of operating performance such as the amortization of acquired intangible assets and transaction, separation and integration-related costs.

Incremental amortization of intangible assets acquired through business combinations may result in a significant difference in period over period amortization expense on a GAAP basis. We exclude amortization of certain acquired intangibles assets as these non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Although DXC management excludes amortization of acquired intangible assets primarily customer related intangible assets, from its non-GAAP expenses, we believe that it is important for investors to understand that such intangible assets were recorded as part of purchase accounting and support revenue generation. Any future transactions may result in a change to the acquired intangible asset balances and associated amortization expense.

There are limitations to the use of the non-GAAP financial measures presented in this report. One of the limitations is that they do not reflect complete financial results. We compensate for this limitation by providing a reconciliation between our non-GAAP financial measures and the respective most directly comparable financial measure calculated and presented in accordance with GAAP. Additionally, other companies, including companies in our industry, may calculate non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes between companies.

Selected references are made on a “constant currency basis” so that certain financial results can be viewed without the impact of fluctuations in foreign currency rates, thereby providing comparisons of operating performance from period to period. Financial results on a “constant currency basis” are non GAAP measures calculated by translating current period activity into U.S. dollars using the comparable prior period’s currency conversion rates. This approach is used for all results where the functional currency is not the U.S. dollar. Please see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Results of Operations—Fiscal 2021 Highlights.”

59

Non-GAAP financial measures and the respective most directly comparable financial measures calculated and presented in accordance with GAAP include:
Three Months Ended
(in millions) September 30, 2020 September 30, 2019 Change
Loss before income taxes $ (306) $ (1,999) $ 1,693 
Non-GAAP income before income taxes $ 212  $ 492  $ (280)
Net loss $ (246) $ (2,115) $ 1,869 
Adjusted EBIT $ 283  $ 529  $ (246)

Six Months Ended
(in millions) September 30, 2020 September 30, 2019 Change
Loss before income taxes $ (531) $ (1,793) $ 1,262 
Non-GAAP income before income taxes $ 319  $ 1,083  $ (764)
Net loss $ (445) $ (1,947) $ 1,502 
Adjusted EBIT $ 473  $ 1,181  $ (708)

Reconciliation of Non-GAAP Financial Measures

Our non-GAAP adjustments include:
•Restructuring costs - reflects costs, net of reversals, related to workforce optimization and real estate charges.
•Transaction, separation and integration-related (“TSI”) costs - reflects costs to execute on strategic alternatives, costs related to integration, planning, financing and advisory fees associated with the HPES Merger and other acquisitions and costs related to the separation of USPS and other divestitures.(1)
•Amortization of acquired intangible assets - reflects amortization of intangible assets acquired through business combinations.
•Pension and OPEB actuarial and settlement gains and losses - reflects pension and OPEB actuarial and settlement gains and losses.
•Goodwill impairment losses - reflects impairment losses on goodwill.
•Gain on arbitration award - reflects a gain related to the HPES merger arbitration award.
•Tax adjustment - for fiscal 2021 periods, reflects the impact of tax entries related to prior restructuring charges and an adjustment to the tax expense relating to USPS, and for fiscal 2020 periods, reflects the impact of tax entries related to prior restructuring charges. Income tax expense of non-GAAP adjustments is computed by applying the jurisdictional tax rate to the pre-tax adjustments on a jurisdictional basis.

(1) TSI costs for all periods presented include fees and other expenses associated with legal, accounting, consulting, due diligence, investment banking advisory, and other services, as well as financing fees, retention incentives, and resolution of transaction related claims in connection with, or resulting from, exploring or executing potential acquisitions, dispositions and strategic alternatives, whether or not announced or consummated.


60

A reconciliation of reported results to non-GAAP results is as follows:

Three Months Ended September 30, 2020
(in millions, except per-share amounts) As Reported Restructuring Costs Transaction, Separation and Integration-Related Costs Amortization of Acquired Intangible Assets Tax Adjustment Non-GAAP Results
Costs of services (excludes depreciation and amortization and restructuring costs) $ 3,563  $ —  $ —  $ —  $ —  $ 3,563 
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) 539  —  (108) —  —  431 
(Loss) income before income taxes (306) 265  101  152  —  212 
Income tax (benefit) expense (60) 52  26  35  (2) 51 
Net (loss) income (246) 213  75  117  2  161 
Less: net loss attributable to non-controlling interest, net of tax (2) —  —  —  —  (2)
Net (loss) income attributable to DXC common stockholders $ (244) $ 213  $ 75  $ 117  $ 2  $ 163 
Effective Tax Rate 19.6  % 24.1  %
Basic EPS $ (0.96) $ 0.84  $ 0.30  $ 0.46  $ 0.01  $ 0.64 
Diluted EPS $ (0.96) $ 0.83  $ 0.29  $ 0.46  $ 0.01  $ 0.64 
Weighted average common shares outstanding for:
Basic EPS 254.13  254.13  254.13  254.13  254.13  254.13 
Diluted EPS 254.13  255.18  255.18  255.18  255.18  255.18 


Six Months Ended September 30, 2020
(in millions, except per-share amounts) As Reported Restructuring Costs Transaction, Separation and Integration-Related Costs Amortization of Acquired Intangible Assets Pension and OPEB Actuarial and Settlement Losses Tax Adjustment Non-GAAP Results
Costs of services (excludes depreciation and amortization and restructuring costs) $ 7,192  $ —  $ —  $ —  $ —  $ —  $ 7,192 
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) 1,078  —  (218) —  —  —  860 
(Loss) income before income taxes (531) 337  211  300  2  —  319 
Income tax (benefit) expense (86) 64  54  69  —  (2) 99 
Net (loss) income (445) 273  157  231  2  2  220 
Less: net income attributable to non-controlling interest, net of tax 4  —  —  —  —  —  4 
Net (loss) income attributable to DXC common stockholders $ (449) $ 273  $ 157  $ 231  $ 2  $ 2  $ 216 
Effective Tax Rate 16.2  % 31.0  %
Basic EPS $ (1.77) $ 1.08  $ 0.62  $ 0.91  $ 0.01  $ 0.01  $ 0.85 
Diluted EPS $ (1.77) $ 1.07  $ 0.62  $ 0.91  $ 0.01  $ 0.01  $ 0.85 
Weighted average common shares outstanding for:
Basic EPS 253.88  253.88  253.88  253.88  253.88  253.88  253.88 
Diluted EPS 253.88  254.76  254.76  254.76  254.76  254.76  254.76 
61

Three Months Ended September 30, 2019
(in millions, except per-share amounts) As Reported Restructuring Costs Transaction, Separation and Integration-Related Costs Amortization of Acquired Intangible Assets Goodwill Impairment Losses Gain on Arbitration Award Tax Adjustment Non-GAAP Results
Costs of services (excludes depreciation and amortization and restructuring costs) $ 3,679  $ —  $ —  $ —  $ —  $ —  $ —  $ 3,679 
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) 489  —  (53) —  —  —  —  $ 436 
(Loss) income before income taxes (1,999) 32  53  151  2,887  (632) —  492 
Income tax expense (benefit) 116  4  5  34  —  —  (29) 130 
Net (loss) income (2,115) 28  48  117  2,887  (632) 29  362 
Less: net income attributable to non-controlling interest, net of tax 4  —  —  —  —  —  —  4 
Net (loss) income attributable to DXC common stockholders $ (2,119) $ 28  $ 48  $ 117  $ 2,887  $ (632) $ 29  $ 358 
Effective Tax Rate (5.8) % 26.4  %
Basic EPS $ (8.19) $ 0.11  $ 0.19  $ 0.45  $ 11.16  $ (2.44) $ 0.11  $ 1.38 
Diluted EPS $ (8.19) $ 0.11  $ 0.18  $ 0.45  $ 11.10  $ (2.43) $ 0.11  $ 1.38 
Weighted average common shares outstanding for:
Basic EPS 258.71  258.71  258.71  258.71  258.71  258.71  258.71  258.71 
Diluted EPS 258.71  260.03  260.03  260.03  260.03  260.03  260.03  260.03 


Six Months Ended September 30, 2019
(in millions, except per-share amounts) As Reported Restructuring Costs Transaction, Separation and Integration-Related Costs Amortization of Acquired Intangible Assets Goodwill Impairment Losses Gain on Arbitration Award Tax Adjustment Non-GAAP Results
Costs of services (excludes depreciation and amortization and restructuring costs) $ 7,301  $ —  $ —  $ —  $ —  $ —  $ —  $ 7,301 
Selling, general, and administrative (excludes depreciation and amortization and restructuring costs) 996  —  (158) —  —  —  —  $ 838 
(Loss) income before income taxes (1,793) 174  158  289  2,887  (632) —  1,083 
Income tax expense (benefit) 154  32  27  65  —  —  (29) 249 
Net (loss) income (1,947) 142  131  224  2,887  (632) 29  834 
Less: net income attributable to non-controlling interest, net of tax 9  —  —  —  —  —  —  9 
Net (loss) income attributable to DXC common stockholders $ (1,956) $ 142  $ 131  $ 224  $ 2,887  $ (632) $ 29  $ 825 
Effective Tax Rate (8.6) % 23.0  %
Basic EPS $ (7.44) $ 0.54  $ 0.50  $ 0.85  $ 10.98  $ (2.40) $ 0.11  $ 3.14 
Diluted EPS $ (7.44) $ 0.54  $ 0.50  $ 0.85  $ 10.91  $ (2.39) $ 0.11  $ 3.12 
Weighted average common shares outstanding for:
Basic EPS 262.83  262.83  262.83  262.83  262.83  262.83  262.83  262.83 
Diluted EPS 262.83  264.61  264.61  264.61  264.61  264.61  264.61  264.61 



62

A reconciliation of net income to EBIT and adjusted EBIT is as follows:
Three Months Ended Six Months Ended
(in millions) September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Net loss $ (246) $ (2,115) $ (445) $ (1,947)
Income tax (benefit) expense (60) 116  (86) 154 
Interest income (25) (67) (48) (97)
Interest expense 96  104  202  195 
EBIT (235) (1,962) (377) (1,695)
Restructuring costs 265  32  337  174 
Transaction, separation and integration-related costs 101  53  211  158 
Amortization of acquired intangible assets 152  151  300  289 
Pension and OPEB actuarial and settlement losses —  —  2  — 
Goodwill impairment losses —  2,887  —  2,887 
Gain on arbitration award —  (632) —  (632)
Adjusted EBIT $ 283  $ 529  $ 473  $ 1,181 

63

Liquidity and Capital Resources

Cash and Cash Equivalents and Cash Flows

As of September 30, 2020, our cash and cash equivalents ("cash") was $3.1 billion, of which $1.2 billion was held outside of the U.S. As of March 31, 2020, our cash was $3.7 billion, of which $1.2 billion was held outside of the U.S. A substantial portion of funds can be returned to the U.S. from funds advanced previously to finance our foreign acquisition initiatives. As a result of the Tax Cuts and Jobs Act of 2017, and after the mandatory one-time income inclusion (deemed repatriation) of the historically untaxed earnings of our foreign subsidiaries and current income inclusions for global intangible low taxed income, we expect a significant portion of the cash held by our foreign subsidiaries will no longer be subject to U.S. federal income tax consequences upon subsequent repatriation to the U.S. However, a portion of this cash may still be subject to foreign and U.S. state income tax consequences upon future remittance. Therefore, if additional funds held outside the U.S. are needed for our operations in the U.S., we plan to repatriate these funds not designated as indefinitely reinvested.

The following table summarizes our cash flow activity:
Six Months Ended
(in millions) September 30, 2020 September 30, 2019 Change
Net cash provided by operating activities $ 591  $ 1,585  $ (994)
Net cash used in investing activities (234) (2,047) 1,813 
Net cash (used in) provided by financing activities (963) 480  (1,443)
Effect of exchange rate changes on cash and cash equivalents 9  (37) 46 
Cash classified within current assets held for sale (3) —  (3)
Net decrease in cash and cash equivalents $ (600) $ (19) $ (581)
Cash and cash equivalents at beginning-of-year 3,679  2,899 
Cash and cash equivalents at the end-of-period $ 3,079  $ 2,880 

Operating cash flow

Net cash provided by operating activities during the first six months of fiscal 2021 was $591 million as compared to $1,585 million during the comparable period of the prior fiscal year. The decrease of $994 million was due to a decrease in net income, net of adjustments of $1,244 million, partially offset by a decrease in working capital cash outflows of $250 million. Net loss, net of adjustments include cash received on arbitration award of $668 million in the prior fiscal year.

Investing cash flow

Net cash used in investing activities during the first six months of fiscal 2021 was $234 million as compared to $2,047 million during the comparable period of the prior fiscal year. The decrease in cash used of $1,813 million was primarily due to a decrease in cash paid for acquisitions of $1,911 million, short-term investing of $75 million during fiscal 2020 that didn’t occur during fiscal 2021, and a decrease in purchases of property and equipment of $36 million. This was partially offset by a decrease in cash collections related to deferred purchase price receivable of $212 million.

Financing cash flow

Net cash (used in) provided by financing activities during the first six months of fiscal 2021 was $(963) million as compared to $480 million during the comparable period of the prior fiscal year. The $1,443 million increase in cash used was primarily due to a decrease in borrowings on term loans and other long-term debt of $1,205 million, repayments of borrowings under lines of credit of $2,750 million, and an increase in payments on long-term debt of $957 million. This was partially offset by borrowings under lines of credit of $2,500 million, absence of common stock repurchases and advance payment for accelerated share repurchase of $650 million in fiscal 2020, and an increase of commercial paper borrowings, net of repayments of $309 million.
64


Capital Resources

See Note 21 - "Commitments and Contingencies" for a discussion of the general purpose of guarantees and commitments. The anticipated sources of funds to fulfill such commitments are listed below and under the subheading "Liquidity."

The following table summarizes our total debt:
As of
(in millions) September 30, 2020 March 31, 2020
Short-term debt and current maturities of long-term debt $ 1,622  $ 1,276 
Long-term debt, net of current maturities 8,046  8,672 
Total debt $ 9,668  $ 9,948 

The $0.3 billion decrease in total debt during the first six months of fiscal 2021 was primarily attributed to the prepayment of our term loan facilities of €500 million of Euro Term Loan due fiscal 2023, £450 million of GBP Term Loan due fiscal 2022, A$300 million of AUD Term Loan due fiscal 2022, and $100 million of USD Term Loan due fiscal 2025, offset by the issuance of new senior notes with an aggregate principal of $1.0 billion, consisting of (i) $500 million of 4.00% Senior Notes due fiscal 2024 and (ii) $500 million of 4.13% Senior Notes due fiscal 2026.

During the first quarter of fiscal 2021, we applied for and were confirmed eligible to participate in the Bank of England’s (“BOE”) COVID Corporate Funding Facility, a BOE program that provides term liquidity funding to investment grade corporate issuers with significant operations in the UK, in order to stabilize and facilitate continued access to sterling commercial paper markets. At our option, we can borrow up to a maximum of €1 billion or its equivalent in Euro, British Pound and U.S. dollar. On June 15, 2020, DXC Capital Funding DAC (previously named DXC Capital Funding Limited), an indirect subsidiary of the Company, issued £600 million in commercial paper maturing May 2021 under its existing €1.0 billion commercial paper program via direct sale to the BOE.

During the first six months of fiscal 2021, we borrowed the remaining $2.5 billion under the $4.0 billion credit facility agreement and repaid $2.75 billion on the same. The purpose of the borrowing was to mitigate our reliance on volatile short-term commercial paper markets and to strengthen our cash and liquidity position given the uncertainties related to COVID-19 pandemic and its potential impact on our clients and our business. The credit facility repayment resulted from accessing other liquidity resources. The repaid credit facility amounts became available under the revolving credit facility for redraw at the request of the Company. Subsequent to September 30, 2020, we repaid the entire $1.25 billion outstanding on our credit facility, making the entire $4.0 billion available for redraw at the request of the Company.

We were in compliance with all financial covenants associated with our borrowings as of September 30, 2020 and September 30, 2019.

65

The debt maturity chart below summarizes the future maturities of long-term debt principal for fiscal years subsequent to September 30, 2020, and excludes maturities of borrowings for assets acquired under long-term financing and finance lease liabilities. See Note 12 - "Debt" for more information.
DXC-20200930_G4.JPG
The following table summarizes our capitalization ratios:
As of
(in millions) September 30, 2020 March 31, 2020
Total debt $ 9,668  $ 9,948 
Cash and cash equivalents 3,079  3,679 
Net debt(1)
$ 6,589  $ 6,269 
Total debt $ 9,668  $ 9,948 
Equity 4,751  5,129 
Total capitalization $ 14,419  $ 15,077 
Debt-to-total capitalization 67.1  % 66.0  %
Net debt-to-total capitalization(1)
45.7  % 41.6  %
        

(1) Net debt and Net debt-to-total capitalization are non-GAAP measures used by management to assess our ability to service our debts using only our cash and cash equivalents. We present these non-GAAP measures to assist investors in analyzing our capital structure in a more comprehensive way compared to gross debt based ratios alone.


66

Our credit ratings are as follows:
Rating Agency Long Term Ratings Short Term Ratings Outlook
Fitch BBB F-2 Stable
Moody's Baa2 P-2 Negative
S&P BBB- - Stable

See Note 21 - "Commitments and Contingencies" for a discussion of the general purpose of guarantees and commitments. The anticipated sources of funds to fulfill such commitments are listed below at "Liquidity".

Liquidity

We expect our existing cash and cash equivalents, together with cash generated from operations, will be sufficient to meet our normal operating requirements for the next 12 months. We expect to continue to use cash generated by operations as a primary source of liquidity; however, should we require funds greater than that generated from our operations to fund discretionary investment activities, such as business acquisitions, we have the ability to raise capital through the issuance of capital market debt instruments such as commercial paper, term loans, and bonds. In addition, we currently utilize, and will further utilize our cross currency cash pool for liquidity needs. However, there is no guarantee that we will be able to obtain debt financing, if required, on terms and conditions acceptable to us, if at all, in the future.

Our exposure to operational liquidity risk is primarily from long-term contracts which require significant investment of cash during the initial phases of contracts. The recovery of these investments is over the life of contracts and is dependent upon our performance as well as customer acceptance.

The following table summarizes our total liquidity:
As of
(in millions) September 30, 2020
Cash and cash equivalents $ 3,079 
Available borrowings under our revolving credit facility 2,750 
Total liquidity
$ 5,829 

67

In October 2020 subsequent to the end of the current quarter, the company used the proceeds from the sale of HHS Business to prepay the following debt: $1,250 million of Revolver Credit Facility, £600 million of GBP commercial paper, €350 million of Euro Term Loan due fiscal 2024, $381 million of USD Term loan due fiscal 2025, A$500 million of AUD Term Loan due fiscal 2022, and €250 million of Euro Term Loan due fiscal 2022 and 2023.

The debt maturity chart below summarizes the future maturities of long-term debt principal taking into effect of prepayments as mentioned above for fiscal years subsequent to November 5, 2020 and excludes maturities of borrowings for assets acquired under long-term financing and capitalized lease liabilities.

DXC-20200930_G5.JPG

Share Repurchases

During the first quarter of fiscal 2018, our Board of Directors authorized the repurchase of up to $2.0 billion of our common stock and during the third quarter of fiscal 2019, our Board of Directors approved an incremental $2.0 billion share repurchase. This program became effective on April 3, 2017 with no end date established. There were no share repurchases during the second quarter ended September 30, 2020.

Dividends

To enhance our financial flexibility we elected to suspend payment of quarterly dividends.

68

Off-Balance Sheet Arrangements

In the normal course of business, we are party to arrangements that include guarantees, the receivables securitization facility and certain other financial instruments with off-balance sheet risk, such as letters of credit and surety bonds. We also use performance letters of credit to support various risk management insurance policies. No liabilities related to these arrangements are reflected in our condensed consolidated balance sheets. There have been no material changes to our off-balance-sheet arrangements reported under Part II, Item 7 of our Annual Report on Form 10-K other than as disclosed below and in Note 6 - "Receivables" and Note 21 - "Commitments and Contingencies" to the financial statements in this Quarterly Report on Form 10-Q.

Contractual Obligations

With the exception of the new senior notes with an aggregate principal amount of $1.0 billion, consisting of (i) $500 million of 4.00% Senior Notes due fiscal 2024; and (ii) $500 million of 4.13% Senior Notes due fiscal 2026; and repayment of term loan facilities consisting of (i) €500 million of Euro Term Loan due fiscal 2023, (ii) £450 million of GBP Term Loan due fiscal 2022, (iii) A$300 million of AUD Term Loan due fiscal 2022, and (iv) $100 million of USD Term Loan due fiscal 2025 as discussed above under the subheading "Capital Resources," there have been no material changes, outside the ordinary course of business, to our contractual obligations since March 31, 2020. For further information see "Contractual Obligations" in Item 7 of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

Critical Accounting Policies and Estimates

The preparation of consolidated financial statements in accordance with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the disclosure of contingent assets and liabilities. These estimates may change in the future if underlying assumptions or factors change. Accordingly, actual results could differ materially from our estimates under different assumptions, judgments or conditions. We consider the following policies to be critical because of their complexity and the high degree of judgment involved in implementing them: revenue recognition, income taxes, business combinations, defined benefit plans and valuation of assets. We have discussed the selection of our critical accounting policies and the effect of estimates with the audit committee of our board of directors. During the three months ended September 30, 2020, there were no changes to our accounting estimates from those described in our fiscal 2020 Annual Report on Form 10-K except as mentioned in Note 1 - "Summary of Significant Accounting Policies."

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

For quantitative and qualitative disclosures about market risk affecting DXC, see "Quantitative and Qualitative Disclosures About Market Risk" in Item 7A of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020. Our exposure to market risk has not changed materially since March 31, 2020.


69

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of September 30, 2020 because of the material weakness in our internal control over financial reporting described below.

Control Activities

As previously disclosed during the third quarter of fiscal 2020, Management concluded there was a material weakness in internal controls over financial reporting related to the design and implementation of effective control activities based on the criteria established in the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control – Integrated Framework (2013). These control deficiencies constituted a material weakness in the aggregate related to reassessing policies and procedures, to determine their continued relevance, as impacted by complex transactions and processes.

Deficiencies that contributed to the aggregation included:

•Management did not reassess in a timely manner the control activities related to goodwill impairment upon adoption of ASU 2017-04 which resulted in an immaterial out of period adjustment between quarters within fiscal 2020 related to the tax effect of the impairment recognized.
•Management did not reassess the control and procedures related to the balance sheet classification of deferred revenue following a large and complex acquisition which resulted in an immaterial out of period adjustment to the balance sheets during the third quarter ended December 31, 2019.

As a result, we have concluded that there is a reasonable possibility that a material misstatement to our Condensed Consolidated Financial Statements would not be prevented or detected on a timely basis and therefore we concluded that the aggregation of these deficiencies represents a material weakness in our internal control over financial reporting as of September 30, 2020.

Notwithstanding the identified material weakness, management believes that the Condensed Consolidated Financial Statements and related financial information included in this 10-Q fairly present, in all material respects, our balance sheets, statements of operations, comprehensive (loss) income and cash flows as of and for the periods presented.

Remediation Plan

Our remediation efforts are ongoing. Management continues to implement remediation actions to address the specific control deficiencies that, in the aggregate, led to a material weakness. Additionally, Management has completed a detailed root cause analysis which was designed to identify areas of focus where enhancements can be made to the internal control environment to support the continued timely reassessment of policies and procedures and reduce the occurrence of future deficiencies caused by complex transactions and processes. Management has remediated certain of the identified control deficiencies that lead to the material weakness.

The following activities are designed as part of this remediation plan:

•Appointment of a new advisor reporting directly to our Chief Financial Officer with the appropriate level of knowledge and experience to help develop and execute the remediation plan.
•Enhance periodic reviews by management and review existing documentation to determine if policies, procedures, and related control activities have continued relevance or need updating due to changes within the organization with a specific focus on the areas identified by the root cause analysis.
•Align the Sarbanes-Oxley Act (“SOX") compliance function under the newly appointed Chief Risk Officer.
•Establish periodic reporting of the remediation plan progress to the Audit Committee.
•Expand SOX training and implementation of succession planning for SOX control owners.
70


Management continues to be actively engaged to take steps to remediate the material weakness noted above, including (1) appointment of an external advisor to lead the remediation activities (2) hiring a new Global SOX Director reporting to the Chief Risk Officer (3) establishment of progress reporting to the Audit Committee and (4) establishment of a control owner transition process. In additional to the items noted above, Management has developed expanded SOX training to be incorporated in the onboarding process and evaluated management level reporting to identify key performance indicators for monitoring. These additional remediation efforts have begun and are expected to be completed in the subsequent quarters. While we have made significant progress, there has not been sufficient time to resolve the material weakness in internal control over financial reporting.

As we continue to improve the effectiveness of our internal control over financial reporting, we may supplement our remediation activities as our work progresses where appropriate. Our goal is to have enhanced control policies, procedures, processes in place as promptly as practicable. However, due to the nature of the work and subsequent testing required to conclude that a material weakness no longer exists, we are not in a position to complete our remediation plan and concluded that our internal control over financial reporting is not designed or operating effectively as of the quarter ended September 30, 2020.

Changes in Internal Control over Financial Reporting

In addition to the remediation efforts described above, we adopted ASC 326 effective April 1, 2020, as described in Note 2 - “Recent Accounting Pronouncements” to the financial statements during the first quarter of fiscal 2021. We began using a new model and redesigned certain processes and controls relating to our reserves and expected losses.

There were no changes in our internal control over financial reporting during the three months ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
71

PART II


ITEM 1. LEGAL PROCEEDINGS

See Note 21 - "Commitments and Contingencies" to the financial statements under the caption “Contingencies” for information regarding legal proceedings in which we are involved.

ITEM 1A. RISK FACTORS

Our operations and financial results are subject to various risks and uncertainties, which may materially and adversely affect our business, financial condition, and results of operations, and the actual outcome of matters as to which forward-looking statements are made in this Quarterly Report on Form 10-Q. In such case, the trading price for DXC common stock could decline, and you could lose all or part of your investment. Past performance may not be a reliable indicator of future financial performance and historical trends should not be used to anticipate results or trends in future periods. Future performance and historical trends may be adversely affected by the aforementioned risks, and other variables and risks and uncertainties not currently known or that are currently expected to be immaterial may also materially and adversely affect our business, financial condition, and results of operations or the price of our common stock in the future. Apart from the risk factors disclosed below, there have been no material changes in the three months ended September 30, 2020 to the risk factors described in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020 and in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020, which are hereby incorporated by reference herein other than the updated risk factors below. Future performance and historical trends may be adversely affected by the aforementioned risks, and other variables and risks and uncertainties not currently known or that are currently expected to be immaterial may also materially and adversely affect our business, financial condition, and results of operations or the price of our common stock in the future.

Risks Relating to Our Business

Our inability to procure third-party license required for the operation of our products and service offerings may result in decreased revenue or increased costs.

Many of our products and service offerings depends on the continued performance and availability of software licensed from third-party vendors under our contractual arrangements. Because of the nature of these licenses and arrangements, we cannot assure you that we would be able to retain all of these intellectual property rights upon renewal, expiration or termination of such licenses or that we will be able to procure, renew or extend such licenses on commercially reasonable terms which may result in increased costs. Certain of our licenses are concentrated in one or more third-party licensors where multiple licenses are up for renewal at the same time, which could decrease our ability to negotiate reasonable license fees and could result in our loss of rights under such licenses.

Risks Related to the proposed sale of the healthcare provider software business to Dedalus

The sale of the healthcare provider software business is contingent upon the satisfaction of a number of conditions, and the transaction may not be consummated on the terms or timeline currently contemplated, or at all.

On July 17, 2020, we entered into a Purchase Agreement with Dedalus. Pursuant to the Purchase Agreement, Dedalus will acquire DXC’s healthcare provider software business for total cash consideration of approximately €459.4 million (approximately $525 million) (the “HPS Sale”). We currently expect the transaction to close by March 2021 and plan to use the after-tax proceeds from the HPS Sale to repay outstanding indebtedness.

The closing of the HPS Sale is subject to certain conditions, including (i) receipt of certain regulatory consents, (ii) the absence of any injunction or other order from a governmental authority that prevents the closing, and (iii) subject to certain exceptions, the accuracy of the representations and warranties of, and compliance with covenants by, the other party. In addition, the closing of the HPS sale is subject to certain conditions for the benefit of Dedalus, including (a) the absence of a material adverse effect on the business or the ability of DXC to consummate the transaction and (b) receipt of certain customer consents. For these and other reasons, the HPS Sale may not be completed by the end of March 2021 or otherwise on the terms or timeline contemplated, if at all. In the event that the HPS Sale is not completed, we will not be able to use the after-tax sale proceeds to repay outstanding indebtedness, which would have an adverse effect on our business, financial condition, results of operations and/or cash flows.

The proposed transaction may result in disruptions to relationships with customers and other business partners or may not achieve the intended results.

If we complete the proposed HPS Sale, there can be no assurance that we will be able to realize the intended benefits of the transaction. Specifically, the proposed HPS Sale could cause disruptions in our remaining businesses, including by disrupting operations or causing customers to delay or to defer decisions or to end their relationships, or otherwise limiting the ability to compete for or perform certain contracts or services. Other challenges and risks to our remaining businesses include the potential loss of key suppliers, vendors and other key business partners; declining employee morale and employee retention issues; difficulty in making new and strategic hires of new employees; the need to separate operations, systems (including accounting, management, information, human resource and other administrative systems), technologies, products and personnel, and the inefficiencies and lack of control that may result if such separation is delayed or not implemented effectively, and unforeseen difficulties and expenditures that may arise as a result. Other challenges and risks to our remaining businesses include the potential loss of key suppliers, vendors and other key business partners; declining employee morale and employee retention issues; difficulty in making new and strategic hires of new employees; the need to separate operations, systems (including accounting, management, information, human resource and other administrative systems), technologies, products and personnel, and the inefficiencies and lack of control that may result if such separation is delayed or not implemented effectively, and unforeseen difficulties and expenditures that may arise as a result. Any of the foregoing could adversely affect our remaining businesses, the financial condition of such businesses and their results of operations and prospects. The HPS business is accounted for as part of the GBS segment.

The actions required to implement the HPS Sale will take significant management time and attention and will require us to incur significant costs.

The HPS Sale will require significant amounts of management’s time and resources, which will be in addition to and may divert management’s time and attention from the operation of our remaining businesses and the execution of our other strategic initiatives. Additionally, we will incur costs in connection with the HPS Sale. These costs must be paid regardless of whether the HPS Sale is consummated.







72

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Unregistered Sales of Equity Securities
    
None during the period covered by this report.

Use of Proceeds

Not applicable.

Issuer Purchases of Equity Securities
    
On April 3, 2017, DXC announced the establishment of a share repurchase plan approved by the Board of Directors with an initial authorization of $2.0 billion for future repurchases of outstanding shares of DXC common stock. On November 8, 2018, DXC's Board of Directors approved an incremental $2.0 billion share repurchase. An expiration date has not been established for this repurchase plan. Share repurchases may be made from time to time through various means, including in open market purchases, 10b5-1 plans, privately-negotiated transactions, accelerated stock repurchases, block trades and other transactions, in compliance with Rule 10b-18 under the Exchange Act, as well as, to the extent applicable, other federal and state securities laws and other legal requirements. The timing, volume, and nature of share repurchases pursuant to the share repurchase plan are at the discretion of management and may be suspended or discontinued at any time.

There was no share repurchase activity during the three months and six months ended September 30, 2020.


ITEM 3. DEFAULT UPON SENIOR SECURITIES

None.


ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.


ITEM 5. OTHER INFORMATION

None.


73

ITEM 6. EXHIBITS
Exhibit
Number
Description of Exhibit
10.1
10.2
10.3*
31.1**
31.2**
32.1***
32.2***
101.INS Interactive Data Files
101.SCH XBRL Taxonomy Extension Schema
101.CAL XBRL Taxonomy Extension Calculation
101.LAB XBRL Taxonomy Extension Labels
101.PRE XBRL Taxonomy Extension Presentation
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

    * Management contract or compensatory plan or agreement
    ** Filed herewith
    *** Furnished herewith
74


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
DXC TECHNOLOGY COMPANY
Dated: November 5, 2020 By: /s/ Neil A. Manna
Name: Neil A. Manna
Title: Interim CFO, Senior Vice President, Corporate Controller Principal Accounting Officer

75
Exhibit 10.1
TENTH AMENDMENT TO THE
RECEIVABLES PURCHASE AGREEMENT
This TENTH AMENDMENT TO THE RECEIVABLES PURCHASE AGREEMENT (this “Amendment”), dated as of August 6, 2020, is entered into by and among the following parties:
i.DXC RECEIVABLES LLC (F/K/A CSC RECEIVABLES LLC), a Delaware limited liability company, as Seller (the “Seller”);
ii.DXC TECHNOLOGY COMPANY, a Nevada corporation, as Servicer (the “Servicer”);
iii.PNC BANK, NATIONAL ASSOCIATION, as a Committed Purchaser, as Group Agent for its Purchaser Group and as Administrative Agent (in such capacity, the “Administrative Agent”);
iv.WELLS FARGO BANK, NATIONAL ASSOCIATION, as a Committed Purchaser and as Group Agent for its Purchaser Group;
v.MUFG BANK, LTD. (F/K/A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), as a Committed Purchaser and as Group Agent for its Purchaser Group;
vi.FIFTH THIRD BANK, NATIONAL ASSOCIATION (F/K/A FIFTH THIRD BANK), as a Committed Purchaser and as Group Agent for its Purchaser Group;
vii.MIZUHO BANK, LTD., as a Committed Purchaser and as Group Agent for its Purchaser Group; and
viii.THE TORONTO DOMINION BANK, as a Committed Purchaser and as Group Agent for its Purchaser Group.
Capitalized terms used but not otherwise defined herein (including such terms used above) have the respective meanings assigned thereto in the Receivables Purchase Agreement described below.
BACKGROUND
A.    The parties hereto have entered into a Receivables Purchase Agreement, dated as of December 21, 2016 (such date, the “Original Closing Date”) (as amended, restated, supplemented or otherwise modified through the date hereof, the “Receivables Purchase Agreement”).
B.    Concurrently herewith, the Seller, as buyer, the Servicer, PDA Software Services LLC (the “Exiting Originator”), Alliance-One Services, Inc., Computer Sciences Corporation, CSC Consulting, Inc., CSC Covansys Corporation, CSC Cybertek Corporation, CSC Puerto Rico, LLC, DXC Technology Services LLC, Mynd Corporation and Tribridge Holdings, LLC
1

are entering into that certain Sixth Amendment to the Purchase and Sale Agreement, dated as of the date hereof (the “Sale Agreement Amendment”).
C.    Concurrently herewith, the parties hereto and PNC Capital Markets LLC, as Structuring Agent, are entering into that certain Seventh Amended and Restated Fee Letter, dated as of the date hereof (the “Amended Fee Letter”).
D.    Concurrently herewith, the Exiting Originator, CSC Cybertek Corporation, CSC Covansys Corporation, the Seller and the Administrative Agent, are entering into that certain Assignment Agreement (the “Assignment Agreement”), dated as of the date hereof, whereby the Seller agrees to sell back certain Receivables originated by the Exiting Originator, CSC Cybertek Corporation and CSC Covansys Corporation to the Exiting Originator, CSC Cybertek Corporation and CSC Covansys Corporation, respectively.
E.    The parties hereto acknowledge and agree that certain of the Receivables originated by the Exiting Originator, CSC Cybertek Corporation and CSC Covansys Corporation include MMIS Receivables and pursuant to the Ninth Amendment, dated as of May 29, 2020 (such date, the “Ninth Amendment Date”, and such amendment, the “Ninth Amendment”), among the parties hereto, whereby the parties hereto, amongst other things, designated such MMIS Receivables as Excluded Receivables. The Seller, the Originators (including CSC Cybertek Corporation and CSC Covansys Corporation), the Exiting Originator and the Servicer have informed the Administrative Agent and each Group Agent that all Information Packages and other similar reports delivered by the Servicer, the Originators or the Seller pursuant to the Transaction Documents on and after the Ninth Amendment Date with respect to the Pool Receivables and the transactions contemplated by the Transaction Documents have treated such Receivables as Excluded Receivables for all purposes. Therefore, the parties hereto desire to enter into the Assignment Agreement effective as of the Ninth Amendment Date to sell back to the Exiting Originator, CSC Cybertek Corporation and CSC Covansys Corporation, as applicable, such MMIS Receivables that were sold, contributed, assigned, pledged or otherwise transferred to the Seller or the Administrative Agent pursuant to the Transaction Documents prior to the Ninth Amendment Date and, on and after the Ninth Amendment Date, to confirm that such Receivables have not been sold, contributed, assigned, pledged or otherwise transferred to the Seller or the Administrative Agent pursuant to the Transaction Documents.
F.    The parties hereto desire to amend the Receivables Purchase Agreement as set forth herein.
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
SECTION 1.Amendments to the Receivables Purchase Agreement. The Receivables Purchase Agreement is hereby amended as shown on the marked pages of the Receivables Purchase Agreement attached hereto as Exhibit A.
c.Notices and Consents.
2


i.Confirmation regarding certain Excluded Receivables. The parties hereto confirm their agreement that, after the Ninth Amendment Date, no MMIS Receivables have been sold, contributed, assigned, pledged or otherwise transferred to the Seller or the Administrative Agent pursuant to the Transaction Documents.
ii.Notice of Entry into the Assignment Agreement. The Seller hereby provides notice of its entry into the Assignment Agreement along with duly executed copy of the Assignment Agreement and requests that each of the parties hereto acknowledge and consent to the execution of the Assignment Agreement.
iii.Consent to Entry into the Assignment Agreement. Each of the parties hereto acknowledges, consents and agrees to the terms of the Assignment Agreement and waives any otherwise applicable conditions precedent thereto under the Receivables Purchase Agreement and the other Transactions Documents (other than as set forth herein).
iv.Consent to Filing Certain UCC Financing Statements. In connection with the execution of the Assignment Agreement and the Sale Agreement Amendment, each of the parties hereto hereby consents to the filing of the financing statements attached hereto as Exhibit B.
d.Representations and Warranties of the Seller and Servicer. Each of the Seller and the Servicer hereby represents and warrants, as to itself, to the Administrative Agent, each Purchaser and each Group Agent, as follows:
1.Representations and Warranties. Immediately after giving effect to this Amendment, the representations and warranties made by such Person in the Transaction Documents to which it is a party are true and correct as of the date hereof (unless stated to relate solely to an earlier date, in which case such representations or warranties were true and correct as of such earlier date).
2.Enforceability. This Amendment and each other Transaction Document to which it is a party, as amended hereby, constitute the legal, valid and binding obligation of such Person enforceable against such Person in accordance with its respective terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization or other similar laws affecting the enforcement of creditors’ rights generally and by general principles of equity, regardless of whether enforceability is considered in a proceeding in equity or at law.
3.No Termination Event. No event has occurred and is continuing, or would result from the transactions contemplated hereby, that constitutes an Event of Termination, Non-Reinvestment Event, Unmatured Event of Termination or Unmatured Non-Reinvestment Event.
c.Effect of Amendment. All provisions of the Receivables Purchase Agreement and the other Transaction Documents, as expressly amended and modified by this Amendment, shall remain in full force and effect. After this Amendment becomes effective, all references in the Receivables Purchase Agreement (or in any other Transaction Document) to “this Receivables Purchase Agreement”, “this Agreement”, “hereof”, “herein” or words of similar effect referring to the Receivables Purchase Agreement shall be deemed to be references to the
3


Receivables Purchase Agreement as amended by this Amendment. This Amendment shall not be deemed, either expressly or impliedly, to waive, amend or supplement any provision of the Receivables Purchase Agreement other than as set forth herein.
d.Consent to Sale Agreement Amendment. Each of the parties hereto hereby consent to the execution and delivery of Sale Agreement Amendment in the form of Exhibit D attached hereto.
e.Effectiveness. This Amendment shall become effective as of the date hereof upon receipt by the Administrative Agent of each of the documents, agreements (in fully executed form), UCC filings and other deliverables listed on the closing memorandum attached as Exhibit C hereto, in each case, in form and substance acceptable to the Administrative Agent.
f.Counterparts. This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute but one and the same instrument. Delivery of an executed counterpart of a signature page to this Amendment by facsimile or e-mail transmission shall be effective as delivery of a manually executed counterpart hereof.
g.GOVERNING LAW. THIS AMENDMENT, INCLUDING THE RIGHTS AND DUTIES OF THE PARTIES HERETO, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT WITHOUT REGARD TO ANY OTHER CONFLICTS OF LAW PROVISIONS THEREOF).
h.Section Headings. The various headings of this Amendment are included for convenience only and shall not affect the meaning or interpretation of this Amendment, the Receivables Purchase Agreement or any provision hereof or thereof.
[Signature Pages Follow.]
4


IN WITNESS WHEREOF, the parties hereto have executed this Amendment by their duly authorized officers as of the date first above written.


DXC RECEIVABLES LLC,
as Seller


By: /s/ H.C. Charles Diao
Name: H.C. Charles Diao    
Title: President and Treasurer    


DXC TECHNOLOGY COMPANY,
as Servicer



By: /s/ H.C. Charles Diao
Name: H.C. Charles Diao    
Title: Senior Vice President and Treasury and    
Corporate Development    


    


5


PNC BANK, NATIONAL ASSOCIATION,
as Administrative Agent


By: /s/ Michael Brown________________    
Name: Michael brown
Title: Senior Vice President

PNC BANK, NATIONAL ASSOCIATION,
as a Committed Purchaser


By: /s/ Michael Brown________________    
Name: Michael brown
Title: Senior Vice President
PNC BANK, NATIONAL ASSOCIATION,
as Group Agent for its Purchaser Group


By: /s/ Michael Brown_________________
Name: Michael brown
Title: Senior Vice President



6


WELLS FARGO, NATIONAL ASSOCIATION,
as a Committed Purchaser




By: /s/ Jonathan Davis
Name: Jonathan Davis
Title: Asst Vice President
WELLS FARGO, NATIONAL ASSOCIATION,
as Group Agent for its Purchaser Group



By: /s/ Jonathan Davis
Name: Jonathan Davis
Title: Asst Vice President



MUFG BANK, LTD.,
as a Committed Purchaser



By: /s/ Eric Williams
Name: Eric Williams
Title: Managing Director

MUFG BANK, LTD.,
as Group Agent for its Purchaser Group



By: /s/ Eric Williams
Name: Eric Williams
Title: Managing Director


7


FIFTH THIRD BANK, NATIONAL ASSOCIATION,
as a Committed Purchaser

    

By: /s/ Brian Gardner
Name: Brian Gardner
Title: Managing Director
FIFTH THIRD BANK, NATIONAL ASSOCIATION,
as Group Agent for its Purchaser Group


By:    
Name:
Title:

By: /s/ Brian Gardner
Name: Brian Gardner
Title: Managing Director



MIZUHO BANK, LTD.,
as a Committed Purchaser

    

By: /s/ Richard A. Burke
Name: Richard A. Burke
Title: Managing Director
MIZUHO BANK, LTD.,
as Group Agent for its Purchaser Group



By: /s/ Richard A. Burke
Name: Richard A. Burke
Title: Managing Director



THE TORONTO DOMINION BANK,
as a Committed Purchaser

    

By:
/s/ Luna Mills
Name: Luna Mills
Title: Managing Director
THE TORONTO DOMINION BANK,
as Group Agent for its Purchaser Group

    


By:
/s/ Luna Mills
Name: Luna Mills
Title: Managing Director

8


With respect to Section 2(a):
CSC CYBERTEK CORPORATION,
as an Originator


By:_/s/ H.C. Charles Diao_____________________
Name: H.C. Charles Diao
Title: President and Treasurer



CSC COVANSYS CORPORATION,
as an Originator


By:_/s/ H.C. Charles Diao _____________________
Name: H.C. Charles Diao
Title: President and Treasurer


PDA SOFTWARE SERVICES LLC,
as Exiting Originator


By:_/s/ H.C. Charles Diao_____________________
Name: H.C. Charles Diao
Title: President and Treasurer


12


Exhibit A

Amendments to the Receivables Purchase Agreement

[Attached]



13

Exhibit B

UCC Financing Statements


[Attached]
14


Exhibit C

Closing Memorandum


[Attached]
15


Exhibit D

Sale Agreement Amendment


[Attached]

16

Exhibit 10.2
SIXTH AMENDMENT TO THE
PURCHASE AND SALE AGREEMENT
This SIXTH AMENDMENT TO THE PURCHASE AND SALE AGREEMENT (this “Amendment”), dated as of August 6, 2020 (such date, the “Sixth Amendment Effective Date”), is entered into by and among the following parties:
i.DXC TECHNOLOGY COMPANY, as Servicer (the “Servicer”);
ii.PDA SOFTWARE SERVICES LLC, as exiting Originator under the Agreement described below (the “Exiting Originator”);
iii.THE VARIOUS PARTIES LISTED ON THE SIGNATURE PAGES HERETO AS REMAINING ORIGINATORS, as remaining Originators (collectively, the “Remaining Originators” and each, a “Remaining Originator”, and together with the Exiting Originator, the “Originators”); and
iv.DXC RECEIVABLES LLC (F/K/A CSC RECEIVABLES LLC), as Buyer under the Agreement described below (the “Buyer”).
Capitalized terms used but not otherwise defined herein (including such terms used above) have the respective meanings assigned thereto in the Agreement described below.
BACKGROUND
A.The Originators, the Servicer and the Buyer entered into that certain Purchase and Sale Agreement, dated as of December 21, 2016 (as amended, restated, supplemented or otherwise modified through the date hereof, the “Agreement”).
B.Concurrently herewith, the Servicer, the Buyer, as seller, the Committed Purchasers, the Group Agents and the Administrative Agent are entering into that certain Tenth Amendment to the Receivables Purchase Agreement, dated as of the date hereof (the “Receivables Purchase Agreement Amendment”).
C.The Exiting Originator desires to no longer be party to the Agreement as an Originator thereunder on the Sixth Amendment Effective Date.
D.The parties hereto desire to amend the Agreement as set forth herein.
NOW, THEREFORE, with the intention of being legally bound hereby, and in consideration of the mutual undertakings expressed herein, each party to this Amendment hereby agrees as follows:
1

SECTION 1.Amendments to the Agreement. The Agreement is hereby amended as follows:
(a)Schedule I of the Agreement is hereby replaced in its entirety with the schedule attached hereto as Schedule I.
(b)Schedule II of the Agreement is hereby replaced in its entirety with the schedule attached hereto as Schedule II.
(c)Schedule III of the Agreement is hereby replaced in its entirety with the schedule attached hereto as Schedule III.
SECTION 2.Release of Exiting Originator. The parties hereto hereby agree that upon the effectiveness of this Amendment, the Exiting Originator shall no longer be a party to the Agreement or any other Transaction Document and shall no longer have any obligations or rights thereunder (other than such obligations which by their express terms survive termination of the Agreement or such other Transaction Document).
SECTION 3.Delegation and Assumption of Exiting Originator’s Obligations. Effective immediately prior to the removal of the Exiting Originator as a party to the Agreement pursuant to Section 2 above, the Exiting Originator hereby delegates to the Remaining Originators, and the Remaining Originators hereby assume all of the Exiting Originator’s duties, obligations and liabilities, to the extent if any, under the Agreement and each of the other Transaction Documents.
SECTION 4.Cancellation of Subordinated Notes. The Exiting Originator represents and warrants to the other parties hereto that it (a) currently holds the Subordinated Note made by the Buyer to the Exiting Originator (the “Exiting Originator Note”) and (b) has not sold, pledged, assigned, or otherwise transferred the Exiting Originator Note or any interest therein. The Exiting Originator acknowledges and agrees that all the Buyer’s outstanding obligations (including, without limitation, any payment obligations) under the Exiting Originator Note have been finally and fully paid and performed on or prior to the Sixth Amendment Effective Date. The Exiting Originator Note is hereby cancelled and shall have no further force or effect.
SECTION 5.Representations and Warranties of the Remaining Originators. The Remaining Originators hereby represent and warrant to each of the parties hereto as of the date hereof as follows:
i.Representations and Warranties. The representations and warranties made by such Person in the Agreement and each of the other Transaction Documents to which it is a party are true and correct as of the date hereof (unless such representations or warranties relate to an earlier date, in which case as of such earlier date).
ii.Enforceability. The execution and delivery by it of this Amendment, and the performance of its obligations under this Amendment, the Agreement (as amended hereby) and the other Transaction Documents to which it is a party are within its organizational powers and
2


have been duly authorized by all necessary action on its part, and this Amendment, the Agreement (as amended hereby) and the other Transaction Documents to which it is a party are (assuming due authorization and execution by the other parties thereto) its valid and legally binding obligations, enforceable in accordance with its terms, except (x) the enforceability thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws from time to time in effect relating to creditors’ rights, and (y) the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.
iii.No Event of Default; No Purchase and Sale Termination Event. No Event of Termination, Unmatured Event of Termination, Non-Reinvestment Event, Unmatured Non-Reinvestment Event, Purchase and Sale Termination Event or Unmatured Purchase and Sale Termination Event has occurred and is continuing, or would occur as a result of this Amendment or the transactions contemplated hereby.
SECTION 6.Effect of Amendment; Ratification. All provisions of the Agreement and the other Transaction Documents, as expressly amended and modified by this Amendment, shall remain in full force and effect. After this Amendment becomes effective, all references in the Agreement (or in any other Transaction Document) to “this Purchase and Sale Agreement”, “this Agreement”, “hereof”, “herein” or words of similar effect referring to the Agreement shall be deemed to be references to the Agreement as amended by this Amendment. This Amendment shall not be deemed, either expressly or impliedly, to waive, amend or supplement any provision of the Agreement other than as set forth herein. The Agreement, as amended by this Amendment, is hereby ratified and confirmed in all respects.
SECTION 7.Effectiveness. This Amendment shall become effective as of the Sixth Amendment Effective Date upon (a) receipt by the Buyer and the Administrative Agent’s receipt of counterparts to this Amendment executed by each of the parties hereto, and (b) the effectiveness of the Receivables Purchase Agreement Amendment.
SECTION 8.Severability. Any provisions of this Amendment which are prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.
SECTION 9.Transaction Document. This Amendment shall be a Transaction Document for purposes of the Receivables Purchase Agreement.
SECTION 10.Counterparts. This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute but one and the same instrument. Delivery of an executed counterpart of a signature page to this Amendment by facsimile or e-mail transmission shall be effective as delivery of a manually executed counterpart hereof.
3


SECTION 11.GOVERNING LAW AND JURISDICTION.
iv.THIS AMENDMENT, INCLUDING THE RIGHTS AND DUTIES OF THE PARTIES HERETO, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT WITHOUT REGARD TO ANY OTHER CONFLICTS OF LAW PROVISIONS THEREOF).
v.EACH PARTY HERETO HEREBY IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF ANY NEW YORK STATE OR FEDERAL COURT SITTING IN NEW YORK CITY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AMENDMENT, AND EACH PARTY HERETO HEREBY IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN SUCH NEW YORK STATE COURT OR, TO THE EXTENT PERMITTED BY LAW, IN SUCH FEDERAL COURT. THE PARTIES HERETO HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT THEY MAY EFFECTIVELY DO SO, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING. THE PARTIES HERETO AGREE THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW.
SECTION 12.Section Headings. The various headings of this Amendment are included for convenience only and shall not affect the meaning or interpretation of this Amendment, the Agreement or any provision hereof or thereof.

[Signature Pages Follow]

4


IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first written above.
DXC RECEIVABLES LLC,
as Buyer


By:_/s/ H. C. Charles Diao____________________
    Name: H. C. Charles Diao
    Title: President and Treasurer


DXC TECHNOLOGY COMPANY,
as Servicer


By:_/s/ H. C. Charles Diao____________________
    Name: H. C. Charles Diao
    Title: Senior Vice President, Treasury and
Corporate Development


DXC TECHNOLOGY SERVICES LLC,
as a Remaining Originator


By:_/s/ H. C. Charles Diao____________________
    Name: H. C. Charles Diao
    Title: President and Treasurer


5



ALLIANCE-ONE SERVICES, INC.,
as a Remaining Originator


By:_/s/ Phillip Charles Ratcliff_________________
    Name: Phillip Charles Ratcliff
    Title: President


COMPUTER SCIENCES CORPORATION,
as a Remaining Originator


By:_/s/ H. C. Charles Diao____________________
    Name: H. C. Charles Diao
    Title: President and Treasurer


CSC CONSULTING, INC.,
as a Remaining Originator


By:_/s/ H. C. Charles Diao____________________
    Name: H. C. Charles Diao
    Title: President and Treasurer


CSC CYBERTEK CORPORATION,
as a Remaining Originator


By:_/s/ H. C. Charles Diao____________________
    Name: H. C. Charles Diao
                            Title: President and Treasurer
6


MYND CORPORATION,
as a Remaining Originator


By:_/s/ H. C. Charles Diao____________________
    Name: H. C. Charles Diao
    Title: President and Treasurer


CSC PUERTO RICO, LLC,
as a Remaining Originator


By:_/s/ H. C. Charles Diao____________________
    Name: H. C. Charles Diao
    Title: President and Treasurer



CSC COVANSYS CORPORATION,
as a Remaining Originator


By:_/s/ H. C. Charles Diao____________________
    Name: H. C. Charles Diao
    Title: President and Treasurer


TRIBRIDGE HOLDINGS, LLC,
as a Remaining Originator


By:_/s/ H. C. Charles Diao____________________
    Name: H. C. Charles Diao
    Title: President and Treasurer

7




PDA SOFTWARE SERVICES LLC,
as an Exiting Originator


By:_/s/ H. C. Charles Diao____________________
    Name: H. C. Charles Diao
    Title: President and Treasurer






8


Acknowledged by:
PNC BANK, NATIONAL ASSOCIATION
as Administrative Agent
By: /s/ Christopher Blaney____________
Name: Christopher Blaney
Title: Senior Vice President

9


Schedule I

LIST AND LOCATION OF EACH ORIGINATOR
10



Schedule II

LOCATION OF BOOKS AND RECORDS OF ORIGINATORS



11



Schedule III
TRADE NAMES


12

Exhibit 10.3
SEPARATION AGREEMENT
This Separation Agreement (this “Agreement”) is made and entered into as of October 2, 2020 (the “Effective Date”), by and between DXC Technology Company, a Nevada corporation (including any subsidiaries and affiliates, the “Company”), and Paul Saleh, a Virginia resident (“you”). For certain good and valuable consideration, the receipt, adequacy and legal sufficiency of which are hereby acknowledged, you and the Company, intending to be legally bound, hereby agree as follows:
1.Introduction. You acknowledge and agree that you hereby resign as the Chief Financial Officer and that your employment with the Company will terminate immediately as of close of business on October 1, 2020 (the “Separation Date”).
2.Cooperation. You shall reasonably cooperate with and assist the Company with any pending or future litigation, arbitration (including, without limitation, the Perspecta arbitration), internal or external investigation (including, without limitation, by any governmental body) or inquiry related to the Company. This cooperation shall include, without limitation, responding to requests for information concerning facts or events relating to the Company that may be within your knowledge; providing assistance to the Company’s counsel, experts, and consultants; and providing truthful testimony in pretrial and trial or hearing proceedings. This cooperation will also include providing timely notice to the Company as to any subpoenas or other compulsory process related to the Company or facts, documents, or information gained during your employment with the Company so that the Company may intervene and object if appropriate. The parties agree to work in good faith to ensure cooperation is for a reasonable amount of time necessary to achieve the above and to provide notice and scheduling in a reasonable manner, taking into consideration your then current business, employment and personal commitments. You will be reimbursed by the Company for your reasonable out-of-pocket expenses supported by receipts or other reasonable documentation, including reasonable attorneys’ fees if you and the Company mutually agree in good faith that you need legal advice to cooperate and the Company’s counsel would have a conflict of interest in representing you. You shall not be required to travel during the COVID-19 pandemic.
3.Restrictive Covenants. You acknowledge and agree that you are subject to, and shall fully comply with, the terms of the Non-Competition/Non-Solicitation Agreement between you and the Company (or its predecessors or subsidiaries as the case may be) dated May 10, 2012, and all restrictive covenants set forth in any equity award or other agreement between you and the Company and its subsidiaries (the “Restrictive Covenants”). For the avoidance of doubt, notwithstanding anything to the contrary herein, the Restrictive Covenants will remain in effect in accordance with their terms.

US-DOCS\117986909.5

4.Non-Disparagement. You agree not to disparage the Company, and similarly the Company agrees it shall not disparage you in any official announcement or press release and shall direct its executive officers not to disparage you, in each case other than in truthful testimony given in response to a lawful subpoena or similar court or government order or to enforce the terms of this Agreement.
5.Compensation. In consideration of your representations, warranties and covenants set forth in Section 6 and your signing and not revoking the Release (defined below), and subject to your compliance with your obligations hereunder, including without limitation your obligations under Sections 2, 3, 4, and 6 herein, the Company shall:
(a)Pay you a cash lump sum in the amount of $4,000,000, less estimated applicable deductions and withholdings, immediately following your execution of this Separation Agreement and the Release; provided, however, that if you revoke the Release in accordance with its terms you must immediately return this amount; and
(b)Not pay you any amount pursuant to that certain retention agreement entered into by you and the Company dated September 23, 2019 (the “Retention Agreement”).
The compensation described in this Section 5 shall be the sole consideration paid by the Company and its subsidiaries and affiliates to you following the Separation Date; for the avoidance of doubt, you expressly agree that you are not entitled to and waive any other payments, benefits or compensatory entitlements in connection with or as of your Separation Date, including continued equity vesting as of, or following the Separation Date, and any and all severance, retention, separation payments or similar compensation under the Severance Plan for Senior Management and Key Employees and the Retention Agreement or any other Company plan, agreement, or arrangement. It shall be a condition to your right to receive the amounts provided in this Section 5, that you execute and deliver to the Company the “General Release of Paul Saleh” attached hereto as Exhibit A (the “Release”) within 21 days following the Effective Date and that you not revoke the Release in accordance with its terms.
6.Representations, Warranties and Covenants. You represent and warrant that (a) you have all necessary legal capacity to execute and deliver this Agreement and to perform your obligations hereunder; (b) this Agreement has been executed and delivered by you, constitutes a legal, valid and binding obligation, and is enforceable against you in accordance with its terms; (c) you have had an opportunity to consult with counsel of your choosing with respect to this Agreement and all of the terms and provisions hereof; (d) you are not aware of any dispute, or facts that could give rise to any dispute, between Gainwell Technologies LLC and the Company; (e) you are entering into this Agreement voluntarily and with complete knowledge as to the terms and provisions set forth herein. Additionally, you agree that you will fully and completely recuse yourself from participation in any dispute or potential dispute arising between Gainwell Technologies LLC and the Company. For the avoidance of doubt, such recusal shall, without limitation, prohibit you from participating in or contributing to in any discussion or decision regarding any dispute or potential dispute between Gainwell Technologies LLC and the Company (unless the Company consents in writing to your participation in such a discussion), and from sharing information related to the Company obtained during your employment at the

2


Company with Gainwell Technologies LLC (or its employees, agents, attorneys and advisors) in connection with any such dispute or potential dispute.
7.Clawback. The Company shall have the right to clawback the net after-tax value of all compensation paid pursuant to Sections 5(a) and (b) herein upon the occurrence of:
(a)A breach by you of any of the Restrictive Covenants, as described in Section 3 herein; or
(b)A breach by you of Sections 2, 4 or 6 of the Agreement.
8.General Provisions.
(a)Entire Agreement. This Agreement supersedes all prior negotiations, understandings, agreements, representations, warranties, and courses of conduct and dealing, whether written or oral, between the parties with respect to its subject matter. This Agreement constitutes a complete and exclusive statement of the terms and conditions of the agreement between the parties with respect to its subject matter. This Agreement is not a contract of employment between you and the Company, and you and the Company hereby agree and acknowledge that this Agreement does not impose any obligation on the Company to offer employment to you at any time.
(b)Notices. All notices, consents, waivers and other communications required or permitted by this Agreement shall be in writing and shall be deemed given to a party when (1) delivered to the appropriate address by hand or by nationally recognized overnight courier service (costs prepaid), (2) sent by e-mail with confirmation of transmission by the transmitting equipment, or (3) received or rejected by the addressee, if sent by certified mail, return receipt requested, in each case to the following addresses, or e-mail addresses and marked to the attention of the person (by name or title) designated below, or to such other address, e-mail address or person as a party may designate by notice to the other party:
Company: DXC Technology Company
Address: 1775 Tysons Boulevard
Tysons, Va 22102
Attn: Bill Deckelman
Telephone: +1 (703) 245-4585
E-mail: bill.deckelman@dxc.com
You: Paul Saleh
                                                        
                                                        
Telephone:
E-mail:


3


(c)Enforcement of Agreement. You acknowledge and agree that the Company would be irreparably damaged if you do not perform or comply with any provision of this Agreement in accordance with its specific terms, and that the Company could not be adequately compensated for any Breach of this Agreement by you by monetary damages alone in all cases. Accordingly, in addition to any other right or remedy to which the Company may be entitled, at law or in equity, the Company shall be entitled to enforce any provision of this Agreement by a decree of specific performance and to temporary, preliminary and permanent injunctive relief to prevent any breach or threatened breach of this Agreement by you, without posting any bond or other undertaking.
(d)Remedies Cumulative. The rights and remedies of the parties to this Agreement are cumulative and not alternative. Neither any failure nor any delay by any party in exercising any right, power or privilege under this Agreement shall operate as a waiver of such right, power or privilege, and no single or partial exercise of any such right, power or privilege shall preclude any other or further exercise of such right, power or privilege or the exercise of any other right, power or privilege.
(e)Waiver. To the maximum extent permitted by applicable law, no claim or right arising from this Agreement can be discharged by a party, in whole or in part, by a waiver of the claim or right unless such waiver is in writing and is signed by the waiving party, and no waiver that may be given by a party shall be applicable except in the specific instance for which it is given.
(f)Amendment. This Agreement may not be amended, supplemented, or otherwise modified except by a written agreement executed by all of the parties.
(g)Assignment; Successors. This Agreement is personal to you and, therefore, you may not assign this Agreement or any of his rights or obligations hereunder to any person or entity. The Company may assign this Agreement and its rights and obligations hereunder to any person or entity, without your consent, in which event this Agreement shall apply to, be binding in all respects upon, and inure to the benefit of the successors and assignees of the Company.
(h)Severability. If a court of competent jurisdiction holds that any provision of this Agreement or portion thereof is illegal, invalid or unenforceable, then such provision shall be modified automatically to the extent necessary to make such provision fully legal, valid or enforceable. If such court does not modify any such provision or portion thereof as contemplated herein, but instead declares it to be wholly illegal, invalid or unenforceable, then such provision or portion thereof shall be severed from this Agreement, this Agreement and the rights and obligations of the parties shall be construed as if this Agreement did not contain such severed provision or portion thereof, and this Agreement otherwise shall remain in full force and effect.
(i)Construction. The headings of sections in this Agreement are provided for convenience only and shall not affect its construction or interpretation.

4


(j)Governing Law. This Agreement shall be governed by, construed under, and enforced in accordance with the laws of the Commonwealth of Virginia in effect from time to time without regard to conflicts-of-laws principles that would require the application of any other law.
(k)Execution of Agreement. This Agreement may be executed in one or more counterparts, each of which will be deemed to be an original copy of this Agreement and all of which, when taken together, will be deemed to constitute one and the same agreement. The exchange of copies of this Agreement and of signature pages by electronic transmission shall constitute effective execution and delivery of this Agreement as to the parties and may be used in lieu of the original Agreement for all purposes. Signatures of the parties transmitted electronically shall be deemed to be their original signatures for all purposes.
(l)Authority. You hereby acknowledge and agree that, you shall have no right or authority to enter into any agreements or other arrangements in the name or on behalf of the Company, or to assume or create any obligation or liability of any kind whatsoever, express or implied, in the name or on behalf of the Company.
(m)Arbitration and Equitable Remedies. Any dispute or controversy arising under, out of, in connection with or in relation to this Agreement and your services to the Company or termination by the Company shall be finally determined and settled by arbitration in Tyson, Virginia in accordance with the rules and procedures of the JAMS/Endispute Arbitration Rules and Procedures for Employment Disputes, and judgment upon the award may be entered in any court having jurisdiction thereof. Notwithstanding the foregoing, you acknowledge and agree that it would be impossible or inadequate to measure and calculate the Company’s damages from any breach of the covenants or other obligations set forth in Sections 2, 3, 4 and 6 herein. Accordingly, you agree that if you breach any such Section, the Company will have available, in addition to any other right or remedy available, the right to obtain an injunction from a court of competent jurisdiction restraining such breach or threatened breach and to specific performance of any such provision of this agreement. You further agree that no bond or other security shall be required in obtaining such equitable relief and that you consent to the issuance of such injunction and to the ordering of specific performance.
[signature page follows]
IN WITNESS WHEREOF, this Agreement is executed and delivered by the parties on the date first set forth above.

5


COMPANY:

DXC Technology Company


By:     
Name:     
Title:     


    
Paul Saleh

Exhibit A

6



General Release of Paul Saleh

1.    In connection with your termination of employment as described in that certain Separation Agreement dated October 2, 2020 between Paul Saleh (“you”) and DXC Technology Company (“DXC”) (the “Separation Agreement”), on behalf of yourself, your agents, heirs, successors, legal representatives and assigns, you hereby knowingly and voluntarily, irrevocably and unconditionally, release and forever discharge DXC and its current and/or former predecessors, successors, parents, subsidiaries (including Computer Sciences Corporation), assigns, affiliates, and representatives and all of its and their officers, agents, directors, employees, representatives, and all persons acting by, through, under, or in concert with any of them (collectively the “Releasees”) from any and all actions, causes of action, suits, debts, charges, complaints, claims, liabilities, obligations, promises, agreements, controversies, damages, and expenses, including attorney fees, of any nature whatsoever, in law or in equity, known or unknown, suspected or unsuspected (hereinafter referred to as “Claim” or “Claims”) which you at any time had or claimed to have against any Releasees or which you may have or claim to have regarding events that have occurred as of the date you sign this release, including, without limitation, any and all Claims related or in any manner incidental to your employment or other services to DXC, or the events preceding and/or leading to your employment and the termination of said employment relationship. You expressly waive any and all rights under any applicable statute or principle of law restricting the right to release claims that you do not know or suspect to exist at the time of executing a release, which claims, if known, may have materially affected your decision to give such release. You acknowledge that you may hereafter discover claims currently unknown or unsuspected, or facts in addition to or different from those that are now believed to be true with respect to the matters released herein. Nevertheless, it is your intention that this release settles each and every claim, dispute and controversy, known or unknown, fixed or contingent that you have or may have against the Releasees, including, but not limited to any claims arising under federal, state or local statute, rule, executive order, law or ordinance, tort, express or implied contract, public policy or other obligations. All of your releases herein should be construed broadly to the maximum extent permissible under applicable law. It is expressly understood by you that among the various rights and claims being waived by you in this release are those arising under the Age Discrimination in Employment Act.

Specifically, but not by way of limitation, you release the Releasees from, and covenant not to sue Releasees for, any and all Claims, including without limitation (i) Claims which are or may be related to any employment or other service relationship, including for the avoidance of doubt, any claim to other payments, benefits or compensatory entitlements in connection with or as of your Separation Date (as defined in the Separation Agreement), including continued equity vesting as of or following the Separation Date, and any and all severance, retention, separation payments or similar compensation under the Severance Plan for Senior Management and Key Employees and the Retention Agreement or any other Company plan, agreement, or arrangement; (ii) Claims arising under any federal or state fair employment practices act, anti-discrimination law, and/or any law, ordinance, or regulation promulgated by any county, municipality, or other state subdivision (including, without limitation, the Age Discrimination in Employment Act, 29 U.S.C. §§621, et seq; Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. §§2000e, et seq.; 42 U.S.C. §1981; the Employee Retirement Income Security Act, 29 U.S.C. §§1001, et seq.; the Family and Medical Leave Act, 29 U.S.C. §§2601 et seq.; the Americans With Disabilities Act of 1990 as amended, 42 U.S.C. §§126, et seq; (iii) Claims for breach of duty and/or implied covenant of good faith and fair dealing; (iv) Claims for interference with and/or breach of contract (express or implied, in fact or in law, oral or written); (v)

7


Claims for retaliatory, constructive, or wrongful discharge of any kind; (vi) Claims for intentional or negligent infliction of emotional distress or mental anguish; (vii) Claims for breach of duty, fraud, fraudulent inducement, fraudulent concealment, misrepresentation, deceit, breach of or invasion of right of privacy, libel, slander, defamation, or tortuous conduct of any kind; (viii) any and all other Claims arising under law or in equity; and (xi) any and all other Claims asserted or which could have been asserted by you.
Nothing contained in this release is a waiver of any rights or claims (including any which may arise under the Age Discrimination in Employment Act) that may arise after the date of execution by you or which, as a matter of law, cannot be released. Further, nothing in this release prevents you from filing a lawsuit limited to challenging the validity of your waiver of the Age Discrimination in Employment Act and the Older Workers Benefit Protection Act, or from filing claims with government agencies as provided in the paragraph below. Nothing in this release waives any rights to enforce this release.

Nothing in this release, including the release of claims clauses, restricts or prohibits you from initiating communications directly with, responding to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority or a government agency or entity, including the U.S. Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General (collectively, the "Regulators"), or from making other disclosures that are protected under the whistleblower provisions of state or federal law or regulation. However, to the maximum extent permitted by law, you are waiving your right to receive any individual monetary relief from DXC or any other Releasees covered by the release resulting from such claims or conduct, regardless of whether you or another party has filed them, and in the event you obtain such monetary relief DXC or the Releasees will be entitled to an offset for the payments made pursuant to the Separation Agreement. This does not limit your right to receive an award from any Regulator that provides awards for providing information relating to a potential violation of law. You do not need the prior authorization of DXC to engage in conduct protected by this paragraph, and you do not need to notify DXC that you have engaged in such conduct. Please take notice that federal law provides criminal and civil immunity to federal and state claims for trade secret misappropriation to individuals who disclose a trade secret to their attorney, a court, or a government official in certain, confidential circumstances that are set forth at 18 U.S.C. §§ 1833(b)(1) and 1833(b)(2), related to the reporting or investigation of a suspected violation of the law, or in connection with a lawsuit for retaliation for reporting a suspected violation of the law. In addition, you recognize and agree that, in connection with any such activity outlined above, you must inform the Regulators, your attorney, a court or a government official that the information you are providing is confidential. Despite the foregoing, you are not permitted to reveal to any third-party, including any governmental, law enforcement, or regulatory authority, information you came to learn during the course of your employment with DXC that is protected from disclosure by any applicable privilege, including but not limited to the attorney client privilege and/or attorney work product doctrine. DXC does not waive any applicable privileges or the right to continue to protect its privileged attorney-client information, attorney work product, and other privileged information.

2.    Neither this release nor any consideration given hereunder constitutes an admission nor is to be construed as an admission of liability of any kind on the part of DXC or Releasees, and in fact the Parties expressly deny any violation of any law.

8


3.    You agree and acknowledge that you have returned all originals and copies of DXC documents and all DXC property, including without limitation, computer files, database information, client information, telephones, computers, badges, and keys no later than the Separation Date (as defined in the Separation Agreement). You also reaffirm and agree to comply with your post-employment obligations under any confidentiality agreement, non-competition/non-solicitation agreement, the post-employment provisions in your equity agreements, the Separation Agreement and other such agreements with DXC and any predecessors, subsidiaries or assigns.
4.    With respect to your execution of this release, you agree and covenant that:
a.You have carefully reviewed this release and that all questions concerning it have been answered to your satisfaction. You affirm that this release is written in a manner you understand, and that the consideration set forth in the Separation Agreement is sufficient for your entering into this release and consists of benefits to which you are not otherwise entitled.
b.Prior to execution of this release, you were and hereby are advised and encouraged to consult with and review it with your attorney(s) and have in fact done so to the extent desired, and that, also prior to its execution, you were encouraged and afforded the opportunity to review it with anyone else you desired.
c.You further acknowledge and agree that you were informed that you have twenty-one (21) days to consider and reflect upon the terms of this release, and that any changes to this release subsequently agreed upon by the parties do not restart this period for consideration; that you knowingly and voluntarily executed it after deliberate consideration of its terms; and that you were not coerced, pressured, or forced in any way to accept the terms of this release.
d.You also acknowledge a complete understanding that you may be giving up certain legal rights by entering into this release and that you have seven (7) days to revoke this release following its execution by sending notice of revocation by certified mail, return receipt requested, or by Federal Express, to Mary Finch, 1775 Tysons Boulevard McLean Virginia 22102, with a confirmation email to Mary Finch at mary.finch@dxc.com.
e.If you revoke this release, it shall not be effective or enforceable and you will not receive the consideration described in Section 5 of the Separation Agreement. Moreover, you further agree that in the event you attempt to revoke or rescind this release you shall immediately return to and/or reimburse DXC for all of the benefits described above and that the return to and/or reimbursement is a contractual prerequisite to any administrative or legal action brought or sought by you.
f.If you do not revoke this release within seven (7) days of signing it, then this release becomes final, binding and effective on the eighth (8th) day after you sign it.
5.    This release supersedes any and all prior oral and/or written agreements between you and DXC and any predecessors, subsidiaries and affiliates regarding the subject matter described herein, and along with the Separation Agreement, sets forth the entire agreement regarding the subject matter described herein; provided, however, for purposes of clarification, this release does not supersede or eliminate any post-employment obligations you may have to DXC or their predecessors and successors, including but not limited to those arising from any confidentiality agreement or non-competition/non-

9


solicitation agreement, post-employment provisions in any equity agreements, the Separation Agreement and other such agreements. No modifications hereof shall be deemed valid unless reduced to writing and signed by the parties. The parties agree that the rule of construction that ambiguities are resolved against the drafting party will be subordinated to the principle that the terms of this release will be construed fairly as to all parties and not in favor of or against any party. Any failure or delay on the part of either party to exercise any remedy or right under this release shall not operate as a waiver.
6.    This release shall be governed and construed in accordance with the laws of the Commonwealth of Virginia. Any action arising out of or relating to any of the provisions of this release may, at the election of either party, be brought and prosecuted only in the courts of, or located in, the Commonwealth of Virginia, and in the event of such election, the parties hereto consent to the jurisdiction and venue of said courts. The terms of this release are severable, and if for any reason any part hereof shall be found to be unenforceable the remaining terms and conditions shall be enforced in full.

* * * * *

IN WITNESS WHEREOF, and intending to be legally bound, the undersigned has executed the foregoing on the date set forth below.


By:____________________________     Date:_______________________________
Paul Saleh


10


Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, Michael J. Salvino, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of DXC Technology Company;
 
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
         
 Date:   November 5, 2020     /s/ Michael J. Salvino
        Michael J. Salvino President and Chief Executive Officer


Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, Neil A. Manna, certify that:
 
1.I have reviewed this Quarterly Report on Form 10-Q of DXC Technology Company;
 
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. 
         
 Date:   November 5, 2020     /s/ Neil A. Manna
        Neil A. Manna
Interim CFO, Senior Vice President, Corporate Controller Principal Accounting Officer


Exhibit 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Michael J. Salvino, President and Chief Executive Officer of DXC Technology Company (the "Company"), hereby certify that, to my knowledge:
 
(1)The Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020, (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
 
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Dated: November 5, 2020   /s/ Michael J. Salvino
    Michael J. Salvino
President and Chief Executive Officer





Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
 
 
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Neil A. Manna, Interim CFO, Senior Vice President, Corporate Controller and Principal Accounting Officer of DXC Technology Company (the "Company"), hereby certify that, to my knowledge:

(1)The Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020, (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
     
Dated: November 5, 2020   /s/ Neil A. Manna
    Neil A. Manna
Interim CFO, Senior Vice President, Corporate Controller Principal Accounting Officer